<SEC-DOCUMENT>0001193805-20-001546.txt : 20201216
<SEC-HEADER>0001193805-20-001546.hdr.sgml : 20201216
<ACCEPTANCE-DATETIME>20201216163717
ACCESSION NUMBER:		0001193805-20-001546
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		16
CONFORMED PERIOD OF REPORT:	20201216
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Material Modifications to Rights of Security Holders
ITEM INFORMATION:		Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20201216
DATE AS OF CHANGE:		20201216

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ADMA BIOLOGICS, INC.
		CENTRAL INDEX KEY:			0001368514
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				562590442
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36728
		FILM NUMBER:		201392850

	BUSINESS ADDRESS:	
		STREET 1:		C/O ADMA BIOLOGICS, INC.
		STREET 2:		465 STATE ROUTE 17
		CITY:			RAMSEY
		STATE:			NJ
		ZIP:			07446
		BUSINESS PHONE:		(201) 478-5552

	MAIL ADDRESS:	
		STREET 1:		C/O ADMA BIOLOGICS, INC.
		STREET 2:		465 STATE ROUTE 17
		CITY:			RAMSEY
		STATE:			NJ
		ZIP:			07446

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	R&R ACQUISITION VI, INC
		DATE OF NAME CHANGE:	20060707
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>e620138_8k-adma.htm
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:us-roles="http://fasb.org/us-roles/2020-01-31" xmlns:country="http://xbrl.sec.gov/country/2020-01-31" xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:ADMA="http://admabiologics.com/20201216">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_029_US%2DGAAP%2D2020 -->
<!-- Field: Set; Name: xdx; ID: xdx_030_ADMA_admabiologics.com_20201216 -->
<!-- Field: Set; Name: xdx; ID: xdx_04F_20201216_20201216 -->
<!-- Field: Set; Name: xdx; ID: xdx_05D_edei%2D%2DEntityCentralIndexKey_0001368514 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_051_edei%2D%2DCurrentFiscalYearEndDate_%2D%2DLS0xMi0zMQ== -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
  <ix:hidden>
    <ix:nonNumeric contextRef="From2020-12-16to2020-12-16" name="dei:EntityCentralIndexKey">0001368514</ix:nonNumeric>
    <ix:nonNumeric contextRef="From2020-12-16to2020-12-16" format="ixt:booleanfalse" name="dei:AmendmentFlag">false</ix:nonNumeric>
    <ix:nonNumeric contextRef="From2020-12-16to2020-12-16" name="dei:CurrentFiscalYearEndDate">--12-31</ix:nonNumeric>
    </ix:hidden>
  <ix:references>
    <link:schemaRef xlink:href="adma-20201216.xsd" xlink:type="simple" />
    </ix:references>
  <ix:resources>
    <xbrli:context id="From2020-12-16to2020-12-16">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001368514</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-12-16</xbrli:startDate>
        <xbrli:endDate>2020-12-16</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    </ix:resources>
  </ix:header>
</div>


<p style="margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>UNITED STATES </b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SECURITIES AND EXCHANGE COMMISSION </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>WASHINGTON, D.C. 20549</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FORM <span id="xdx_903_edei--DocumentType_c20201216__20201216_zr7z094Qygld"><ix:nonNumeric contextRef="From2020-12-16to2020-12-16" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b></b>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CURRENT REPORT </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Pursuant to Section 13 or 15(d) </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>of the Securities Exchange Act of 1934</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Date of Report (Date of earliest event
reported): <span style="font-size: 10pt"><span id="xdx_90D_edei--DocumentPeriodEndDate_c20201216__20201216_zybGuTbe39ha"><ix:nonNumeric contextRef="From2020-12-16to2020-12-16" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate">December 16, 2020</ix:nonNumeric></span></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_908_edei--EntityRegistrantName_c20201216__20201216_zL6gafFIVtfk"><ix:nonNumeric contextRef="From2020-12-16to2020-12-16" name="dei:EntityRegistrantName">ADMA BIOLOGICS, INC.</ix:nonNumeric></span> </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Exact Name of Registrant as Specified
in its Charter) </b></p>

<table cellspacing="0" cellpadding="0" style="font-size: 10pt; width: 100%; border-collapse: collapse">
<tr>
    <td style="width: 30%">&#160;</td>
    <td style="vertical-align: bottom; width: 2%">&#160;</td>
    <td style="width: 30%">&#160;</td>
    <td style="vertical-align: bottom; width: 2%">&#160;</td>
    <td style="width: 30%">&#160;</td></tr>
<tr>
    <td style="vertical-align: top; font-size: 10pt; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_901_edei--EntityIncorporationStateCountryCode_c20201216__20201216_zjOhcCyZKdw3"><ix:nonNumeric contextRef="From2020-12-16to2020-12-16" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></b></span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; font-size: 10pt; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_90D_edei--EntityFileNumber_c20201216__20201216_zZad2kx8iNhc"><ix:nonNumeric contextRef="From2020-12-16to2020-12-16" name="dei:EntityFileNumber">001-36728</ix:nonNumeric></span></b></span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; font-size: 10pt; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_90F_edei--EntityTaxIdentificationNumber_c20201216__20201216_zLxKcTJQGDnd"><ix:nonNumeric contextRef="From2020-12-16to2020-12-16" name="dei:EntityTaxIdentificationNumber">56-2590442</ix:nonNumeric></span></b></span></td></tr>
<tr>
    <td style="vertical-align: top">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(State or Other Juris-</b></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>diction of Incorporation)</b></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Commission</b></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>File Number)</b></p></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(IRS Employer</b></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Identification No.)</b></p></td></tr>
<tr>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top">&#160;</td></tr>
</table>
<table cellspacing="0" cellpadding="0" style="font-size: 10pt; width: 100%; border-collapse: collapse">
<tr>
    <td style="width: 45%">&#160;</td>
    <td style="vertical-align: bottom; width: 2%">&#160;</td>
    <td style="width: 45%">&#160;</td></tr>
<tr>
    <td style="vertical-align: top">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_909_edei--EntityAddressAddressLine1_c20201216__20201216_ztEV6kHzigke"><ix:nonNumeric contextRef="From2020-12-16to2020-12-16" name="dei:EntityAddressAddressLine1">465 State Route 17</ix:nonNumeric></span></b></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_901_edei--EntityAddressCityOrTown_c20201216__20201216_z9ymiwiHEFJ8"><ix:nonNumeric contextRef="From2020-12-16to2020-12-16" name="dei:EntityAddressCityOrTown">Ramsey</ix:nonNumeric></span>, <span id="xdx_907_edei--EntityAddressStateOrProvince_c20201216__20201216_zrjCMo5UPbw1"><ix:nonNumeric contextRef="From2020-12-16to2020-12-16" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince">New Jersey</ix:nonNumeric></span></b></p></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom; font-size: 10pt; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_902_edei--EntityAddressPostalZipCode_c20201216__20201216_zXKhqHc7U0Z8"><ix:nonNumeric contextRef="From2020-12-16to2020-12-16" name="dei:EntityAddressPostalZipCode">07446</ix:nonNumeric></span></b></span></td></tr>
<tr>
    <td style="vertical-align: top; font-size: 10pt; text-align: center"><span style="font-size: 10pt"><b>(Address of Principal Executive Offices)</b></span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; font-size: 10pt; text-align: center"><span style="font-size: 10pt"><b>(Zip Code)</b></span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Registrant&#8217;s telephone number,
including area code: <span id="xdx_90A_edei--CityAreaCode_c20201216__20201216_z9v2kWWCXP63"><ix:nonNumeric contextRef="From2020-12-16to2020-12-16" name="dei:CityAreaCode">(201)</ix:nonNumeric></span> <span id="xdx_903_edei--LocalPhoneNumber_c20201216__20201216_zk25ktVBdjL2"><ix:nonNumeric contextRef="From2020-12-16to2020-12-16" name="dei:LocalPhoneNumber">478-5552</ix:nonNumeric></span> </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_90B_edei--EntityInformationFormerLegalOrRegisteredName_c20201216__20201216_zAIHa2pf6MT"><ix:nonNumeric contextRef="From2020-12-16to2020-12-16" name="dei:EntityInformationFormerLegalOrRegisteredName">Not Applicable</ix:nonNumeric> </span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Former Name or Former Address, if Changed
Since Last Report) </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (<i>see</i> General Instruction
A.2. below):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font-size: 10pt; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 4%; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_901_edei--WrittenCommunications_c20201216__20201216_zXrExp0IFAsi"><ix:nonNumeric contextRef="From2020-12-16to2020-12-16" format="ixt:booleanfalse" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font-size: 10pt"><span style="font-size: 10pt">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) </span></td></tr>
<tr style="vertical-align: top">
    <td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90E_edei--SolicitingMaterial_c20201216__20201216_zrFjKFzLCrX6"><ix:nonNumeric contextRef="From2020-12-16to2020-12-16" format="ixt:booleanfalse" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font-size: 10pt"><span style="font-size: 10pt">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr>
<tr style="vertical-align: top">
    <td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90C_edei--PreCommencementTenderOffer_c20201216__20201216_zMAfIJ4D7BPg"><ix:nonNumeric contextRef="From2020-12-16to2020-12-16" format="ixt:booleanfalse" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font-size: 10pt"><span style="font-size: 10pt">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr>
<tr style="vertical-align: top">
    <td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_901_edei--PreCommencementIssuerTenderOffer_c20201216__20201216_zhWx75Hp5jV1"><ix:nonNumeric contextRef="From2020-12-16to2020-12-16" format="ixt:booleanfalse" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font-size: 10pt"><span style="font-size: 10pt">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Securities registered pursuant to Section 12(b) of the Act:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font-size: 10pt; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: center; width: 30%"><span style="font-size: 10pt"><b>Title of each class</b></span></td>
    <td style="width: 2%">&#160;</td>
    <td style="border-bottom: black 1pt solid; font-size: 10pt; text-align: center; width: 25%"><span style="font-size: 10pt"><b>Trading Symbol(s)</b></span></td>
    <td style="width: 2%">&#160;</td>
    <td style="border-bottom: black 1pt solid; font-size: 10pt; text-align: center; width: 30%"><span style="font-size: 10pt"><b>Name of each exchange on which registered</b></span></td></tr>
<tr>
    <td style="vertical-align: top; font-size: 10pt; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_904_edei--Security12bTitle_c20201216__20201216_zJV5AbQk68l1"><ix:nonNumeric contextRef="From2020-12-16to2020-12-16" name="dei:Security12bTitle">Common Stock, $0.0001 par value</ix:nonNumeric></span></b></span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; font-size: 10pt; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_90D_edei--TradingSymbol_c20201216__20201216_zqlp87qpDA5e"><ix:nonNumeric contextRef="From2020-12-16to2020-12-16" name="dei:TradingSymbol">ADMA</ix:nonNumeric></span></b></span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; font-size: 10pt; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_902_edei--SecurityExchangeName_c20201216__20201216_zdjdabLnDTy5"><ix:nonNumeric contextRef="From2020-12-16to2020-12-16" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">Nasdaq Global Market</ix:nonNumeric></span></b></span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Indicate by check mark whether the registrant is an emerging
growth company as defined in Rule 405 of the Securities Act of 1933 (&#167; 230.405 of this chapter) or Rule 12b-2 of the Securities
Exchange Act of 1934 (&#167; 240.12b-2 of this chapter).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Emerging growth company <span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90C_edei--EntityEmergingGrowthCompany_c20201216__20201216_zQnUz9L7sT74"><ix:nonNumeric contextRef="From2020-12-16to2020-12-16" format="ixt:booleanfalse" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If an emerging growth company, indicate by check mark if
the registrant has elected not to use the extended transition period for complying with any new or revised financial
accounting standards provided pursuant to Section 13(a) of the Exchange Act. <span style="font-family: Times New Roman, Times, Serif">&#9744;</span></p>







<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 2px solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt"></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt; text-align: right; font-size: 8pt"></p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Item&#160;1.01. Entry into a Material Definitive Agreement.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On December 16, 2020,
the Board of Directors (the &#8220;Board&#8221;) of ADMA Biologics, Inc., a Delaware corporation (the &#8220;Company&#8221;), approved
and adopted a Rights Agreement, dated as of December 16, 2020 (the &#8220;Rights Agreement&#8221;), by and between the Company
and Continental Stock Transfer and Trust Company, as rights agent. Pursuant to the Rights Agreement, the Board declared a dividend
of one preferred share purchase right (each, a &#8220;Right&#8221;) for each outstanding share of common stock, par value $0.0001,
of the Company (each, a &#8220;Common Share&#8221; and, collectively, the &#8220;Common Shares&#8221;). The Rights are distributable
to stockholders of record as of the close of business on December 30, 2020 (the &#8220;Record Date&#8221;). One Right also will
be issued together with each Common Share issued by the Company after December 30, 2020, but before the Distribution Date (as defined
below) (or the earlier redemption or expiration of the Rights) and, in certain circumstances, after the Distribution Date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Generally, the Rights
Agreement works by causing substantial dilution to any person or group that acquires beneficial ownership of ten percent (10%)
or more of the Common Shares without the approval of the Board. As a result, the overall effect of the Rights Agreement and the
issuance of the Rights may be to render more difficult or discourage a merger, tender or exchange offer or other business combination
involving the Company that is not approved by the Board. The Rights Agreement is not intended to interfere with any merger, tender
or exchange offer or other business combination approved by the Board. The Rights Agreement also does not prevent the Board from
considering any offer that it considers to be in the best interest of its stockholders.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following is a
summary description of the Rights and material terms and conditions of the Rights Agreement. This summary is intended to provide
a general description only, does not purport to be complete and is qualified in its entirety by reference to the complete text
of the Rights Agreement, a copy of which is filed as Exhibit 4.1 to this Current Report on Form 8-K and incorporated herein by
reference. All capitalized terms used but not defined herein shall have the meanings ascribed to such terms in the Rights Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><i>The Rights</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Subject to the terms,
provisions and conditions of the Rights Agreement, if the Rights become exercisable, each Right would initially represent the right
to purchase from the Company one one-thousandth of a share of a newly-designated series of preferred stock, Series A Junior Participating
Preferred Stock, par value $0.0001 per share, of the Company (each, a &#8220;Series A Preferred Share&#8221; and, collectively,
the &#8220;Series A Preferred Shares&#8221;), at an exercise price of $12.50 per one one-thousandth of a Series A Preferred
Share, subject to adjustment (the &#8220;Exercise Price&#8221;). If issued, each one one-thousandth of a Series A Preferred Share
would give the stockholder approximately the same dividend, voting and liquidation rights as does one Common Share. However, prior
to exercise, a Right does not give its holder any rights as a stockholder of the Company, including, without limitation, any dividend,
voting or liquidation rights. A copy of the Certificate of Designation of Series A Junior Participating Preferred Stock (the &#8220;Series
A Certificate of Designation&#8221;) that the Company intends to file with the Secretary of State of the State of Delaware on December
16, 2020 to designate the Series A Preferred Shares is filed as Exhibit 3.1 to this Current Report on Form 8-K and is incorporated
herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Initial Exercisability</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Initially, the Rights
will not be exercisable, certificates will not be sent to stockholders and the Rights will automatically trade with the Common
Shares. Until the Rights separate from the Common Shares and become exercisable (or the earlier redemption or expiration of the
Rights), the Rights will be evidenced by Common Share certificates, Rights relating to any uncertificated Common Shares that are
registered in book entry form will be represented by a notation in book entry on the records of the Company, and the surrender
for transfer of any Common Shares will also constitute the transfer of the associated Rights.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Subject to certain
exceptions specified in the Rights Agreement, the Rights will separate from the Common Shares and become exercisable following&#160;the
earlier to occur of the tenth (10th) business day (or such later date as may be determined by the Board) after (i) the day on which
a public announcement or filing with the Securities and Exchange Commission (the &#8220;SEC&#8221;) is made indicating that a person
has become an Acquiring Person (as defined below) or that discloses information that reveals the existence of an Acquiring Person
(the &#8220;Shares Acquisition Date&#8221;), or (ii) the commencement by any person (other than certain exempted persons) of, or
the first public announcement of the intent of any person (other than certain exempted persons) to commence, a tender or exchange
offer by or on behalf of a person, the successful consummation of which would result in any person (other than certain exempted
persons) becoming an Acquiring Person, irrespective of whether any shares are actually purchased or exchanged pursuant to such
offer (the earlier of these dates is called the &#8220;Distribution Date&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 2px solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt"></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt; text-align: right; font-size: 8pt"></p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">After the Distribution
Date, separate rights certificates will be issued and the Rights may be transferred other than in connection with the transfer
of the underlying Common Shares unless and until the Board has determined to effect an exchange pursuant to the Rights Agreement
(as described below).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Acquiring Person</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under the Rights Agreement,
an Acquiring Person is any person who or that, together with all Affiliates and Associates (as defined in the Rights Agreement)
of such person, from and after the first public announcement by the Company of the adoption of the Rights Agreement, is or becomes
the beneficial owner of ten percent (10%) or more of the Common Shares outstanding, subject to various exceptions. For purposes
of the Rights Agreement, beneficial ownership is defined to include the ownership of derivative securities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; text-indent: 0.5in">The
Rights Agreement provides that an Acquiring Person does not include the Company, any subsidiary of the Company, any employee benefit
plan of the Company or any subsidiary of the Company, or any person organized, appointed, or established to hold Common Shares
pursuant to any employee benefit plan of the Company or for the purpose of funding any such plan.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; text-indent: 0.5in">The
Rights Agreement also provides that the following persons shall not be deemed an Acquiring Person thereunder: (i) any person who
becomes the beneficial owner of ten percent (10%) or more of the shares of Common Stock of the Company then outstanding solely
as a result of the initial grant or vesting of any options, warrants, rights or similar interests (including restricted shares
and restricted stock units) by the Company to its directors, officers and employees pursuant to any employee benefit or stock ownership
plan of the Company, or the acquisition of shares of Common Stock of the Company upon the exercise or conversion of any such securities
so granted; (ii) any person who as the result of an acquisition of shares of Common Stock by the Company (or any subsidiary of
the Company, or any person organized, appointed, established or holding shares of Common Stock of the Company for or pursuant to
the terms of any such plan) that, by reducing the number of shares of Common Stock of the Company outstanding, increases the proportionate
number of shares of Common Stock of the Company beneficially owned by such person to ten percent (10%) or more of the Common Shares
then outstanding; (iii) any person who or that became the beneficial owner of ten percent (10%) or more of the Common Shares then
outstanding as a result of the acquisition of Common Shares directly from the Company; or (iv) any person who or that would otherwise
be an Acquiring Person who or that the Board determines had become such inadvertently (including, without limitation, because (A)
such person was unaware that it beneficially owned a percentage of the Common Shares that would otherwise cause such person to
be an &#8220;Acquiring Person,&#8221; or (B) such person was aware of the extent of its beneficial ownership of Common Shares but
had no actual knowledge of the consequences of such beneficial ownership under the Rights Agreement), and who or that thereafter
within five (5) business days of being requested by the Company, reduces such person&#8217;s beneficial ownership to less than
ten percent (10%) of the Common Shares then outstanding.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#8220;Grandfathering&#8221; of Existing
Holders</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Rights Agreement
also provides that any person who beneficially owned ten percent (10%) or more of the Common Shares immediately prior to the first
public announcement by the Company of the adoption of the Rights Agreement (each a &#8220;Grandfathered Person&#8221;), shall not
be deemed to be an &#8220;Acquiring Person&#8221; for purposes of the Rights Agreement unless and until a Grandfathered Person
becomes the beneficial owner of one or more additional Common Shares after the first public announcement by the Company of the
adoption of the Rights Agreement (other than pursuant to a dividend or distribution paid or made by the Company on the outstanding
Common Shares, pursuant to a split, reclassification or subdivision of the outstanding Common Shares or pursuant to the acquisition
of beneficial ownership of Common Shares upon the vesting or exercise of any option, warrants or other rights, or upon the initial
grant or vesting of restricted stock, granted or issued by the Company to its directors, officers and employees, pursuant to a
compensation or benefits plan or arrangement adopted by the Board). However, if upon acquiring beneficial ownership of one or more
additional Common Shares at any time after the first public announcement by the Company of the adoption of the Rights Agreement,
the Grandfathered Person does not, at such time, beneficially own ten percent (10%) or more of the Common Shares then outstanding,
the Grandfathered Person will not be treated as an &#8220;Acquiring Person&#8221; for purposes of the Rights Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 2px solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt"></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt; text-align: right; font-size: 8pt"></p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i>Flip-In Trigger</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">If
a person becomes an Acquiring Person, then, following the occurrence of the Distribution Date and subject to the terms, provisions
and conditions of the Rights Agreement, each Right will entitle the holder thereof to purchase from the Company, upon payment of
the Exercise Price, in lieu of a number of one one-thousandths of a Series A Preferred Share, a number of Common Shares (or, in
certain circumstances, cash, property or other securities of the Company) having a then-current market value of twice the Exercise
Price. However, the Rights are not exercisable until such time as the Rights are no longer redeemable by the Company, as further
described below.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Following
the occurrence of an event set forth in the preceding paragraph, all Rights that are or, under certain circumstances specified
in the Rights Agreement, were beneficially owned by an Acquiring Person or certain of its transferees will become null and void
and nontransferable.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i>Flip-Over Trigger</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">If,
after an Acquiring Person obtains beneficial ownership of ten percent (10%) or more of the Common Shares, (i)&#160;the Company
merges into another entity, (ii) an acquiring entity merges into the Company, or (iii) the Company sells or transfers more than
fifty percent (50%) of its assets, cash flow or earning power, then each Right (except for Rights that have previously been voided
as set forth above) will entitle the holder thereof to purchase, upon payment of the Exercise Price, in accordance with the terms
of the Rights Agreement, a number of shares of common stock of the person engaging in the transaction having a then-current market
value of twice the Exercise Price.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i>Redemption
of the Rights</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">At any time until the
close of business on the tenth (10th) business day after the Shares Acquisition Date (or, if the tenth (10th) business day after
the Shares Acquisition Date occurs before the Record Date, the close of business on the Record Date), or thereafter under certain
circumstances, the Company may redeem the Rights in whole, but not in part, at a price of $0.001 per Right (the &#8220;Redemption
Price&#8221;). The Redemption Price may be paid in cash, Common Shares or other forms of consideration, as determined by the Board,
in the exercise of its sole discretion. The redemption of the Rights may be made effective at such time, on such basis and subject
to such conditions as the Board in its sole discretion may establish. Immediately upon any redemption of the Rights, the right
to exercise the Rights will terminate and the only right of the holders of Rights will be to receive the Redemption Price without
any interest thereon.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i>Exchange of
the Rights</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">At
any time after any person (other than certain exempted persons and Grandfathered Persons) becomes an Acquiring Person, and prior
to the acquisition by any person of beneficial ownership of fifty percent (50%) or more of the Common Shares, the Board may, at
its option, cause the Company to exchange all or part of the then outstanding and exercisable Rights (other than Rights held by
the Acquiring Person or any Affiliate or Associate thereof, which would have become null and void and nontransferable in accordance
with the terms of the Rights Agreement), in whole or in part, for Common Shares at an exchange ratio (subject to adjustment) of
one Common Share for each Right.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">In
any exchange of the Rights pursuant to the Rights Agreement, the Company, at its option, may, and to the extent there are an insufficient
number of authorized Common Shares not reserved for any other purpose to exchange for all of the outstanding Rights, shall, substitute
preferred stock or other securities of the Company for some or all of the Common Shares exchangeable for Rights such that the aggregate
value received by a holder of Rights in exchange for each Right is substantially the same value as one Common Share. The exchange
of the Rights by the Board may be made effective at such time, on such basis, and subject to such conditions as the Board in its
sole discretion may establish. Immediately upon the action of the Board authorizing the exchange of the Rights, the right to exercise
the Rights will terminate, and the only right of the holders of Rights will be to receive the Common Shares or other consideration
issuable in connection with the exchange.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"></p>

<!-- Field: Page; Sequence: 4 -->
    <div style="border-bottom: Black 2px solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt"></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt; text-align: right; font-size: 8pt"></p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i>Expiration
of the Rights </i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Rights and the
Rights Agreement will expire upon the earliest to occur of (i) the date on which all of the Rights are redeemed, (ii) the date
on which the Rights are exchanged, and (iii) the close of business on December 15, 2021.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i>Amendment of
Rights Agreement</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; text-indent: 0.5in">Except
as otherwise provided in the Rights Agreement, the Company, by action of the Board, may from time to time, in its sole and absolute
discretion, supplement or amend any provision of the Rights Agreement in any respect without the approval of any holders of Rights,
including, without limitation, in order to (i)&#160;cure any ambiguity in the Rights Agreement, (ii)&#160;correct or supplement
any provision contained in the Rights Agreement that may be defective or inconsistent with any other provisions contained therein,
(iii)&#160;shorten or lengthen any time period in the Rights Agreement, or (iv)&#160;otherwise change, amend, or supplement any
provisions in the Rights Agreement in any manner that the Company may deem necessary or desirable; <i>provided,&#160;however</i>,
that from and after such time as any person becomes an Acquiring Person, the Rights Agreement may not be supplemented or amended
in any manner that would adversely affect the interests of the holders of Rights (other than Rights that have become null and void
pursuant to the Rights Agreement) as such or cause the Rights Agreement to become amendable other than in accordance with the terms
of the Rights Agreement. Without limiting the foregoing, the Company, by action of the Board, may at any time before any person
becomes an Acquiring Person amend the Rights Agreement to make the provisions of the Rights Agreement inapplicable to a particular
transaction by which a person might otherwise become an Acquiring Person or to otherwise alter the terms and conditions of the
Rights Agreement as they may apply with respect to any such transaction.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i>Rights of Holders</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Until
a Right is exercised, a Right does not give its holder any rights as a stockholder of the Company, including, without limitation,
any dividend, voting or liquidation rights.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i>Anti-Dilution
Provisions</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The
Board may adjust the Exercise Price, the number of Series A Preferred Shares issuable and the number of outstanding Rights to prevent
dilution that may occur from a stock dividend, a stock split or a reclassification of the Series A Preferred Shares or Common Shares.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">With
certain exceptions, no adjustments to the Exercise Price will be made until the cumulative adjustments amount to at least one percent
(1%) of the Exercise Price. No fractional Series A Preferred Shares will be issued other than fractions that are integral multiples
of one one-thousandth of a share and, in lieu thereof, an adjustment in cash will be made based on the current market price of
the Series A Preferred Shares.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i>Tax Consequences</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; text-indent: 0.5in">The
adoption of the Rights Agreement and the subsequent distribution of the Rights to stockholders should not be a taxable event for
the Company or its stockholders under presently existing U.S. federal income tax laws. However, if the Rights become exercisable
or if the Rights are redeemed, stockholders may recognize taxable income, depending on the circumstances then existing.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i>Accounting
Treatment</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The distribution of
the Rights as a dividend to the Company&#8217;s stockholders is not expected to have any financial accounting or reporting impact.
The fair value of the Rights is expected to be zero when they are distributed because the Rights will be &#8220;out of the money&#8221;
when distributed and no value should be attributable to them. Additionally, the Rights do not meet the definition of a liability
under generally accepted accounting principles in the United States and are therefore not accounted for as a long-term obligation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 5 -->
    <div style="border-bottom: Black 2px solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt"></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt; text-align: right; font-size: 8pt"></p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Authority of the Board </i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">When evaluating decisions
relating to the redemption of the Rights or any amendment to the Rights Agreement to delay or prevent the Rights from detaching
and becoming exercisable as a result of a particular transaction, pursuant to the Rights Agreement, the Board, or any future board
of directors, would not be subject to restrictions such as those commonly known as &#8220;dead-hand,&#8221; &#8220;slow-hand,&#8221;
&#8220;no-hand,&#8221; or similar provisions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Certain Anti-Takeover Effects </i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Rights are not
intended to prevent a takeover of the Company and should not interfere with any merger or other business combination approved by
the Board. However, the Rights may cause substantial dilution to a person or group that acquires beneficial ownership of ten percent
(10%) or more of the issued and outstanding Common Shares (which includes for this purpose stock referenced in derivative transactions
and securities) without the approval of the Board.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>SEC Registration </i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Since the Rights are
not exercisable immediately, registration with the SEC of the Series A Preferred Shares issuable upon exercise of the Rights is
not required until the Rights become exercisable.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Item 3.03. Material Modification to
Rights of Security Holders.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The
information included in Item&#160;1.01 of this Current Report on Form 8-K is incorporated by reference into this Item&#160;3.03.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Item 5.03.
Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">In
connection with the adoption of the Rights Agreement described in Item 1.01 above, on December 16, 2020, the Board approved the
Series A Certificate of Designation. The Series A Certificate of Designation sets forth the rights, powers and preferences of the
Series A Preferred Shares. The Company intends to file the Series A Certificate of Designation with the Secretary of State of the
State of Delaware on December 16, 2020.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The
summary of the rights, powers and preferences of the Series A Preferred Shares set forth in Item&#160;1.01 of this Current Report
on Form 8-K is incorporated by reference into this Item&#160;5.03. A copy of the Series A Certificate of Designation is attached
to this Current Report on Form 8-K as Exhibit 3.1 and is incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Item 8.01 Other Events.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">On
December 16, 2020, the Company issued a press release announcing that the Board had approved and adopted the Rights Agreement and
declared the dividend of the Rights. A copy of the press release is attached to this Current Report on Form 8-K as Exhibit 99.1
and is incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"></p>

<!-- Field: Page; Sequence: 6 -->
    <div style="border-bottom: Black 2px solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt"></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt; text-align: right; font-size: 8pt"></p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Item 9.01. &#160;Financial Statements and Exhibits.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(d) &#160;&#160;&#160;&#160;&#160;&#160;&#160;Exhibits</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">See the Exhibit Index below, which is incorporated by reference
herein.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>EXHIBIT INDEX</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font-size: 10pt; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="border-bottom: Black 1pt solid; width: 15%; font-size: 10pt"><span style="font-size: 10pt"><b>Exhibit Number</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 85%; font-size: 10pt; text-align: center"><span style="font-size: 10pt"><b>Description</b></span></td></tr>
<tr style="vertical-align: top">
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: center">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="font-size: 10pt"><span style="font-size: 10pt">3.1</span></td>
    <td style="font-size: 10pt"><span style="font-size: 10pt"><a href="e620138_ex3-1.htm">Certificate of Designation of Series A Junior Participating Preferred Stock of ADMA Biologics, Inc.</a></span></td></tr>
<tr style="vertical-align: top">
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="font-size: 10pt"><span style="font-size: 10pt">4.1</span></td>
    <td style="font-size: 10pt"><span style="font-size: 10pt"><a href="e620138_ex4-1.htm">Rights Agreement, dated as of December 16, 2020, by and between ADMA Biologics, Inc. and Continental Stock Transfer and Trust Company, as rights agent</a></span></td></tr>
<tr style="vertical-align: top">
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="font-size: 10pt"><span style="font-size: 10pt">99.1</span></td>
    <td style="font-size: 10pt"><span style="font-size: 10pt"><a href="e620138_ex99-1.htm">Press release of ADMA Biologics, Inc. issued December 16, 2020</a></span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 7 -->
    <div style="border-bottom: Black 2px solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt"></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt; text-align: right; font-size: 8pt"></p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SIGNATURE</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 20.25pt">Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 20.25pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font-size: 10pt; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="font-size: 10pt">&#160;</td>
    <td colspan="2" style="font-size: 10pt"><span style="font-size: 10pt"><b>ADMA BIOLOGICS, INC.</b></span></td></tr>
<tr style="vertical-align: top">
    <td style="font-size: 10pt">&#160;</td>
    <td colspan="2" style="font-size: 10pt">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="width: 51%; font-size: 10pt"><span style="font-size: 10pt">&#160;Date: December 16, 2020</span></td>
    <td style="width: 3%; font-size: 10pt"><span style="font-size: 10pt">By:</span></td>
    <td style="border-bottom: Black 1pt solid; width: 35%; font-size: 10pt"><span style="font-size: 10pt">/s/ Adam S. Grossman</span></td></tr>
<tr style="vertical-align: top">
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt"><span style="font-size: 10pt">Adam S. Grossman</span></td></tr>
<tr style="vertical-align: top">
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt"><span style="font-size: 10pt">President and Chief Executive Officer</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

</body>
</html>
<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjdEKgkAQRb/Afxj2WWwVJPAxqYgsQiR6XXKKJd2R2dXqk/rLViUaBoaZO+deIUKxpY1ukOGyKguosO0a5RBKvCGjuaL/yHf7DPws8a6tY2XctP7AnDyDnkmj9Orv0+egLdYZxMkiTheJhFhmcgmngwhGPSdz0zUap1UDytRwYupYo1P8nh0q9SJD7XtKOiNbTcbbRXKWP5DIOIEjDepJ/LBQFLkIwqkCsWXquzGmt45aWDfY+iw7o/8OvtwPSRY= -->
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.1
<SEQUENCE>2
<FILENAME>e620138_ex3-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B><U>Exhibit 3.1</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">CERTIFICATE OF DESIGNATION</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">OF</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">SERIES A JUNIOR PARTICIPATING PREFERRED
STOCK</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">OF</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase">ADMA
BIOLOGICS, inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Pursuant to Section 151 of the Delaware
General Corporation Law)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">ADMA Biologics, Inc.
(the &ldquo;<B>Corporation</B>&rdquo;), a corporation organized and existing under the General Corporation Law of the State of
the Delaware, as amended (the &ldquo;<B>DGCL</B>&rdquo;), hereby certifies that, pursuant to the authority granted by Article FOURTH
of the Certificate of Incorporation of the Corporation, as amended (the &ldquo;<B>Restated Certificate of Incorporation</B>&rdquo;),
and in accordance with Section 151 of the DGCL, the Board of Directors of the Corporation (hereinafter being referred to as the
&ldquo;<B>Board of Directors</B>&rdquo; or the &ldquo;<B>Board</B>&rdquo;), at a meeting duly called and held on December 16, 2020,
has adopted the following resolution with respect to the designations, number of shares, preferences, voting powers and other rights
and the restrictions and limitations thereof, of the Series A Junior Participating Preferred Stock:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">RESOLVED, that, pursuant
to the authority granted to and vested in the Board of Directors in accordance with the provisions of the Restated Certificate
of Incorporation, the designations, number of shares, preferences, voting powers and other rights and the restrictions and limitations
thereof of the Series A Junior Participating Preferred Stock are as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Designation and Amount</U>. The shares of such series shall be designated as &ldquo;Series A Junior Participating Preferred
Stock&rdquo; (the &ldquo;<B>Series A Preferred Stock</B>&rdquo;) and the number of shares constituting the Series A Preferred Stock
shall be 10,000. Such number of shares may be increased or decreased by resolution of the Board of Directors prior to issuance;
<U>provided</U>, <U>however</U><I>,</I> that no decrease shall reduce the number of shares of the Series A Preferred Stock to a
number less than the number of shares then outstanding plus the number of shares reserved for issuance upon the exercise of outstanding
options, rights or warrants or upon the conversion of any outstanding securities issued by the Corporation convertible into the
Series A Preferred Stock; <U>provided</U>, <U>further</U>, that if more than a total 10,000 shares of Series A Preferred Stock
shall be issuable upon the exercise of Rights (the &ldquo;<B>Rights</B>&rdquo;) issued pursuant to the Rights Agreement, dated
as of December 16, 2020, and as supplemented, restated or amended from time to time, by and between the Corporation and Continental
Stock Transfer and Trust Company, as rights agent (the &ldquo;<B>Rights Agreement</B>&rdquo;), the Board, pursuant to Section 151(g)
of the DGCL, shall direct by resolution or resolutions that a certificate be properly executed, acknowledged, filed and recorded,
in accordance with the provisions of Section 103 of the DGCL, providing for the total number of shares of Series A Preferred Stock
authorized to be issued to be increased (to the extent that the Restated Certificate of Incorporation then permits) to the largest
number of whole shares (rounded up to the nearest whole number) issuable upon exercise of such Rights.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt; text-align: right; font-size: 8pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Dividends and Distributions</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Subject to the rights of the holders of any shares of any series of Preferred Stock of the Corporation (the &ldquo;<B>Preferred
Stock</B>&rdquo;) (or any similar stock) ranking prior and superior to the shares of Series A Preferred Stock with respect to dividends,
the holders of shares of the Series A Preferred Stock, in preference to the holders of common stock, par value $0.0001 per share,
of the Corporation (the &ldquo;<B>Common Stock</B>&rdquo;) and of any other stock of the Corporation ranking junior to the Series
A Preferred Stock, shall be entitled to receive, when, as and if declared by the Board of Directors out of funds of the Corporation
legally available for the payment of dividends, quarterly dividends payable in cash on the last day of each fiscal quarter of the
Corporation in each year, or such other dates as the Board of Directors shall approve (each such date being referred to herein
as a &ldquo;<B>Quarterly Dividend Payment Date</B>&rdquo;), commencing on the first Quarterly Dividend Payment Date after the first
issuance of a share or fraction of a share of the Series A Preferred Stock (the &ldquo;<B>Issue Date</B>&rdquo;), in an amount
per share (rounded to the nearest cent) equal to the greater of (i) $1.00 or (ii) subject to the provision for adjustment hereinafter
set forth, 1,000 times the aggregate per share amount of all cash dividends, and 1,000 times the aggregate per share amount (payable
in kind) of all non-cash dividends or other distributions other than a dividend payable in shares of Common Stock or a subdivision
of the outstanding shares of the Common Stock (by reclassification or otherwise), declared on the Common Stock since the immediately
preceding Quarterly Dividend Payment Date or, with respect to the first Quarterly Dividend Payment Date, since the first issuance
of any share or fraction of a share of Series A Preferred Stock. In the event the Corporation shall at any time after the Issue
Date (A) declare and pay any dividend on the Common Stock payable in shares of Common Stock, or (B) effect a subdivision or combination
or consolidation of the outstanding shares of Common Stock (by reclassification or otherwise than by payment of a dividend in shares
of Common Stock) into a greater or lesser number of shares of Common Stock, then in each such case the amount to which holders
of shares of Series A Preferred Stock were entitled immediately prior to such event under clause (ii) of the preceding sentence
shall be adjusted by multiplying such amount by a fraction, the numerator of which is the number of shares of Common Stock outstanding
immediately after such event and the denominator of which is the number of shares of Common Stock that were outstanding immediately
prior to such event. In the event the Corporation shall at any time declare or pay any dividend on the Series A Preferred Stock
payable in shares of Series A Preferred Stock, or effect a subdivision, combination or consolidation of the outstanding shares
of Series A Preferred Stock (by reclassification or otherwise than by payment of a dividend in shares of Series A Preferred Stock)
into a greater or lesser number of shares of Series A Preferred Stock, then in each such case the amount to which holders of shares
of Series A Preferred Stock were entitled immediately prior to such event under clause (ii) of the first sentence of this Section
2(a) shall be adjusted by multiplying such amount by a fraction, the numerator of which is the number of shares of Series A Preferred
Stock that were outstanding immediately prior to such event and the denominator of which is the number of shares of Series A Preferred
Stock outstanding immediately after such event.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Corporation shall declare a dividend or distribution on the Series A Preferred Stock as provided in paragraph (a) of
this Section 2 immediately after it declares a dividend or distribution on the Common Stock (other than a dividend payable in shares
of Common Stock); and the Corporation shall pay such dividend or distribution on the Series A Preferred Stock before the dividend
or distribution declared on the Common Stock is paid or set apart; <U>provided that</U>, in the event no dividend or distribution
shall have been declared on the Common Stock during the period between any Quarterly Dividend Payment Date and the next subsequent
Quarterly Dividend Payment Date, a dividend of $1.00 per share on the Series A Preferred Stock shall nevertheless be payable, when,
as and if declared, on such subsequent Quarterly Dividend Payment Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt; text-align: right; font-size: 8pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Dividends shall begin to accrue and be cumulative, whether or not declared, on outstanding shares of Series A Preferred
Stock from the Quarterly Dividend Payment Date next preceding the date of issue of such shares, unless the date of issue of such
shares is prior to the record date for the first Quarterly Dividend Payment Date, in which case dividends on such shares shall
begin to accrue from the date of issue of such shares, or unless the date of issue is a Quarterly Dividend Payment Date or is
a date after the record date for the determination of holders of shares of Series A Preferred Stock entitled to receive a quarterly
dividend and before such Quarterly Dividend Payment Date, in either of which events such dividends shall begin to accrue and be
cumulative from such Quarterly Dividend Payment Date. Accrued but unpaid dividends shall not bear interest. Dividends paid on
the shares of Series A Preferred Stock in an amount less than the total amount of such dividends at the time accrued and payable
on such shares shall be allocated pro rata on a share-by-share basis among all such shares at the time outstanding. The Board
of Directors may fix a record date for the determination of holders of shares of Series A Preferred Stock entitled to receive
payment of a dividend or distribution declared thereon, which record date shall be not more than sixty (60) calendar days prior
to the date fixed for the payment thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Voting Rights</U>. The holders of shares of Series A Preferred Stock shall have the following voting rights:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Subject to the provision for adjustment hereinafter set forth and except as otherwise provided in the Restated Certificate
of Incorporation or required by law, each share of Series A Preferred Stock shall entitle the holder thereof to 1,000 votes on
all matters upon which the holders of the Common Stock of the Corporation are entitled to vote. In the event the Corporation shall
at any time after the Issue Date (i) declare or pay any dividend on the Common Stock payable in shares of Common Stock, or (ii)
effect a subdivision or combination or consolidation of the outstanding shares of Common Stock (by reclassification or otherwise
than by payment of a dividend in shares of Common Stock) into a greater or lesser number of shares of Common Stock, then in each
such case the number of votes per share to which holders of shares of Series A Preferred Stock were entitled immediately prior
to such event shall be adjusted by multiplying such number by a fraction, the numerator of which is the number of shares of Common
Stock outstanding immediately after such event and the denominator of which is the number of shares of Common Stock that were outstanding
immediately prior to such event. In the event the Corporation shall at any time declare or pay any dividend on the Series A Preferred
Stock payable in shares of Series A Preferred Stock, or effect a subdivision, combination or consolidation of the outstanding shares
of Series A Preferred Stock (by reclassification or otherwise than by payment of a dividend in shares of Series A Preferred Stock)
into a greater or lesser number of shares of Series A Preferred Stock, then in each such case the number of votes per share to
which holders of shares of Series A Preferred Stock were entitled immediately prior to such event shall be adjusted by multiplying
such amount by a fraction, the numerator of which is the number of shares of Series A Preferred Stock that were outstanding immediately
prior to such event and the denominator of which is the number of shares of Series A Preferred Stock outstanding immediately after
such event.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt; text-align: right; font-size: 8pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Except as otherwise provided herein, in the Restated Certificate of Incorporation or in any other Certificate of Designations
creating a series of Preferred Stock or any similar stock, and except as otherwise required by law, the holders of shares of Series
A Preferred Stock and the holders of shares of Common Stock and any other capital stock of the Corporation having general voting
rights shall vote together as one class on all matters submitted to a vote of stockholders of the Corporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>(i)&#9;If at any time dividends on any Series A Preferred Stock shall be in arrears in an amount equal to six (6) quarterly
dividends thereon, then and in such event the holders of the Series A Preferred Stock, voting as a separate series from all other
series of Preferred Stock and classes of capital stock, shall be entitled to elect two (2) members of the Board in addition to
any Directors elected by any other series, class or classes of securities and the authorized number of Directors will automatically
be increased by two (2). Promptly thereafter, the Board of the Corporation shall, as soon as may be practicable, call a special
meeting of holders of Series A Preferred Stock for the purpose of electing such members of the Board. Such special meeting shall
in any event be held within forty-five (45) calendar days of the occurrence of such arrearage.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>During any period when the holders of Series A Preferred Stock, voting as a separate series, shall be entitled and shall
have exercised their right to elect two (2) Directors, then, and during such time as such right continues, (a) the then authorized
number of Directors shall be increased by two (2), and the holders of Series A Preferred Stock, voting as a separate series, shall
be entitled to elect the additional Directors so provided for, and (b) each such additional Director shall serve until the next
annual meeting of stockholders for the election of Directors, or until his successor shall be elected and shall qualify, or until
his right to hold such office terminates pursuant to the provisions of this <U>Section 3(c)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(iii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>A Director elected pursuant to the terms hereof may be removed with or without cause by the holders of Series A Preferred
Stock entitled to vote in an election of such Director.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(iv)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>If, during any interval between annual meetings of stockholders for the election of Directors and while the holders of Series
A Preferred Stock shall be entitled to elect two (2) Directors, there is no such Director in office by reason of resignation, death
or removal, then, promptly thereafter, the Board shall call a special meeting of the holders of Series A Preferred Stock for the
purpose of filling such vacancy and such vacancy shall be filled at such special meeting. Such special meeting shall in any event
be held within forty-five (45) calendar days of the occurrence of such vacancy.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(v)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>At such time as the arrearage is fully cured, and all dividends accumulated and unpaid on any shares of Series A Preferred
Stock outstanding are paid, and, in addition thereto, at least one regular dividend has been paid subsequent to curing such arrearage,
the term of office of any Director elected pursuant to this Section 3(c), or his successor, shall automatically terminate, and
the authorized number of Directors shall automatically decrease by two (2), the rights of the holders of the shares of the Series
A Preferred Stock to vote as provided in this <U>Section 3(c)</U> shall cease, subject to renewal from time to time in the case
of any such future dividend default or defaults upon the same terms and conditions, and the holders of shares of the Series A Preferred
Stock shall have only the limited voting rights elsewhere herein set forth.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt; text-align: right; font-size: 8pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Except as set forth herein, or as otherwise provided by law, the holders of Series A Preferred Stock shall have no special
voting rights and their consent shall not be required (except to the extent they are entitled to vote with holders of Common Stock
as set forth herein) for taking any corporate action.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Certain Restrictions</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Whenever quarterly dividends or other dividends or distributions payable on the Series A Preferred Stock as provided in
<U>Section 2</U> hereof are in arrears, thereafter and until all accrued and unpaid dividends and distributions, whether or not
declared, on shares of Series A Preferred Stock outstanding shall have been paid in full, the Corporation shall not:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>declare or pay dividends, or make any other distributions, on any shares of stock ranking junior (either as to dividends
or upon liquidation, dissolution or winding up) to the Series A Preferred Stock;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>declare or pay dividends, or make any other distributions, on any shares of stock ranking on a parity (either as to dividends
or upon liquidation, dissolution or winding up) with the Series A Preferred Stock, except dividends paid ratably on the Series
A Preferred Stock and all such parity stock on which dividends are payable or in arrears in proportion to the total amounts to
which the holders of all such shares are then entitled;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(iii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>redeem or purchase or otherwise acquire for consideration shares of any stock ranking junior (either as to dividends or
upon liquidation, dissolution or winding up) to the Series A Preferred Stock, <U>provided that</U>, the Corporation may at any
time redeem, purchase or otherwise acquire shares of any such junior stock in exchange for shares of any stock of the Corporation
ranking junior (either as to dividends or upon dissolution, liquidation or winding up) to the Series A Preferred Stock or rights,
warrants or options to acquire such junior stock; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(iv)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>redeem or purchase or otherwise acquire for consideration any shares of Series A Preferred Stock, or any shares of stock
ranking on a parity (either as to dividends or upon liquidation, dissolution or winding up) with the Series A Preferred Stock,
except in accordance with a purchase offer made in writing or by publication (as determined by the Board of Directors) to all holders
of such shares upon such terms as the Board of Directors, after consideration of the respective annual dividend rates and other
relative rights and preferences of the respective series and classes, shall determine in good faith will result in fair and equitable
treatment among the respective series or classes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Corporation shall not permit any subsidiary of the Corporation to purchase or otherwise acquire for consideration any
shares of stock of the Corporation unless the Corporation could, under paragraph (a) of this <U>Section 4</U>, purchase or otherwise
acquire such shares at such time and in such manner.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Reacquired
Shares</U>. Any shares of Series A Preferred Stock purchased or otherwise acquired by the Corporation in any manner whatsoever
shall be retired and cancelled promptly after the acquisition thereof. All such shares shall upon their cancellation become authorized
but unissued shares of Preferred Stock and may be reissued, without designation as to series until such shares are once more designated
as part of a particular series of Preferred Stock by resolution or resolutions of the Board of Directors, subject to the conditions
and restrictions on issuance set forth herein, in the Restated Certificate of Incorporation, or in any other Certificate of Designations
creating a series of Preferred Stock or any similar stock or as otherwise required by law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt; text-align: right; font-size: 8pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">6.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Liquidation, Dissolution or Winding Up</U>. (a) Upon any liquidation, dissolution or winding up of the Corporation, no
distribution shall be made (i) to the holders of the Common Stock or of shares of any other stock of the Corporation ranking junior,
either as to dividends or upon liquidation, dissolution or winding up, to the Series A Preferred Stock unless, prior thereto, the
holders of shares of Series A Preferred Stock shall have received $1,000 per share, plus an amount equal to accrued and unpaid
dividends and distributions thereon, whether or not declared, to the date of such payment, <U>provided that</U>, the holders of
shares of Series A Preferred Stock shall be entitled to receive an aggregate amount per share, subject to the provision for adjustment
hereinafter set forth, equal to 1,000 times the aggregate amount to be distributed per share to holders of shares of Common Stock,
or (ii) to the holders of shares of stock ranking on a parity either as to dividends or upon liquidation, dissolution or winding
up with the Series A Preferred Stock, except distributions made ratably on the Series A Preferred Stock and all such parity stock
in proportion to the total amounts to which the holders of all such shares are entitled upon such liquidation, dissolution or winding
up. In the event, however, that there are not sufficient assets available to permit payment in full of the Series A Preferred Stock
liquidation preference and the liquidation preferences of all other classes and series of stock of the Corporation, if any, that
rank on a parity with the Series A Preferred Stock in respect thereof, then the assets available for such distribution shall be
distributed ratably to the holders of the Series A Preferred Stock and the holders of such parity shares in the proportion to their
respective liquidation preferences. In the event the Corporation shall at any time after the Issue Date (A) declare or pay any
dividend on the Common Stock payable in shares of Common Stock, or (B) effect a subdivision or combination or consolidation of
the outstanding shares of Common Stock (by reclassification or otherwise than by payment of a dividend in shares of Common Stock)
into a greater or lesser number of shares of Common Stock, then in each such case the aggregate amount to which holders of shares
of Series A Preferred Stock were entitled immediately prior to such event under the proviso in clause (i) of this <U>Section 6(a)</U>
shall be adjusted by multiplying such amount by a fraction the numerator of which is the number of shares of Common Stock outstanding
immediately after such event and the denominator of which is the number of shares of Common Stock that were outstanding immediately
prior to such event. In the event the Corporation shall at any time declare or pay any dividend on the Series A Preferred Stock
payable in shares of Series A Preferred Stock, or effect a subdivision, combination or consolidation of the outstanding shares
of Series A Preferred Stock (by reclassification or otherwise than by payment of a dividend in shares of Series A Preferred Stock)
into a greater or lesser number of shares of Series A Preferred Stock, then in each such case the aggregate amount to which holders
of shares of Series A Preferred Stock were entitled immediately prior to such event under the proviso in clause (i) of this <U>Section
6(a)</U> shall be adjusted by multiplying such amount by a fraction, the numerator of which is the number of shares of Series A
Preferred Stock that were outstanding immediately prior to such event and the denominator of which is the number of shares of Series
A Preferred Stock outstanding immediately after such event.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Neither the merger, consolidation or other business combination of the Corporation into or with another entity nor the merger,
consolidation or other business combination of any other entity into or with the Corporation (nor the sale, lease, exchange or
conveyance of all or substantially all of the property, assets or business of the Corporation) shall be deemed to be a liquidation,
dissolution or winding up of the Corporation within the meaning of this Section 6.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt; text-align: right; font-size: 8pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">7.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Consolidation,
Merger, etc.</U> Notwithstanding anything to the contrary contained herein, in case the Corporation shall enter into any consolidation,
merger, combination or other transaction in which the shares of Common Stock are converted into, exchanged for or changed into
other stock or securities, cash and/or any other property (payable in kind), then in any such case each share of Series A Preferred
Stock shall at the same time be similarly converted into, exchanged for or changed into an amount per share (subject to the provision
for adjustment hereinafter set forth) equal to 1,000 times the aggregate amount of stock, securities, cash and/or any other property
(payable in kind), as the case may be, into which or for which each share of Common Stock is converted or exchanged. In the event
the Corporation shall at any time after the Issue Date (i) declare or pay any dividend on the Common Stock payable in shares of
Common Stock, or (ii) effect a subdivision or combination or consolidation (by reclassification or otherwise than by payment of
a dividend in shares of Common Stock) of the outstanding shares of Common Stock into a greater or lesser number of shares of Common
Stock, then in each such case the amount set forth in the preceding sentence with respect to the conversion, exchange or change
of shares of Series A Preferred Stock shall be adjusted by multiplying such amount by a fraction, the numerator of which is the
number of shares of Common Stock outstanding immediately after such event and the denominator of which is the number of shares
of Common Stock that were outstanding immediately prior to such event. In the event the Corporation shall at any time declare
or pay any dividend on the Series A Preferred Stock payable in shares of Series A Preferred Stock, or effect a subdivision, combination
or consolidation of the outstanding shares of Series A Preferred Stock (by reclassification or otherwise than by payment of a
dividend in shares of Series A Preferred Stock) into a greater or lesser number of shares of Series A Preferred Stock, then in
each such case the amount set forth in the first sentence of this Section 7 with respect to the exchange or change of shares of
Series A Preferred Stock shall be adjusted by multiplying such amount by a fraction, the numerator of which is the number of shares
of Series A Preferred Stock that were outstanding immediately prior to such event and the denominator of which is the number of
shares of Series A Preferred Stock outstanding immediately after such event.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">8.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>No Redemption</U>. The shares of Series A Preferred Stock shall not be redeemable from any holder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">9.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Rank</U>. The Series A Preferred Stock shall rank, with respect to the payment of dividends and the distribution of assets
upon liquidation, dissolution or winding up of the Corporation, junior to all series of any other class of the Preferred Stock
issued either before or after the issuance of the Series A Preferred Stock, unless the terms of any such series shall provide otherwise,
and shall rank senior to the Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">10.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Amendment</U>. At such time as any shares of Series A Preferred Stock are outstanding, if any proposed amendment to the
Restated Certificate of Incorporation (including this Certificate of Designation) would materially alter, change or repeal any
of the preferences, powers or special rights given to the Series A Preferred Stock so as to affect the Series A Preferred Stock
adversely, then the holders of the Series A Preferred Stock shall be entitled to vote separately as a class upon such amendment,
and the affirmative vote of two-thirds of the outstanding shares of the Series A Preferred Stock, voting separately as a single
class, shall be necessary for the adoption thereof, in addition to such other vote as may be required by the DGCL.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt; text-align: right; font-size: 8pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">11.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Fractional Shares</U>. Series A Preferred Stock may be issued in fractions of a share that shall entitle the holder,
in proportion to such holder&rsquo;s fractional shares, to exercise voting rights, receive dividends, participate in distributions
and to have the benefit of all other rights of holders of Series A Preferred Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>IN WITNESS WHEREOF</B>,
the undersigned have signed and attested this Certificate of Designation on this 16th day of December 2020.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="text-transform: uppercase">ADMA BIOLOGICS, INC.</FONT></TD>
    </TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 35%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>By:</TD>
    <TD STYLE="border-bottom: Black 1pt solid">/s/ Adam S. Grossman</TD>
    </TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Name:&nbsp;</TD>
    <TD>Adam S. Grossman</TD>
    </TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Title:</TD>
    <TD>President and Chief Executive Officer</TD>
    </TR>
</TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%">Attest:</TD>
    <TD STYLE="width: 35%">&nbsp;</TD>
    <TD STYLE="width: 50%">&nbsp;</TD>
    </TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid">/s/ Brian Lenz</TD>
    <TD>&nbsp;</TD>
    </TR>
<TR STYLE="vertical-align: top">
    <TD>Name:&nbsp;</TD>
    <TD>Brian Lenz</TD>
    <TD>&nbsp;</TD>
    </TR>
<TR STYLE="vertical-align: top">
    <TD>Title:</TD>
    <TD>Executive Vice President and Chief Financial Officer</TD>
    <TD>&nbsp;</TD>
    </TR>
</TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.1
<SEQUENCE>3
<FILENAME>e620138_ex4-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: right; margin: 0">Exhibit 4.1</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">RIGHTS AGREEMENT</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">by and between<BR>
<BR>
</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase">ADMA
BIOLOGICS, INC.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase">continental
stock transfer and trust company</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-weight: normal">as Rights
Agent,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Dated as of December 16, 2020</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt; text-align: right; font-size: 8pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>TABLE OF CONTENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Page</B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>



<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%">
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman; background-color: rgb(204,238,255)">
    <TD STYLE="width: 90%; text-align: left; text-indent: -1in; padding-top: 0in; padding-bottom: 6pt; padding-left: 1in">Section 1.&nbsp;&nbsp;&nbsp;&#8239;&#8239;Certain Definitions</TD>
    <TD STYLE="width: 10%; text-align: right; padding-top: 0in; padding-bottom: 6pt">1</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman; background-color: White">
    <TD STYLE="text-align: left; text-indent: -1in; padding-top: 0in; padding-bottom: 6pt; padding-left: 1in">Section 2.&nbsp;&nbsp;&nbsp;&#8239;&#8239;Appointment of the Rights Agent</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 6pt">9</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -1in; padding-top: 0in; padding-bottom: 6pt; padding-left: 1in">Section 3.&nbsp;&nbsp;&nbsp;&#8239;&#8239;Issuance of Rights Certificates</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 6pt">10</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman; background-color: White">
    <TD STYLE="text-align: left; text-indent: -1in; padding-top: 0in; padding-bottom: 6pt; padding-left: 1in">Section 4.&nbsp;&nbsp;&nbsp;&#8239;&#8239;Form of Rights Certificates.</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 6pt">12</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -1in; padding-top: 0in; padding-bottom: 6pt; padding-left: 1in">Section 5.&nbsp;&nbsp;&nbsp;&#8239;&#8239;Countersignature and Registration</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 6pt">13</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman; background-color: White">
    <TD STYLE="text-align: left; text-indent: -1in; padding-top: 0in; padding-bottom: 6pt; padding-left: 1in">Section 6.&nbsp;&nbsp;&nbsp;&#8239;&#8239;Transfer, Split-Up, Combination, and Exchange of Rights Certificates; Mutilated, Destroyed, Lost or
Stolen Rights Certificates.</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 6pt">14</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -1in; padding-top: 0in; padding-bottom: 6pt; padding-left: 1in">Section 7.&nbsp;&nbsp;&nbsp;&#8239;&#8239;Exercise of Rights; Purchase Price; Expiration Date of Rights.</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 6pt">15</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman; background-color: White">
    <TD STYLE="text-align: left; text-indent: -1in; padding-top: 0in; padding-bottom: 6pt; padding-left: 1in">Section 8.&nbsp;&nbsp;&nbsp;&#8239;&#8239;Cancellation and Destruction of Rights Certificates</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 6pt">17</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -1in; padding-top: 0in; padding-bottom: 6pt; padding-left: 1in">Section 9.&nbsp;&nbsp;&nbsp;&#8239;&#8239;Reservation and Availability of Capital Stock</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 6pt">17</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman; background-color: White">
    <TD STYLE="text-align: left; text-indent: -1in; padding-top: 0in; padding-bottom: 6pt; padding-left: 1in">Section 10.&nbsp;&nbsp;&nbsp;Preferred Shares Record Date</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 6pt">19</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -1in; padding-top: 0in; padding-bottom: 6pt; padding-left: 1in">Section 11.&nbsp;&nbsp;&nbsp;Adjustment of Purchase Price, Number and Kind of Shares, or Number of Rights</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 6pt">19</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman; background-color: White">
    <TD STYLE="text-align: left; text-indent: -1in; padding-top: 0in; padding-bottom: 6pt; padding-left: 1in">Section 12.&nbsp;&nbsp;&nbsp;Certificate of Adjusted Purchase Price or Number of Shares</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 6pt">27</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -1in; padding-top: 0in; padding-bottom: 6pt; padding-left: 1in">Section 13.&nbsp;&nbsp;&nbsp;Consolidation, Merger, or Sale or Transfer of Assets, Cash Flow or Earning Power</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 6pt">27</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman; background-color: White">
    <TD STYLE="text-align: left; text-indent: -1in; padding-top: 0in; padding-bottom: 6pt; padding-left: 1in">Section 14.&nbsp;&nbsp;&nbsp;Fractional Rights and Fractional Shares</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 6pt">30</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -1in; padding-top: 0in; padding-bottom: 6pt; padding-left: 1in">Section 15.&nbsp;&nbsp;&nbsp;Rights of Action</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 6pt">31</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman; background-color: White">
    <TD STYLE="text-align: left; text-indent: -1in; padding-top: 0in; padding-bottom: 6pt; padding-left: 1in">Section 16.&nbsp;&nbsp;&nbsp;Agreement of Rights Holders</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 6pt">32</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -1in; padding-top: 0in; padding-bottom: 6pt; padding-left: 1in">Section 17.&nbsp;&nbsp;&nbsp;Rights Certificate Holder Not Deemed a Stockholder</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 6pt">32</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman; background-color: White">
    <TD STYLE="text-align: left; text-indent: -1in; padding-top: 0in; padding-bottom: 6pt; padding-left: 1in">Section 18.&nbsp;&nbsp;&nbsp;Concerning the Rights Agent</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 6pt">33</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -1in; padding-top: 0in; padding-bottom: 6pt; padding-left: 1in">Section 19.&nbsp;&nbsp;&nbsp;Merger or Consolidation or Change of Name of the Rights Agent</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 6pt">34</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman; background-color: White">
    <TD STYLE="text-align: left; text-indent: -1in; padding-top: 0in; padding-bottom: 6pt; padding-left: 1in">Section 20.&nbsp;&nbsp;&nbsp;Duties of the Rights Agent</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 6pt">34</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -1in; padding-top: 0in; padding-bottom: 6pt; padding-left: 1in">Section 21.&nbsp;&nbsp;&nbsp;Change of the Rights Agent</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 6pt">37</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman; background-color: White">
    <TD STYLE="text-align: left; text-indent: -1in; padding-top: 0in; padding-bottom: 6pt; padding-left: 1in">Section 22.&nbsp;&nbsp;&nbsp;Issuance of New Rights Certificates</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 6pt">38</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -1in; padding-top: 0in; padding-bottom: 6pt; padding-left: 1in">Section 23.&nbsp;&nbsp;&nbsp;Redemption and Termination</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 6pt">39</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman; background-color: White">
    <TD STYLE="text-align: left; text-indent: -1in; padding-top: 0in; padding-bottom: 6pt; padding-left: 1in">Section 24.&nbsp;&nbsp;&nbsp;Exchange of Rights.</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 6pt">39</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -1in; padding-top: 0in; padding-bottom: 6pt; padding-left: 1in">Section 25.&nbsp;&nbsp;&nbsp;Notice of Certain Events</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 6pt">41</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman; background-color: White">
    <TD STYLE="text-align: left; text-indent: -1in; padding-top: 0in; padding-bottom: 6pt; padding-left: 1in">Section 26.&nbsp;&nbsp;&nbsp;Notices</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 6pt">42</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -1in; padding-top: 0in; padding-bottom: 6pt; padding-left: 1in">Section 27.&nbsp;&nbsp;&nbsp;Supplements and Amendments</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 6pt">43</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman; background-color: White">
    <TD STYLE="text-align: left; text-indent: -1in; padding-top: 0in; padding-bottom: 6pt; padding-left: 1in">Section 28.&nbsp;&nbsp;&nbsp;Successors</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 6pt">43</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -1in; padding-top: 0in; padding-bottom: 6pt; padding-left: 1in">Section 29.&nbsp;&nbsp;&nbsp;Determinations and Actions by the Board</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 6pt">44</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt; text-align: right; font-size: 8pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>TABLE OF CONTENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(continued)</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Page</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%">
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -1in; padding-top: 0in; padding-bottom: 6pt; padding-left: 1in; width: 90%">Section 30.&nbsp;&nbsp;&nbsp;Benefits of this Agreement</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 6pt; width: 10%">44</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman; background-color: White">
    <TD STYLE="text-align: left; text-indent: -1in; padding-top: 0in; padding-bottom: 6pt; padding-left: 1in">Section 31.&nbsp;&nbsp;&nbsp;Severability</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 6pt">44</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -1in; padding-top: 0in; padding-bottom: 6pt; padding-left: 1in">Section 32.&nbsp;&nbsp;&nbsp;Governing Law</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 6pt">44</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman; background-color: White">
    <TD STYLE="text-align: left; text-indent: -1in; padding-top: 0in; padding-bottom: 6pt; padding-left: 1in">Section 33.&nbsp;&nbsp;&nbsp;Counterparts; Facsimiles and PDFs</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 6pt">44</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -1in; padding-top: 0in; padding-bottom: 6pt; padding-left: 1in">Section 34.&nbsp;&nbsp;&nbsp;Descriptive Headings</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 6pt">45</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman; background-color: White">
    <TD STYLE="text-align: left; text-indent: -1in; padding-top: 0in; padding-bottom: 6pt; padding-left: 1in">Section 35.&nbsp;&nbsp;&nbsp;Force Majeure</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 6pt">45</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -1in; padding-top: 0in; padding-bottom: 6pt; padding-left: 1in">Section 36.&nbsp;&nbsp;&nbsp;Further Assurance</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 6pt">45</TD></TR>
</TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2"><B>Exhibits</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 22%">&nbsp;</TD>
    <TD STYLE="width: 78%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD>Exhibit A:</TD>
    <TD><P STYLE="margin-top: 0; margin-bottom: 0">Form of Certificate of Designation of Series A Junior Participating Preferred Stock</P>
        <P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD>Exhibit B:</TD>
    <TD><P STYLE="margin-top: 0; margin-bottom: 0">Form of Rights Certificate</P>
        <P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD>Exhibit C:</TD>
    <TD>Form of Summary of Rights to Purchase Preferred Stock</TD></TR>
</TABLE>
<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt; text-align: right; font-size: 8pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">RIGHTS AGREEMENT</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This RIGHTS AGREEMENT,
dated as of December 16, 2020 (this &ldquo;<B>Agreement</B>&rdquo;), is by and between ADMA Biologics, Inc., a Delaware corporation
(the &ldquo;<B>Company</B>&rdquo;), and Continental Stock Transfer and Trust Company, as rights agent (the &ldquo;<B>Rights Agent</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">RECITALS</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, on December
16, 2020 (the &ldquo;<B>Rights Dividend Declaration Date</B>&rdquo;), the Board of Directors of the Company (the &ldquo;<B>Board</B>&rdquo;)
authorized and declared a dividend distribution of one preferred share purchase right (each, a &ldquo;<B>Right</B>&rdquo; and,
collectively, the &ldquo;<B>Rights</B>&rdquo;) for each Common Share (as hereinafter defined) outstanding at the Close of Business
(as hereinafter defined) on December 30, 2020 (the &ldquo;<B>Record Date</B>&rdquo;), with each Right initially representing the
right to purchase one one-thousandth (subject to adjustment in accordance with the provisions of this Agreement) of a Preferred
Share (as hereinafter defined) and having the rights, preferences and privileges set forth in the form of Certificate of Designation
of Series A Junior Participating Preferred Stock attached hereto as <U>Exhibit A</U>, upon the terms and subject to the conditions
set forth herein; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, the Board
further authorized and directed the issuance of one Right (subject to adjustment in accordance with the provisions of this Agreement)
with respect to each Common Share that becomes outstanding between the Record Date and the earlier of the Distribution Date and
the Expiration Date (as such terms are hereinafter defined); <U>provided</U>, <U>however</U><I>,</I> that Rights may be issued
with respect to Common Shares that shall become outstanding after the Distribution Date and prior to the Expiration Date in accordance
with Section 22 hereof;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">NOW, THEREFORE, in
consideration of the premises and the mutual agreements herein set forth, the parties, intending to be legally bound hereby, agree
as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 1.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Certain Definitions</U>. For purposes of this Agreement, the following terms have the meanings indicated:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>&ldquo;<B>Acquiring Person</B>&rdquo; shall mean any Person who or which, together with all Related Persons of such Person,
from and after the first public announcement by the Company of the adoption of this Agreement, is or becomes the Beneficial Owner
of ten percent (10%) or more of the Common Shares then outstanding, whether or not such Person continues to be the Beneficial Owner
of ten percent (10%) or more of the Common Shares then outstanding, but shall not include an Exempt Person or a Grandfathered Person.
Notwithstanding the foregoing: no Person shall become an Acquiring Person solely as a result of (i) (A) the grant or issuance by
the Company to its directors, officers and/or employees of any options, warrants, rights or similar interests to acquire Common
Shares by the Company pursuant to any employee benefit, stock incentive plan, stock option plan or stock ownership plan of the
Company adopted by the Board, and the subsequent vesting, exercise or conversion of such options, warrants, rights or similar interests,
(B) the grant or issuance by the Company to its directors, officers and/or employees of restricted Common Shares or restricted
stock units, pursuant to a restricted stock or other compensation plan or arrangement adopted by the Board, and/or the subsequent
vesting of such shares or stock units, (C) the acquisition of Common Shares by the Company or another Exempt Person which, by reducing
the number of</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt; text-align: right; font-size: 8pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">Common Shares
outstanding, increases the proportionate number of Common Shares beneficially owned by such Person, together with all Related
Persons of such Person, to ten percent (10%) or more of the Common Shares then outstanding; <U>provided</U>, <U>however</U><I>,
</I>that, if a Person shall become the Beneficial Owner of ten percent (10%) or more of the Common Shares then outstanding by
reason of acquisition of shares by an Exempt Person and shall, after the first public announcement by the Company or other Exempt
Person disclosing such share acquisitions by an Exempt Person, become the Beneficial Owner of any additional Common Shares (other
than pursuant to a stock split, reverse stock split, stock dividend, reclassification or similar transaction effected by the Company)
and immediately thereafter is the Beneficial Owner of ten percent (10%) or more of the Common Shares then outstanding, then such
Person shall be an Acquiring Person, (D) a dividend or distribution paid or made by the Company on the outstanding Common Shares
or pursuant to a stock split, subdivision or similar transaction effected by the Company in which all registered holders of Common
Shares are treated substantially equally, or (E) the acquisition of Common Shares directly from the Company; and (ii) (A) if the
Board determines that a Person who would otherwise be an Acquiring Person has become such inadvertently (including, without limitation,
because such Person was unaware that it beneficially owned a percentage of Common Shares that would otherwise cause such Person
to be an Acquiring Person, or such Person was aware of the extent of its Beneficial Ownership of Common Shares, but had no actual
knowledge of the consequences of such Beneficial Ownership under this Agreement and had no intention of changing or influencing
control of the Company), and (B) such Person and/or its Related Persons divests as promptly as practicable (and in any event within
five (5) Business Days after being so requested by the Company) a sufficient number of Common Shares so that such Person, together
with its Related Persons, is no longer the Beneficial Owner of ten percent (10%) or more of the Common Shares then outstanding
or, in the case solely of Derivative Interests, such Person terminates as promptly as practicable (and in any event within five
(5) Business Days after being so requested by the Company) the subject derivative transaction or transactions or disposes of the
subject derivative security or securities as promptly as practicable (and in any event within five (5) Business Days after being
so requested by the Company), or establishes to the satisfaction of the Board that such Derivative Interests are not held with
any intention of changing or influencing control of the Company, then such Person shall not be deemed to be or ever to have been
an Acquiring Person for any purposes of this Agreement as a result of such inadvertent acquisition.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>&ldquo;<B>Act</B>&rdquo; shall mean the Securities Act of 1933, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>&ldquo;<B>Adjustment Shares</B>&rdquo; shall have the meaning set forth in Section 11(a)(ii) hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>&ldquo;<B>Affiliate</B>&rdquo; and &ldquo;<B>Associate</B>&rdquo; shall have the respective meanings ascribed to such terms
in Rule 12b-2 of the General Rules and Regulations under the Exchange Act; <U>provided</U>, <U>however</U>, that no director or
officer of the Company shall be deemed an Affiliate or Associate of any other director or officer of the Company solely as a result
of his or her being a director or officer of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>&ldquo;<B>Agreement</B>&rdquo; shall have the meaning set forth in the preamble of this Agreement, as it may from time to
time be supplemented, amended, renewed, restated or extended pursuant to the applicable provisions hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(f)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>A Person shall be deemed the &ldquo;<B>Beneficial Owner</B>&rdquo; of, shall be deemed to have &ldquo;<B>Beneficial Ownership</B>&rdquo;
of, and shall be deemed to &ldquo;<B>beneficially own</B>&rdquo; any securities that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<!-- Field: Page; Sequence: 5; Options: NewSection -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">2</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt; text-align: right; font-size: 8pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>such
Person or any of such Person&rsquo;s Related Persons beneficially owns, directly or indirectly (as determined pursuant to Rule
13d-3 of the General Rules and Regulations under the Exchange Act);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>such Person or any of such Person&rsquo;s Related Persons, directly or indirectly, has the legal, equitable or contractual
right to acquire (whether such right is exercisable immediately, only after the passage of time, or upon the satisfaction of one
or more conditions (whether or not within the control of such Person), compliance with regulatory requirements or otherwise) pursuant
to any agreement, arrangement or understanding (whether or not in writing and other than customary agreements with and between
underwriters and selling group members with respect to a bona fide public offering of securities registered under the Securities
Act) or upon the exercise of conversion rights, exchange rights, other rights (other than the Rights), warrants, or options, or
otherwise; <U>provided</U>, <U>however</U>, that a Person shall not be deemed the &ldquo;Beneficial Owner&rdquo; of, to have &ldquo;Beneficial
Ownership&rdquo; of, or to &ldquo;beneficially own,&rdquo; (A) securities tendered pursuant to a tender offer or exchange offer
made in accordance with the General Rules and Regulations under the Exchange Act by or on behalf of such Person or any of such
Person&rsquo;s Related Persons until such tendered securities are accepted for purchase or exchange, (B) securities issuable upon
the exercise of Rights at any time prior to the occurrence of a Triggering Event, or (C) securities issuable upon the exercise
of Rights from and after the occurrence of a Triggering Event, which Rights were acquired by such Person or any of such Person&rsquo;s
Related Persons prior to the Distribution Date or pursuant to Section 3(a) or Section 22 hereof (the &ldquo;<B>Original Rights</B>&rdquo;)
or pursuant to Section 11(i) or Section 11(p) hereof in connection with an adjustment made with respect to any Original Rights;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(iii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>such Person or any of such Person&rsquo;s Related Persons, directly or indirectly, has the right to vote or dispose of,
including pursuant to any agreement, arrangement, or understanding (whether or not in writing); <U>provided</U>, <U>however</U><I>,
</I>that a Person shall not be deemed the &ldquo;Beneficial Owner&rdquo; of, to have &ldquo;Beneficial Ownership&rdquo; of, or
to &ldquo;beneficially own,&rdquo; any security as a result of an agreement, arrangement or understanding (whether or not in writing)
to vote such security if such agreement, arrangement or understanding: (A) arises solely from a revocable proxy or consent (as
such terms are defined in Regulation 14A under the Exchange Act) given to such Person in response to a public proxy or consent
solicitation made pursuant to, and in accordance with, the General Rules and Regulations promulgated under the Exchange Act to
more than ten (10) holders of shares of a class of stock of the Company registered under Section 12 of the Exchange Act, (B) is
not also then reportable by such Person on Schedule 13D under the Exchange Act (or any comparable or successor report); or (C)
arises solely because such security has been tendered pursuant to a tender or exchange offer made by such Person or any Related
Persons thereof until such tendered security is accepted for payment or exchange;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(iv)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>are beneficially owned, directly or indirectly, by any other Person (or any Related Person thereof) with which such Person
(or any of such Person&rsquo;s Related Persons) has any agreement, arrangement or understanding (whether or not in writing) for
the purpose of acquiring, holding, voting (except pursuant to a revocable proxy or consent as described in the proviso to Section
1(f)(iii)), or disposing of any voting securities of the Company; <U>provided</U>, <U>however</U><I>,</I> that nothing in this
Section 1(f)(iv) shall cause a Person engaged in business as an underwriter of securities to be the &ldquo;Beneficial Owner&rdquo;
of, to have &ldquo;Beneficial Ownership&rdquo; of, or to &ldquo;beneficially own,&rdquo; any securities acquired, or which such
Person has the right to acquire, as a result of customary agreements with and between underwriters and selling group members entered
into in connection with a bona fide public offering of securities registered under the Securities Act; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">3</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt; text-align: right; font-size: 8pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(v)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>are the subject of, or the reference securities for, or that underlie, any Derivative Interest of such Person or any of
such Person&rsquo;s Related Persons, with the number of Common Shares deemed beneficially owned being the notional or other number
of Common Shares specified in the documentation evidencing the Derivative Interest as being subject to being acquired upon the
exercise or settlement of the Derivative Interest or as the basis upon which the value or settlement amount of such Derivative
Interest is to be calculated in whole or in part or, if no such number of Common Shares is specified in such documentation, as
determined by the Board in its sole discretion to be the number of Common Shares to which the Derivative Interest relates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Notwithstanding anything
in this definition of Beneficial Ownership to the contrary, for all purposes of this Agreement, the phrase &ldquo;then outstanding,&rdquo;
when used with reference to a Person&rsquo;s Beneficial Ownership of securities of the Company, shall mean the number of such securities
then issued and outstanding together with the number of such securities not then actually issued and outstanding that such Person,
together with all Related Persons, would be deemed to beneficially own hereunder. The number of Common Shares not actually issued
and outstanding that such Person, together with all Related Persons of such Person, is otherwise deemed to beneficially own for
purposes of this Agreement shall be deemed to be issued and outstanding for the purpose of computing the percentage of the outstanding
number of Common Shares owned by such Person, together with all Related Persons of such Person, but shall not be deemed to be issued
and outstanding for the purpose of computing the percentage of outstanding Common Shares owned by any other Person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">No Person who is an
officer, director or employee of an Exempt Person shall be deemed, solely by reason of such Person&rsquo;s status or authority
as such, to be the &ldquo;Beneficial Owner&rdquo; of, to have &ldquo;Beneficial Ownership&rdquo; of or to &ldquo;beneficially own&rdquo;
any securities that are &ldquo;beneficially owned&rdquo; (as defined in this Section 1(f)), including, without limitation, in a
fiduciary capacity, by an Exempt Person or by any other such officer, director or employee of an Exempt Person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Notwithstanding any
of the foregoing, no Person shall be deemed to be the &ldquo;Beneficial Owner&rdquo; of, to have &ldquo;Beneficial Ownership&rdquo;
of or to &ldquo;beneficially own&rdquo; any securities which such Person or any of such Person&rsquo;s Related Persons would otherwise
be deemed to &ldquo;beneficially own&rdquo; pursuant to this Section 1(f) solely as a result of any merger or other acquisition
agreement between the Company and such Person (or one or more of such Person&rsquo;s Related Persons), or any tender, voting or
support agreement entered into by such Person (or one or more of such Person&rsquo;s Related Persons) in connection therewith,
if, prior to such Person becoming an Acquiring Person, the Board has approved such merger or other acquisition agreement, or such
tender, voting or support agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(g)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>&ldquo;<B>Board</B>&rdquo; shall have the meaning set forth in the recitals to this Agreement and also includes any duly
authorized committee thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">4</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt; text-align: right; font-size: 8pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(h)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>&ldquo;<B>Book Entry</B>&rdquo; shall mean an uncertificated book entry for any Common Share or Preferred Share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>&ldquo;<B>Business Day</B>&rdquo; shall mean any day other than a Saturday, Sunday or a day on which banking institutions
in the State of New York are authorized or obligated by law or executive order to close.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(j)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>&ldquo;<B>Bylaws</B>&rdquo; shall mean the Company&rsquo;s Amended and Restated By-laws, as in effect on the date hereof,
and as such may be amended, modified or restated from time to time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(k)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>&ldquo;<B>Close of Business</B>&rdquo; on any given date shall mean 5:00 p.m., New York City time, on such date; <U>provided</U>,
<U>however</U>, that if such date is not a Business Day, it shall mean 5:00 p.m., New York City time, on the next succeeding Business
Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(l)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>&ldquo;<B>Closing Price</B>&rdquo; of any security on any given day shall be the last sale price, regular way, of such security
or, in case no such sale takes place on such day, the average of the closing bid and asked prices, regular way, on the principal
trading market on which such security is then traded.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(m)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>&ldquo;<B>Common Shares</B>&rdquo; shall mean the shares of common stock, par value $0.0001 per share, of the Company or
any other shares of capital stock of the Company into which such shares shall be reclassified or exchanged, except that &ldquo;<B>Common
Shares</B>&rdquo; when used with reference to any Person other than the Company shall mean the capital stock of such Person with
the greatest voting power, or the equity securities or other equity interests having power to control or direct the management
of such Person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(n)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>&ldquo;<B>Common Stock Equivalents</B>&rdquo; shall have the meaning set forth in Section 11(a)(iii) hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(o)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>&ldquo;<B>Company</B>&rdquo; shall have the meaning set forth in the preamble hereto, except as otherwise provided in Section
13(a) hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(p)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>&ldquo;<B>Current Market Price</B>&rdquo; shall have the meaning set forth in Section 11(d) hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(q)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>&ldquo;<B>Current Value</B>&rdquo; shall have the meaning set forth in Section 11(a)(iii) hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(r)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><B>[Reserved.] </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(s)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>&ldquo;<B>Derivative Interest</B>&rdquo; shall mean any derivative securities (as defined under Rule 16a-1 under the Exchange
Act) that increase in value as the value of the underlying equity increases, including, but not limited to, a long convertible
security, a long call option and a short put option position, in each case, regardless of whether (i) such interest conveys any
voting rights in such security, (ii) such interest is required to be, or is capable of being, settled through delivery of such
security or (iii) transactions hedging the economic effect of such interest.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">5</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt; text-align: right; font-size: 8pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(t)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>&ldquo;<B>Distribution Date</B>&rdquo; shall mean the Close of Business on the earlier to occur of (i) the tenth (10th)
Business Day (or such later date as may be determined from time to time by action of a majority of the Board prior to the Distribution
Date that would otherwise have occurred) after the Shares Acquisition Date (or, if the tenth (10th) Business Day after the Shares
Acquisition Date occurs before the Record Date, then the Close of Business on the Record Date), or (ii) the tenth (10th) Business
Day (or such later date as may be determined from time to time by action of a majority of the Board prior to the Distribution Date
that would otherwise have occurred) after the date of the commencement of, or first public announcement of the intent of any Person
(other than an Exempt Person) to commence (within the meaning of Rule 14d-2(a) of the General Rules and Regulations under the Exchange
Act), following the first public announcement by the Company of the adoption of this Agreement, a tender or exchange offer, the
successful consummation of which would result in any Person (other than an Exempt Person) becoming an Acquiring Person, irrespective
of whether any shares are actually purchased or exchanged pursuant to such offer; <U>provided</U>, <U>however</U>, that if a tender
or exchange offer is terminated prior to the occurrence of a Distribution Date, then no Distribution Date shall occur as a result
of such tender or exchange offer. The Board may, if deferral is allowed in clause (i) or (ii) of the preceding sentence, defer
the date set forth in such clause, as applicable, to a specified later date or an unspecified later date to be determined by a
subsequent action or event.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(u)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>&ldquo;<B>Equivalent Preferred Shares</B>&rdquo; shall have the meaning set forth in Section 11(b) hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(v)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>&ldquo;<B>Exchange Act</B>&rdquo; shall mean the Securities Exchange Act of 1934, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(w)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp; </FONT>&ldquo;<B>Exchange Property</B>&rdquo; shall have the meaning set forth in Section 24(f)
hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(x)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>&ldquo;<B>Exchange Ratio</B>&rdquo; shall have the meaning set forth in Section 24(a) hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(y)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>&ldquo;<B>Exchange Recipients</B>&rdquo; shall have the meaning set forth in Section 24(f) hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(z)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>&ldquo;<B>Exempt Person</B>&rdquo; shall mean (i) the Company, (ii) any Subsidiary of the Company, (iii) any employee stock
ownership plan, employee benefit plan or other compensation program or arrangement of the Company or of any of its Subsidiaries,
or any Person holding Common Shares for or pursuant to the terms of any such plan, program or arrangement or for the purpose of
funding any such plan, program or arrangement, and (iv) any Person organized, appointed or established by the Company or any of
its Subsidiaries for or pursuant to the terms of any such plan, program or arrangement during the time such Person acts in such
capacity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(aa)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><B>[Reserved.]</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(bb)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>&ldquo;<B>Expiration Date</B>&rdquo; shall have the meaning set forth in Section 7(a) hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(cc)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>&ldquo;<B>Final Expiration Date</B>&rdquo; shall have the meaning set forth in Section 7(a) hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">6</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt; text-align: right; font-size: 8pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(dd)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>&ldquo;<B>General Rules and Regulations</B>&rdquo; shall mean Part 240, Subpart A &mdash;Rules and Regulations under the
Securities Exchange Act of 1934, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(ee)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>&ldquo;<B>Grandfathered Person</B>&rdquo; shall mean any Person who or which, together with all Related Persons of such
Person, would, as of the time immediately prior to the first public announcement by the Company of the adoption of this Agreement,
be deemed an &ldquo;Acquiring Person;&rdquo; <U>provided</U>, <U>however</U>, that such Person, together with all Related Persons,
shall cease to be a Grandfathered Person and shall become an Acquiring Person if, following the first public announcement by the
Company of the adoption of this Agreement, such Person, together with all Related Persons, shall acquire, without the prior approval
of the Board, Beneficial Ownership of any additional Common Shares (other than as a result of (i) the acquisition of Common Shares
on the date of such announcement pursuant to orders placed prior to such announcement, (ii) a stock dividend, stock split, reverse
stock split, subdivision or similar transaction effected by the Company in which all registered holders of Common Shares are treated
substantially equally, (iii) the grant or issuance by the Company to its directors, officers and/or employees of options, warrants,
rights or similar interests to acquire Common Shares by the Company pursuant to any employee benefit, stock incentive plan, stock
option plan or stock ownership plan of the Company adopted by the Board, and the subsequent vesting, exercise or conversion of
such options, warrants, rights or similar interests, (iv) the grant or issuance by the Company to its directors, officers and/or
employees of restricted Common Shares or restricted stock units pursuant to a restricted stock or other compensation plan or arrangement
adopted by the Board and/or the subsequent vesting of such shares or stock units, or (v) the acquisition of Common Shares directly
from the Company) while such Person (together with all Related Persons) is the Beneficial Owner of ten percent (10%) or more of
the Common Shares then outstanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(ff)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><B>[Reserved.] </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(gg)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>&ldquo;<B>Nasdaq&rdquo; </B>shall mean The Nasdaq Stock Market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(hh)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>&ldquo;<B>NYSE</B>&rdquo; shall mean the New York Stock Exchange.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>&ldquo;<B>Original Rights</B>&rdquo; shall have the meaning set forth in Section 1(f)(ii) hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(jj)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><B>[Reserved.] </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(kk)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&#8239;</FONT><B>[Reserved.] </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(ll)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>&ldquo;<B>Ownership Statements</B>&rdquo; shall have the meaning set forth in Section 3(a) hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(mm)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&#8239;&#8239;&nbsp;&nbsp;
</FONT>&ldquo;<B>Person</B>&rdquo; shall mean any individual, firm, corporation, partnership, limited liability company, limited
liability partnership, trust, association, syndicate or other entity, and shall include any successor (by merger or otherwise)
of such entity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(nn)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>&ldquo;<B>Preferred Shares</B>&rdquo; shall mean shares of Series A Junior Participating Preferred Stock, par value $0.0001
per share, of the Company having the relative rights, preferences and limitations set forth in the form of Certificate of Designation
attached to this Agreement as <U>Exhibit A</U>, and, to the extent that there are not a sufficient number of shares of Series A
Junior Participating Preferred Stock authorized to permit the full exercise of the Rights, any other series of preferred stock
of the Company designated for such purpose containing terms substantially similar to the terms of the Series A Junior Participating
Preferred Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">7</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt; text-align: right; font-size: 8pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(oo)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>&ldquo;<B>Principal Party</B>&rdquo; shall have the meaning set forth in Section 13(b) hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(pp)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>&ldquo;<B>Purchase Price</B>&rdquo; shall have the meaning set forth in Section 7(b) hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(qq)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#8239;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><B>[Reserved.] </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(rr)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><B>[Reserved.]</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(ss)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>&ldquo;<B>Record Date</B>&rdquo; shall have the meaning set forth in the recitals hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(tt)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>&ldquo;<B>Redemption Date</B>&rdquo; shall have the meaning set forth in Section 7(a) hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(uu)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>&ldquo;<B>Redemption Period</B>&rdquo; shall have the meaning set forth in Section 23(a) hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(vv)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>&ldquo;<B>Redemption Price</B>&rdquo; shall have the meaning set forth in Section 23(a) hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(ww)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&#8239;&#8239;&nbsp;&nbsp;
</FONT>&ldquo;<B>Related Person</B>&rdquo; shall mean, as to any Person, any Affiliates or Associates of such Person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(xx)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>&ldquo;<B>Restated Certificate of Incorporation</B>&rdquo; shall mean the Company&rsquo;s Second Amended and Restated Certificate
of Incorporation, as such may be further amended, modified or restated from time to time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(yy)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>&ldquo;<B>Right</B>&rdquo; shall have the meaning set forth in the recitals to this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(zz)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>&ldquo;<B>Rights Agent</B>&rdquo; shall have the meaning set forth in the preamble of this Agreement, except as otherwise
provided in Section 19 and Section 21 hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(aaa)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>&ldquo;<B>Rights Certificate</B>&rdquo; shall have the meaning set forth in Section 3(a) hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(bbb)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>&ldquo;<B>Rights Dividend Declaration Date</B>&rdquo; shall have the meaning set forth in the recitals to this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(ccc)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>&ldquo;<B>SEC</B>&rdquo; shall mean the U.S. Securities and Exchange Commission and any successor agency or instrumentality
of the United States government.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(ddd)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>&ldquo;<B>Section 11(a)(ii) Event</B>&rdquo; shall have the meaning set forth in Section 11(a)(ii) hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(eee)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>&ldquo;<B>Section 11(a)(ii) Trigger Date</B>&rdquo; shall have the meaning set forth in Section 11(a)(iii) hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">8</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt; text-align: right; font-size: 8pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(fff)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>&ldquo;<B>Section 13 Event</B>&rdquo; shall mean any event described in Section 13(a)(i), Section 13(a)(ii) or Section 13(a)(iii)
hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(ggg)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>&ldquo;<B>Securities Act</B>&rdquo; shall mean the Securities Act of 1933, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(hhh)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>&ldquo;<B>Shares Acquisition Date</B>&rdquo; shall mean the first date of public announcement (which, for purposes of this
definition, shall include, without limitation, the filing of a report or an amendment thereto with the SEC pursuant to the Exchange
Act or pursuant to a comparable successor statute) by the Company or an Acquiring Person indicating that an Acquiring Person has
become such or that discloses information which reveals the existence of an Acquiring Person; <U>provided</U>, <U>however</U><I>,</I>
that if a Person is determined by the Board, in its sole discretion, not to have become an Acquiring Person pursuant to Section
1(a)(ii), then no Shares Acquisition Date shall be deemed to have occurred.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(iii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><B>[Reserved.]</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(jjj)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><B>[Reserved.]</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(kkk)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#8239;&#8239;
</FONT><B>[Reserved.] </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(lll)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>&ldquo;<B>Spread</B>&rdquo; shall have the meaning set forth in Section 11(a)(iii) hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(mmm)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT> &ldquo;<B>Subsidiary</B>&rdquo; shall mean, with reference to any Person, any corporation or other Person of which an amount
of voting securities (or other ownership interests having ordinary voting power) sufficient to elect at least a majority of the
directors (or other Persons performing similar functions) of such corporation or other Person is beneficially owned, directly or
indirectly, by such first mentioned Person, or otherwise controlled by such first mentioned Person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(nnn)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>&ldquo;<B>Substitution Period</B>&rdquo; shall have the meaning set forth in Section 11(a)(iii) hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(ooo)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>&ldquo;<B>Summary of Rights</B>&rdquo; shall have the meaning set forth in Section 3(b) hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(ppp)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>&ldquo;<B>Trading Day</B>&rdquo; shall mean a day on which the principal national securities exchange on which the Common
Shares are listed or admitted to trading is open for the transaction of business or, if the Common Shares are not listed or admitted
to trading on any national securities exchange, a Business Day; provided, that if such security is not listed or quoted on the
NYSE or the Nasdaq and the principal market for such security is a non-U.S. securities exchange, then &ldquo;Trading Day&rdquo;
shall mean a day on which such non-U.S. securities exchange is open for the transaction of business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(qqq)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>&ldquo;<B>Triggering Event</B>&rdquo; shall mean a Section 11(a)(ii) Event or any Section 13 Event.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 2.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Appointment of the Rights Agent</U>. The Company hereby appoints the Rights Agent to act as rights agent for the Company
in accordance with the express terms and conditions hereof (and not implied terms and conditions), and the Rights Agent hereby
accepts such appointment. The Company may from time to time appoint such co-rights agents as it may deem necessary or desirable,
upon ten (10) calendar days&rsquo; prior written notice to the Rights Agent. In the event the Company appoints one or more co-rights
agents, the respective duties of the Rights Agent and any co-rights agents under the provisions of this Agreement shall be as the
Company reasonably determines, and the Company shall notify, in writing, the Rights Agent and any co-rights agents of such duties.
The Rights Agent shall have no duty to supervise, and shall in no event be liable for, the acts or omissions of any such co-rights
agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">9</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt; text-align: right; font-size: 8pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 3.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Issuance of Rights Certificates</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Until the Distribution Date (i) the Rights will be evidenced (subject to Section 3(b) and Section 3(c) hereof) by the certificates
for the Common Shares registered in the names of the holders of the Common Shares (which certificates for Common Shares shall be
deemed also to be certificates for Rights) or by the Book Entry Common Shares registered in the name of the holders, evidenced
by notation in accounts reflecting current ownership statements issued with respect to uncertificated Common Shares in lieu of
such certificates (&ldquo;<B>Ownership Statements</B>&rdquo;) (which Book Entry Common Shares, including any Ownership Statements,
shall be deemed also to be certificates for Rights) and not by separate certificates, and the registered holders of the Common
Shares shall also be the registered holders of the associated Rights, and (ii) the Rights will be transferable only in connection
with the transfer of the underlying Common Shares (including a transfer to the Company). As soon as practicable after the Distribution
Date, the Company shall prepare and execute, and upon the written request of the Company, the Rights Agent shall countersign and
the Company will send or cause to be sent (and the Rights Agent will, if so requested and provided with all necessary information
and documents will, at the expense of the Company, send), in accordance with Section 26 hereof, to each record holder of the Common
Shares as of the Close of Business on the Distribution Date (other than an Acquiring Person or any Related Person of an Acquiring
Person), one or more rights certificates, in substantially the form of <U>Exhibit B</U> attached hereto (the &ldquo;<B>Rights Certificates</B>&rdquo;),
evidencing one Right for each Common Share so held, subject to adjustment as provided herein. In the event that an adjustment in
the number of Rights per Common Share has been made pursuant to Section 11(i) or Section 11(p) hereof, at the time of distribution
of the Rights Certificates, the Company shall not be required to issue Rights Certificates evidencing fractional Rights but may,
in lieu thereof, make the necessary and appropriate rounding adjustments (in accordance with Section 14(a) hereof) so that Rights
Certificates evidencing only whole numbers of Rights are distributed and cash is paid in lieu of any fractional Rights. As of and
after the Distribution Date, the Rights will be evidenced solely by such Rights Certificates. The Company shall promptly notify
the Rights Agent in writing upon the occurrence of the Distribution Date. Until such written notice is received by the Rights Agent,
the Rights Agent may presume conclusively for all purposes that the Distribution Date has not occurred.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>As promptly as practicable following the Record Date, the Company shall make available a copy of a Summary of Rights, in
substantially the form attached hereto as <U>Exhibit C</U> (the &ldquo;<B>Summary of Rights</B>&rdquo;), to each record holder
of Common Shares as of the Close of Business on the Record Date who may so request from the Company (in accordance with Section
26 hereof) a copy from time to time prior to the Expiration Date. With respect to Common Shares outstanding as of the Record Date,
or issued subsequent to the Record Date, until the earlier of the Distribution Date and the Expiration Date, the Rights associated
with such Common Shares will be evidenced by the certificate or Book Entry Common Shares registered in the names of the holders
thereof, in each case together with the Summary of Rights. Until the earlier of the Distribution Date and the Expiration Date,
the surrender for transfer of any certificate or the transfer of any Book Entry Common Shares outstanding on the Record Date, with
or without a copy of the Summary of Rights, shall also constitute the transfer of the Rights associated with the Common Shares
evidenced thereby.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">10</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt; text-align: right; font-size: 8pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Rights shall without any further action, be issued in respect of all Common Shares that are issued (whether originally issued
or from the Company&rsquo;s treasury) after the Record Date but prior to the earlier of the Distribution Date and the Expiration
Date and, to the extent provided in Section 22 hereof, in respect of Common Shares issued after the Distribution Date. Certificates
and Book Entry Common Shares evidencing such Common Shares shall have printed or otherwise affixed to them a legend in substantially
the following form:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1in; text-align: justify">&ldquo;This [certificate/statement] also
evidences and entitles the registered holder hereof to certain Rights as set forth in the Rights Agreement between ADMA Biologics,
Inc., a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;), and Continental Stock Transfer and Trust Company, as rights agent
(or any successor rights agent) (the &ldquo;<U>Rights Agent</U>&rdquo;), dated as of December 16, 2020, as the same may be amended,
extended or renewed from time to time (the &ldquo;<U>Rights Agreement</U>&rdquo;), the terms of which are hereby incorporated herein
by reference and a copy of which is on file at the principal executive offices of the Company. Under certain circumstances, as
set forth in the Rights Agreement, such Rights will be evidenced by separate certificates and will no longer be evidenced by this
[certificate/statement]. The Company will mail to the registered holder of this [certificate/statement], without charge, a copy
of the Rights Agreement, as in effect on the date of mailing, promptly after receipt of a written request therefor. Under certain
circumstances set forth in the Rights Agreement, Rights which are issued or transferred to, which are or have been beneficially
owned by an Acquiring Person or any Related Person thereof (as such capitalized terms are defined in the Rights Agreement) or any
purported subsequent holder of such Rights will become null and void and will no longer be transferable. The Rights shall not be
exercisable, and shall be void so long as held, by a holder in any jurisdiction where the requisite qualification to the issuance
to such holder, or the exercise by such holder, of the Rights in such jurisdiction shall not have been obtained or be obtainable.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1in; text-align: justify"></P>

<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">11</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt; text-align: right; font-size: 8pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">With respect to any
Book Entry Common Share, such legend shall be included in the Ownership Statement in respect of such Common Share or in a notice
to the record holder of such Common Share in accordance with applicable law. With respect to such certificates or Ownership Statements
containing the foregoing legend, until the earlier of the Distribution Date and the Expiration Date, the Rights associated with
the Common Shares evidenced by such certificates or Book Entry Common Shares shall be evidenced by such certificates or such Book
Entry Common Shares (including any Ownership Statements) alone and the surrender for transfer of any certificate or transfer of
any Book Entry Common Share shall also constitute the transfer of the Rights associated with the Common Shares evidenced thereby.
Notwithstanding this Section 3(c) or anything to the contrary that may be contained elsewhere in this Agreement, neither the failure
to print the foregoing legend on any certificates representing Common Shares or any defect that may be contained in the legend
that is so printed, nor the failure to provide the notice thereof to the holder of any Book Entry Shares, shall affect the enforceability
of any part of this Agreement or the rights of any holder of the Rights. In the event the Company purchases or otherwise acquires
any Common Shares after the Record Date but prior to the Distribution Date, any Rights associated with such Common Shares shall
be deemed cancelled and retired so that the Company shall not be entitled to exercise any Rights associated with such Common Shares
that are no longer outstanding. In the event that any Common Shares are not represented by certificates, references in this Agreement
to certificates shall be deemed to refer to the notations in the book entry accounts reflecting ownership of such shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">After the Record Date
but prior to the earlier of the Distribution Date and the Expiration Date, if new certificate(s) representing Common Shares are
issued in connection with the transfer, split-up, combination or exchange of certificate(s) representing Common Shares or if new
certificate(s) representing Common Shares are issued to replace any certificate(s) that have been mutilated, destroyed, lost, or
stolen, then such new certificate(s) shall bear a legend in substantially the form of the foregoing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 4.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Form of Rights Certificates</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Rights Certificates (and the forms of election to purchase and of assignment and the certificates contained therein
to be printed on the reverse thereof) shall each be substantially in the form attached hereto as <U>Exhibit B</U> and may have
such marks of identification or designation and such legends, summaries or endorsements printed thereon as the Company may deem
appropriate (but which do not affect the rights, duties, liabilities or responsibilities of the Rights Agent) and as are not inconsistent
with the provisions of this Agreement, or as may be required to comply with any applicable law or with any rule or regulation made
pursuant thereto or with any law, rule or regulation of any national securities exchange on which the Rights may from time to time
be listed, or to conform to usage. Subject to the provisions of Section 22 hereof, the Rights Certificates, whenever distributed,
shall be dated as of the Record Date and on their face shall entitle the registered holders thereof to purchase such number of
one one-thousandths of a Preferred Share as shall be set forth therein at the Purchase Price, but the amount and type of securities,
cash or other assets that may be acquired upon the exercise of each Right and the Purchase Price thereof shall be subject to adjustment
as provided in this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Any Rights Certificate issued pursuant hereto that represents Rights beneficially owned by: (i) an Acquiring Person or any
Related Person of an Acquiring Person, (ii) a transferee of an Acquiring Person (or of any such Related Person) who becomes a transferee
after the Acquiring Person becomes such, or (iii) a transferee of an Acquiring Person (or of any such Related Person) who becomes
a transferee prior to or concurrently with the Acquiring Person becoming such and receives such Rights pursuant to either (A) a
transfer (whether or not for consideration) from the Acquiring Person (or any such Related Person) to holders of equity interests
in such Acquiring Person or to any Person with whom such Acquiring Person has any continuing agreement, arrangement or understanding
(whether or not in writing) regarding the transferred Rights, or (B) a transfer which the Board, in its sole discretion, has determined
is part of a plan, arrangement or understanding which has as a primary purpose or effect the avoidance of Section 7(e) hereof,
and any Rights Certificate issued pursuant to Section 6 or Section 11 hereof upon transfer, exchange, replacement or adjustment
of any other Rights Certificate referred to in this sentence, shall contain (to the extent feasible, and only if the Company has
provided specific written instructions to the Rights Agent) a legend in substantially the following form:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">12</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt; text-align: right; font-size: 8pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1in; text-align: justify">&ldquo;The Rights evidenced by this Rights
Certificate are or were beneficially owned by a Person who was or became an Acquiring Person or a Related Person of an Acquiring
Person (as such capitalized terms are defined in the Rights Agreement by and between ADMA Biologics, Inc., a Delaware corporation,
and Continental Stock Transfer and Trust Company, as Rights Agent (or any successor rights agent), dated as of December 16, 2020,
as the same may be amended, extended or renewed from time to time (the &ldquo;<U>Rights Agreement</U>&rdquo;)). Accordingly, this
Rights Certificate and the Rights evidenced hereby may become null and void in the circumstances specified in Section 7(e) of the
Rights Agreement and may no longer be transferable.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company shall give
written notice to the Rights Agent promptly after it becomes aware of the existence and identity of any Acquiring Person or any
Related Person thereof. Until such notice is received by the Rights Agent, the Rights Agent may presume conclusively for all purposes
that no Person has become an Acquiring Person or a Related Person of an Acquiring Person. The Company shall instruct the Rights
Agent in writing of the Rights which should be so legended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Notwithstanding this
Section 4(b) or anything to the contrary that may be contained elsewhere in this Agreement, the omission of the foregoing legend
or any legend substantially similar thereto shall not affect the enforceability of any part of this Agreement or the rights of
any registered holder of Rights Certificates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 5.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Countersignature and Registration</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Rights Certificates shall be duly executed on behalf of the Company by its Chairman of the Board and Principal Executive
Officer, or any Vice President and the Principal Financial Officer, or the Secretary or an Assistant Secretary, either manually
or by facsimile or portable document format signature. The Rights Certificates shall be countersigned by an authorized signatory
of the Rights Agent, either manually or by facsimile or portable document format signature, and shall not be valid for any purpose
unless so countersigned. In case any officer of the Company who shall have signed any of the Rights Certificates shall cease to
be such officer of the Company before countersignature by an authorized signatory of the Rights Agent and issuance and delivery
by the Company, such Rights Certificates, nevertheless, may be countersigned by an authorized signatory of the Rights Agent and
issued and delivered by the Company with the same force and effect as though the Person who signed such Rights Certificates had
not ceased to be such officer of the Company; and any Rights Certificates may be signed on behalf of the Company by any Person
who, at the actual date of the execution of such Rights Certificate, shall be a proper officer of the Company to sign such Rights
Certificate, although at the date of the execution of this Agreement any such Person was not such an officer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">13</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt; text-align: right; font-size: 8pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Following the Distribution Date, and receipt by the Rights Agent of written notice to that effect and all other relevant
and necessary information and documents referred to in Section 3(a), the Rights Agent will keep, or cause to be kept, at its office
or offices designated as the appropriate place for surrender of Rights Certificates upon exercise or transfer, books for registration
and transfer of the Rights Certificates issued hereunder. Such books shall show the names and addresses of the respective holders
of the Rights Certificates, the number of Rights evidenced on its face by each of the Rights Certificates, and the date of each
of the Rights Certificates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 6.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Transfer, Split-Up, Combination, and Exchange of Rights Certificates; Mutilated, Destroyed, Lost or Stolen Rights Certificates</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Subject to the provisions of Section 4(b), Section 7(e) and Section 14 hereof, at any time after the Close of Business on
the Distribution Date, and at or prior to the Close of Business on the Expiration Date, any Rights Certificate or Rights Certificates
(other than Rights Certificates representing Rights that have become null and void pursuant to Section 7(e) hereof, or evidencing
Rights that have been redeemed or exchanged pursuant to Section 23 or Section 24 hereof) may be transferred, split-up, combined
or exchanged for another Rights Certificate or Rights Certificates, entitling the registered holder to purchase a like number of
one one-thousandths of a Preferred Share (or, following the occurrence of a Triggering Event, Common Shares, other securities,
cash or other assets, as the case may be) as the Rights Certificate or Rights Certificates surrendered then entitles such holder
(or former holder in the case of a transfer) to purchase. Any registered holder desiring to transfer, split-up, combine or exchange
any Rights Certificate or Rights Certificates shall make such request in writing delivered to the Rights Agent, and shall surrender,
together with any required form of assignment duly executed and properly completed, the Rights Certificate or Rights Certificates
to be transferred, split-up, combined, or exchanged, with the form of assignment and certificate contained therein properly completed
and duly executed and with all signatures guaranteed and any other such documentation that the Rights Agent shall reasonably request,
at the office or offices of the Rights Agent designated for such purpose. The Rights Certificates are transferable only on the
registry books of the Rights Agent. Neither the Rights Agent nor the Company shall be obligated to take any action whatsoever with
respect to the transfer of any such surrendered Rights Certificate until the registered holder shall have: (i) properly completed
and duly executed the certificate contained in the form of assignment on the reverse side of such Rights Certificate; (ii) provided
such additional evidence of the identity of the Beneficial Owner (or former Beneficial Owner) of the Rights represented by such
Rights Certificate or Related Persons thereof as the Company or the Rights Agent shall reasonably request; and (iii) paid a sum
sufficient to cover any tax or charge that may be imposed in connection with any transfer, split up, combination or exchange of
Rights Certificates as required by Section 9(e) hereof. Thereupon the Rights Agent shall, subject to Section 4(b), Section 7(e),
Section 14 and Section 24 hereof, countersign and deliver to the Person entitled thereto a Rights Certificate or Rights Certificates,
as the case may be, as so requested. The Company may require payment from a registered holder of a Rights Certificate of a sum
sufficient to cover any tax or governmental charge that may be imposed in connection with any transfer, split-up, combination,
or exchange of Rights Certificates. If and to the extent the Company does require payment of any such taxes or charges, the Company
shall give the Rights Agent prompt written notice thereof and the Rights Agent shall not deliver any Rights Certificate unless
and until it is satisfied that all such payments have been made, and the Rights Agent shall forward any such sum collected by it
to the Company or to such Persons as the Company specifies by written notice. The Rights Agent shall have no duty or obligation
to take any action with respect to a holder of a Rights Certificate under any Section of this Agreement which requires the payment
by such holder of a Rights Certificate of applicable taxes and/or charges unless and until it is satisfied that all such taxes
and/or charges have been paid.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">14</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt; text-align: right; font-size: 8pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Subject to the provisions of this Agreement, at any time after the Distribution Date and prior to the Expiration Date, upon
receipt by the Company and the Rights Agent of evidence reasonably satisfactory to them of the loss, theft, destruction or mutilation
of a Rights Certificate, and, in the case of loss, theft or destruction, of indemnity or security reasonably satisfactory to them,
and reimbursement to the Company and the Rights Agent of all reasonable expenses incidental thereto, and upon surrender to the
Rights Agent and cancellation of the Rights Certificate, if mutilated, the Company will execute and deliver a new Rights Certificate
of like tenor to the Rights Agent for countersignature and delivery to the registered holder in lieu of the Rights Certificate
so lost, stolen, destroyed or mutilated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 7.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&#8239;&nbsp;&nbsp;&nbsp; </FONT><U>Exercise of Rights; Purchase Price; Expiration Date of Rights</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Subject to Section 7(e) hereof or as otherwise provided in this Agreement, at any time after the Distribution Date the registered
holder of any Rights Certificate may exercise the Rights evidenced thereby (except as otherwise provided herein including, without
limitation, the restrictions on exercisability set forth in Section 9(c), Section 11(a)(iii), and Section 23(a) hereof) in whole
or in part upon surrender of the Rights Certificate, with the form of election to purchase and the certificate contained therein
properly completed and duly executed, to the Rights Agent at the office or offices of the Rights Agent designated for such purpose,
accompanied by a signature guarantee and such other documentation as the Rights Agent may reasonably request, together with payment
of the aggregate Purchase Price with respect to the total number of one one-thousandths of a Preferred Share (or, following the
occurrence of a Triggering Event, Common Shares, other securities, cash or other assets, as the case may be) as to which such surrendered
Rights are then exercisable, at or prior to the earliest of (i) the Close of Business on December 15, 2021 (the &ldquo;<B>Final
Expiration Date</B>&rdquo;), (ii) the time at which the Rights are redeemed as provided in Section 23 hereof (the &ldquo;<B>Redemption
Date</B>&rdquo;), and (iii) the time at which the Rights are exchanged in full as provided in Section 24 hereof (the earliest of
(i), (ii), and (iii) being herein referred to as the &ldquo;<B>Expiration Date</B>&rdquo;). Except for those provisions herein
that expressly survive the termination of this Agreement, this Agreement shall terminate at such time as the Rights are no longer
exercisable hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The purchase price for each one one-thousandth of a Preferred Share pursuant to the exercise of a Right initially shall
be $12.50, shall be subject to adjustment from time to time as provided in Section 11 and Section 13(a) hereof, and shall be
payable in accordance with Section 7(c) hereof (such purchase price, as so adjusted, the &ldquo;<B>Purchase Price</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">15</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt; text-align: right; font-size: 8pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Upon receipt of a Rights Certificate evidencing exercisable Rights, with the form of election to purchase and the certificate
contained therein properly completed and duly executed, accompanied by payment, with respect to each Right so exercised, of the
Purchase Price (as such amount may be adjusted as provided herein) per one one-thousandth of a Preferred Share (or, following the
occurrence of a Triggering Event, Common Shares, other securities, cash or other assets, as the case may be) to be purchased as
set forth below and an amount equal to any applicable tax or charge, the Rights Agent shall, subject to Section 7(f) and Section
20(k) hereof, thereupon promptly (i) (A) requisition from any transfer agent of the Preferred Shares (or make available, if the
Rights Agent is the transfer agent for such shares) certificates for the total number of one one-thousandths of a Preferred Share
to be purchased and the Company hereby irrevocably authorizes its transfer agent to comply with all such requests, or (B) if, subject
to Section 14 hereof, the Company shall have elected to deposit the total number of Preferred Shares issuable upon exercise of
the Rights hereunder with a depositary agent, requisition from the depositary agent of depositary receipts evidencing such number
of one one-thousandths of a Preferred Share as are to be purchased (in which case certificates for the Preferred Shares evidenced
by such receipts shall be deposited by the transfer agent with the depositary agent) and the Company will direct the depositary
agent to comply with such request, (ii) if necessary to comply with this Agreement, requisition from the Company the amount of
cash, if any, to be paid in lieu of fractional shares in accordance with Section 14 hereof, (iii) after receipt of such certificates
or depositary receipts, subject to Section 7(f) below, cause the same to be delivered to or upon the order of the registered holder
of such Rights Certificate, registered in such name or names as may be designated by such holder, and (iv) if necessary to comply
with this Agreement, after receipt thereof, subject to Section 7(f) below, deliver such cash, if any, to or upon the order of the
registered holder of such Rights Certificate. The payment of the Purchase Price (as such amount may be reduced pursuant to Section
11(a)(iii) hereof) shall be made in cash or by certified bank check or bank draft payable to the order of the Company. In the event
that the Company is obligated to issue other securities (including Common Shares) of the Company, pay cash or distribute other
property pursuant to Section 11(a) hereof, the Company will make all arrangements necessary so that such other securities, cash
or other property are available for distribution by the Rights Agent, if and when necessary to comply with this Agreement, and
until so received, the Rights Agent shall have no duties or obligations with respect to such securities, cash and/or other property.
The Company reserves the right to require prior to the occurrence of a Triggering Event that, upon any exercise of Rights, a number
of Rights be exercised so that only whole Preferred Shares would be issued.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>In case the registered holder of any Rights Certificate shall exercise less than all the Rights evidenced thereby, a new
Rights Certificate evidencing the Rights remaining unexercised shall be issued by the Rights Agent and delivered to, or upon the
order of, the registered holder of such Rights Certificate, registered in such name or names as may be designated by such holder,
subject to the provisions of Section 6 and Section 14 hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Notwithstanding anything in this Agreement to the contrary, from and after the first occurrence of a Section 11(a)(ii) Event,
any Rights beneficially owned by (i) an Acquiring Person or a Related Person of an Acquiring Person, (ii) a transferee of an Acquiring
Person (or of any Related Person thereof) who becomes a transferee after the Acquiring Person becomes such, or (iii) a transferee
of an Acquiring Person (or of any Related Person thereof) who becomes a transferee prior to or concurrently with the Acquiring
Person becoming such and receives such Rights pursuant to either (A) a transfer (whether or not for consideration) from the Acquiring
Person (or any such Related Person) to holders of equity interests in such Acquiring Person (or any such Related Person) or to
any Person with whom the Acquiring Person (or any such Related Person) has any continuing agreement, arrangement or understanding
(whether or not in writing) regarding the transferred Rights or (B) a transfer that the Board, in its sole discretion, has determined
is part of a plan, arrangement or understanding (whether or not in writing) that has as a primary purpose or effect the avoidance
of this Section 7(e), shall become null and void without any further action and no holder of such Rights shall have any rights
whatsoever with respect to such Rights, whether under any provision of this Agreement, the Rights Certificates or otherwise. The
Company shall notify the Rights Agent when this Section 7(e) applies and shall use all reasonable efforts to ensure that the provisions
of this Section 7(e) and Section 4(b) hereof are complied with, but neither the Company nor the Rights Agent shall have any liability
to any holder of Rights Certificates or any other Person as a result of its failure to make any determinations with respect to
an Acquiring Person or any of its Related Persons or transferees hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">16</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt; text-align: right; font-size: 8pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(f)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Notwithstanding anything in this Agreement or any Rights Certificate to the contrary, neither the Rights Agent nor the Company
shall be obligated to undertake any action with respect to a registered holder of a Rights Certificate upon the occurrence of any
purported exercise as set forth in this Section 7 unless such registered holder shall have (i) properly completed and duly executed
the certificate contained in the form of election to purchase set forth on the reverse side of the Rights Certificate surrendered
for such exercise, and (ii) provided such additional evidence of the identity of the Beneficial Owner (or Related Persons thereof)
or former Beneficial Owner (or Related Persons thereof) of the Rights represented by the Rights Certificate as the Company or the
Rights Agent shall reasonably request.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 8.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><U>Cancellation and Destruction of Rights
Certificates</U>. All Rights Certificates surrendered for the purpose of exercise, transfer, split-up, combination or
exchange shall, if surrendered to the Company or any of its agents, be delivered to the Rights Agent for cancellation or in
cancelled form, or, if surrendered to the Rights Agent, shall be cancelled by it, and no Rights Certificates shall be issued
in lieu thereof except as expressly permitted by any of the provisions of this Agreement. The Company shall deliver to the
Rights Agent for cancellation and retirement, and the Rights Agent shall so cancel and retire, any other Rights Certificate
purchased or acquired by the Company otherwise than upon the exercise thereof. The Rights Agent shall deliver all cancelled
Rights Certificates to the Company, or shall, at the written request of the Company, destroy or cause to be destroyed such
cancelled Rights Certificates, and in such case shall deliver a certificate of destruction thereof to the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 9.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp; </FONT><U>Reservation and Availability of Capital Stock</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Company covenants and agrees that at all times prior to the Expiration Date it will cause to be reserved and kept available
out of its authorized and unissued Preferred Shares (and, following the occurrence of a Triggering Event, out of its authorized
and unissued Common Shares or other securities as may be issuable upon exercise of the Rights and/or out of its securities held
in treasury, as the case may be), the number of Preferred Shares (and, following the occurrence of a Triggering Event, to the extent
reasonably practicable, Common Shares or other securities, as the case may be) that, as provided in this Agreement, including,
but not limited to, Section 11(a)(iii) hereof, will be sufficient to permit the exercise in full of all of the outstanding Rights.
Upon the occurrence of any events resulting in an increase in the aggregate number of Preferred Shares (or other equity securities
of the Company) issuable upon exercise of all outstanding Rights above the number then reserved, the Company shall make appropriate
increases in the number of shares so reserved.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 20 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">17</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt; text-align: right; font-size: 8pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>So long as the Preferred Shares (and, following the occurrence of a Triggering Event, Common Shares or other securities,
as the case may be) issuable and deliverable upon the exercise of the Rights may be listed on any national securities exchange
or quoted on a quotation system, the Company shall use its best efforts to cause, from and after such time as the Rights become
exercisable through the Expiration Date, all shares reserved for such issuance to be listed on such exchange or quoted on such
quotation system, as the case may be, upon official notice of issuance upon such exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Company shall use its best efforts to (i) file, as soon as practicable following the earliest date after the first occurrence
of a Section 11(a)(ii) Event on which the consideration to be delivered by the Company upon exercise of the Rights has been determined
in accordance with Section 11(a) hereof, a registration statement on an appropriate form under the Act, with respect to the securities
purchasable upon exercise of the Rights, (ii) cause such registration statement to become effective as soon as practicable after
such filing, and (iii) cause such registration statement to remain effective (with a prospectus at all times meeting the requirements
of the Act) until the earlier of (A) the date as of which the Rights are no longer exercisable for such securities, and (B) the
Expiration Date. The Company will also take such action as may be appropriate under, or to ensure compliance with, the securities
or &ldquo;blue sky&rdquo; laws of the various states in connection with the exercisability of the Rights. The Company may temporarily
suspend, for a period of time not to exceed ninety (90) calendar days after the date set forth in clause (i) of the first sentence
of this Section 9(c), the exercisability of the Rights in order to prepare and file such registration statement and permit it to
become effective. Upon any such suspension, the Company shall issue a public announcement (with prompt written notice thereof to
the Rights Agent; and until such written notice is received by the Rights Agent, the Rights Agent may presume conclusively that
no such suspension has occurred) stating that the exercisability of the Rights has been temporarily suspended, as well as a public
announcement at such time as the suspension is no longer in effect (with prompt written notice thereof to the Rights Agent; and
until such written notice is received by the Rights Agent, the Rights Agent may presume conclusively that such suspension is still
in effect). In addition, if the Company shall determine that a registration statement is required following the Distribution Date,
the Company similarly may temporarily suspend the exercisability of the Rights until such time as a registration statement has
been declared effective. Notwithstanding any provision of this Agreement to the contrary, the Rights shall not be exercisable in
any jurisdiction if the requisite qualification in such jurisdiction shall not have been obtained, the exercise thereof shall not
be permitted under applicable law, or a registration statement shall not have been declared effective.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Company covenants and agrees that it will take all such action as may be necessary to ensure that all one one-thousandths
of a Preferred Share (and, following the occurrence of a Triggering Event, Common Shares or other securities, as the case may be)
delivered upon exercise of the Rights shall, at the time of delivery of the certificates or depositary receipts for such shares
(subject to payment of the Purchase Price), be duly and validly authorized and issued and fully paid and nonassessable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 21 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">18</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt; text-align: right; font-size: 8pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Company further covenants and agrees that it will pay when due and payable any and all federal and state taxes and charges
that may be payable in respect of the issuance or delivery of the Rights Certificates and of any certificates, entries in the book
entry account system of the transfer agent, or depositary receipts for a number of one one-thousandths of a Preferred Share (or,
following the occurrence of a Triggering Event, Common Shares or other securities, cash or other assets, as the case may be) upon
the exercise of Rights. The Company shall not, however, be required to pay any tax or charge that may be payable in respect of
any transfer or delivery of Rights Certificates or depositary receipts or entries in the book entry account system of the transfer
agent to a Person other than, or the issuance or delivery of a number of one one-thousandths of a Preferred Share (or, following
the occurrence of a Triggering Event, Common Shares or other securities, cash or other assets, as the case may be) in a name other
than that of the registered holder of the Rights Certificates evidencing Rights surrendered for exercise or to issue or deliver
any certificates or depositary receipts or entries in the book entry account system of the transfer agent for a number of one one-thousandths
of a Preferred Share (or, following the occurrence of a Triggering Event, Common Shares or other securities, cash or other assets
as the case may be) in a name other than that of the registered holder upon the exercise of any Rights until such tax or charge
shall have been paid (any such tax or charge being payable by the registered holder of such Rights Certificates at the time of
surrender) or until it has been established to the Company&rsquo;s or to the Rights Agent&rsquo;s satisfaction that no such tax
or charge is due.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 10.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Preferred Shares Record Date</U>. Each Person in whose name any certificate or entry in the book entry account system
of the transfer agent for a number of one one-thousandths of a Preferred Share (or, following the occurrence of a Triggering Event,
Common Shares or other securities, cash or other assets, as the case may be) is issued upon the exercise of Rights shall for all
purposes be deemed to have become the holder of record of such fractional Preferred Shares (or, following the occurrence of a Triggering
Event, Common Shares or other securities, cash, or other assets as the case may be) evidenced thereby on, and such certificate
or entry shall be dated, the date upon which the Rights Certificate evidencing such Rights was duly surrendered and payment of
the Purchase Price (and all applicable taxes and governmental charges) was made; <U>provided</U>, <U>however</U><I>,</I> that,
if the date of such surrender and payment is a date upon which the Preferred Shares (or, following the occurrence of a Triggering
Event, Common Shares or other securities, cash or other assets, as the case may be) transfer books of the Company are closed, such
Person shall be deemed to have become the record holder of such shares (fractional or otherwise) on, and such certificate or entry
shall be dated, the next succeeding Business Day on which the Preferred Shares (or, following the occurrence of a Triggering Event,
Common Shares or other securities, cash, or other assets as the case may be) transfer books of the Company are open and, <U>provided</U>,
<U>further</U>, that if delivery of the Preferred Shares is delayed pursuant to Section 9(c), when such Preferred Shares first
become deliverable. Prior to the exercise of the Rights evidenced thereby, the registered holder of a Rights Certificate, as such,
shall not be entitled to any rights of a stockholder of the Company with respect to shares for which the Rights shall be exercisable,
including, without limitation, the right to vote, to receive dividends or other distributions, or to exercise any preemptive rights,
and shall not be entitled to receive any notice of any proceedings of the Company, except as provided herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 11.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Adjustment of Purchase Price, Number and Kind of Shares, or Number of Rights</U>. The Purchase Price, the number and
kind of shares, or fractions thereof, purchasable upon exercise of each Right, and the number of Rights outstanding are subject
to adjustment from time to time as provided in this Section 11.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 22 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">19</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt; text-align: right; font-size: 8pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>(i)&#9;
&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;In the event the Company shall at any time after the first public announcement by the Company of the adoption of this
Agreement (A) declare or pay a dividend on the Preferred Shares payable in Preferred Shares, (B) subdivide or split the
outstanding Preferred Shares, (C) combine or consolidate the outstanding Preferred Shares into a smaller number of shares, or
(D) issue any shares of its capital stock in a reclassification of the Preferred Shares (including any such reclassification
in connection with a consolidation or merger in which the Company is the continuing or surviving corporation), except as
otherwise provided in this Section 11(a) and Section 7(e) hereof, the Purchase Price in effect at the time of the record date
for such dividend or of the effective date of such subdivision, split, combination, consolidation, or reclassification, and
the number and kind of Preferred Shares or fractions thereof (or other capital stock, as the case may be), issuable on such
date, shall be proportionately adjusted so that the registered holder of any Right exercised after such time shall be
entitled to receive, upon payment of the Purchase Price then in effect, the aggregate number and kind of Preferred Shares or
fractions thereof (or other capital stock, as the case may be), which, if such Right had been exercised immediately prior to
such date (whether or not such Right was then exercisable) and at a time when the Preferred Share (or other capital stock, as
the case may be) transfer books of the Company were open, such holder would have owned upon such exercise and been entitled
to receive by virtue of such dividend, subdivision, split, combination, consolidation, or reclassification. If an event
occurs that would require an adjustment under both this Section 11(a)(i) and Section 11(a)(ii) hereof, the adjustment
provided for in this Section 11(a)(i) shall be in addition to, and shall be made prior to, any adjustment required pursuant
to Section 11(a)(ii) hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>In the event any Person shall become an Acquiring Person (a &ldquo;<B>Section 11(a)(ii) Event</B>&rdquo;), then, promptly
following the occurrence of such Section 11(a)(ii) Event, proper provision shall be made so that, upon expiration of the Redemption
Period and subject to Section 23 hereof, each registered holder of a Right (except as provided below in Section 11(a)(iii) and
in Sections 7(e), 13 and 24 hereof) shall thereafter have the right to receive, upon exercise thereof at the then current Purchase
Price in accordance with the terms of this Agreement, in lieu of a number of one one-thousandths of a Preferred Share, such number
of Common Shares of the Company as shall equal the result obtained by (A) multiplying the then current Purchase Price by the then
number of one one-thousandths of a Preferred Share for which a Right was exercisable immediately prior to the first occurrence
of a Section 11(a)(ii) Event, and (B) dividing that product (which, following such first occurrence, shall thereafter be referred
to as the &ldquo;<B>Purchase Price</B>&rdquo; for each Right and for all purposes of this Agreement) by fifty percent (50%) of
the Current Market Price per Common Share on the date of such first occurrence (such number of shares, the &ldquo;<B>Adjustment
Shares</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 23 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">20</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt; text-align: right; font-size: 8pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(iii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>In the event that (A) the number of Common Shares authorized by the Restated Certificate of Incorporation, but not outstanding
or reserved for issuance for purposes other than upon exercise of the Rights, is not sufficient to permit the exercise in full
of the Rights in accordance with Section 11(a)(ii) hereof or (B) the Board otherwise shall determine to do so in its sole discretion,
the Company, acting by resolution of the Board, shall (1) determine the value of the Adjustment Shares issuable upon the exercise
of a Right (the &ldquo;<B>Current Value</B>&rdquo;), and (2) with respect to each Right (subject to Section 7(e) hereof), make
adequate provision to substitute for the Adjustment Shares, upon the exercise of such Right and payment of the applicable Purchase
Price, (u) cash, (v) a reduction in the Purchase Price, (w) Common Shares or other equity securities of the Company (including,
without limitation, shares, or units of shares, of preferred stock, such as the Preferred Shares, which the Board has deemed to
have essentially the same value or economic rights as Common Shares (such shares of preferred stock being referred to as &ldquo;<B>Common
Stock Equivalents</B>&rdquo;)), (x) debt securities of the Company, (y) other assets, or (z) any combination of the foregoing,
having an aggregate value equal to the Current Value, where such aggregate value has been determined by the Board based upon the
advice of a nationally recognized investment banking firm selected by the Board; <U>provided</U>, <U>however</U>, that, if, under
the circumstances set forth in clause (A) above, the Company shall not have made adequate provision to deliver value pursuant to
clause (2) above within thirty (30) calendar days following the later of (I) the first occurrence of a Section 11(a)(ii) Event
and (II) the date on which the Company&rsquo;s right of redemption pursuant to Section 23(a) hereof expires (the later of (I) and
(II) being referred to herein as the &ldquo;<B>Section 11(a)(ii) Trigger Date</B>&rdquo;), then the Company shall be obligated
to deliver, upon the surrender for exercise of a Right and without requiring payment of the Purchase Price, Common Shares (to the
extent available) and then, if necessary, cash, which shares and cash have an aggregate value equal to the Spread. For purposes
of the preceding sentence, the term &ldquo;<B>Spread</B>&rdquo; shall mean the excess of the Current Value over the Purchase Price.
If the Board determines in good faith that it is likely that sufficient additional Common Shares could be authorized for issuance
upon exercise in full of the Rights, the thirty (30) calendar day period set forth above may be extended to the extent necessary,
but not more than ninety (90) calendar days after the Section 11(a)(ii) Trigger Date, in order that the Company may seek stockholder
approval for the authorization of such additional shares (such thirty (30) calendar day period, as it may be extended, is herein
called the &ldquo;<B>Substitution Period</B>&rdquo;). To the extent that action is to be taken pursuant to the first or third sentences
of this Section 11(a)(iii), the Company shall provide, subject to Section 7(e) hereof, that such action shall apply uniformly to
all outstanding Rights, and the Company may suspend the exercisability of the Rights until the expiration of the Substitution Period
in order to seek such stockholder approval for such authorization of additional shares or to decide the appropriate form of distribution
to be made pursuant to such first sentence and to determine the value thereof. In the event of any such suspension, the Company
shall issue a public announcement (with prompt written notice thereof to the Rights Agent) stating that the exercisability of the
Rights has been temporarily suspended, as well as a public announcement (with prompt written notice thereof to the Rights Agent)
at such time as the suspension is no longer in effect. For purposes of this Section 11(a)(iii), the value of each Adjustment Share
shall be the Current Market Price per Common Share on the Section 11(a)(ii) Trigger Date and the per share or per unit value of
any Common Stock Equivalent shall be deemed to equal the Current Market Price per Common Share on such date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 24 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">21</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt; text-align: right; font-size: 8pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>In case the Company shall fix a record date for the issuance of rights, options, or warrants to all registered holders of
Preferred Shares entitling them to subscribe for or purchase (for a period expiring within forty-five (45) calendar days after
such record date) Preferred Shares (or shares having the same rights, privileges and preferences as the Preferred Shares (&ldquo;<B>Equivalent
Preferred Shares</B>&rdquo;)) or securities convertible into Preferred Shares or Equivalent Preferred Shares at a price per Preferred
Share or Equivalent Preferred Share (or having a conversion price per share, if a security convertible into Preferred Shares or
Equivalent Preferred Shares) less than the Current Market Price per Preferred Share on such record date, the Purchase Price to
be in effect after such record date shall be determined by multiplying the Purchase Price in effect immediately prior to such record
date by a fraction, the numerator of which shall be the number of Preferred Shares outstanding on such record date, plus the number
of Preferred Shares that the aggregate offering price of the total number of Preferred Shares or Equivalent Preferred Shares so
to be offered (or the aggregate initial conversion price of the convertible securities so to be offered) would purchase at such
Current Market Price, and the denominator of which shall be the number of Preferred Shares outstanding on such record date plus
the number of additional Preferred Shares or Equivalent Preferred Shares to be offered for subscription or purchase (or into which
the convertible securities so to be offered are initially convertible). In case such subscription price may be paid by delivery
of consideration, part or all of which may be in a form other than cash, the value of such consideration shall be as determined
in good faith by the Board, whose determination shall be described in a statement filed with the Rights Agent and shall be binding
and conclusive for all purposes on the Rights Agent and the holders of the Rights. Preferred Shares owned by or held for the account
of the Company shall not be deemed outstanding for the purpose of any such computation. Such adjustments shall be made successively
whenever such a record date is fixed, and in the event that such rights, options, or warrants are not so issued, the Purchase Price
shall be adjusted to be the Purchase Price that would then be in effect if such record date had not been fixed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>In case the Company shall fix a record date for a distribution to all registered holders of Preferred Shares (including
any such distribution made in connection with a consolidation or merger in which the Company is the continuing or surviving corporation)
of cash (other than a regular cash dividend out of the earnings or retained earnings of the Company), assets (other than a dividend
payable in Preferred Shares, but including any dividend payable in stock other than Preferred Shares) or evidences of indebtedness,
or of subscription rights or warrants (excluding those referred to in Section 11(b) hereof), the Purchase Price to be in effect
after such record date shall be determined by multiplying the Purchase Price in effect immediately prior to such record date by
a fraction, the numerator of which shall be the Current Market Price per Preferred Share on such record date, less the fair market
value (as determined in good faith by the Board, whose determination shall be described in a statement filed with the Rights Agent
and shall be binding and conclusive for all purposes) of the portion of the cash, assets or evidences of indebtedness so to be
distributed, or of such subscription rights or warrants applicable to a Preferred Share, and the denominator of which shall be
such Current Market Price per Preferred Share. Such adjustments shall be made successively whenever such a record date is fixed,
and in the event that such distribution is not so made, the Purchase Price shall be adjusted to be the Purchase Price that would
then be in effect if such record date had not been fixed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT>(i)&#9;
&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;For the purpose of any computation hereunder, other than computations made pursuant to Section 11(a)(iii) hereof, the
&ldquo;<B>Current Market Price</B>&rdquo; per Common Share on any date shall be deemed to be the average of the daily Closing
Prices per Common Share for the thirty (30) consecutive Trading Days immediately prior to such date, and for purposes of
computations made pursuant to Section 11(a)(iii) hereof, the &ldquo;<B>Current Market Price</B>&rdquo; per Common Share on
any date shall be deemed to be the average of the daily Closing Prices per Common Share for the ten (10) consecutive Trading
Days immediately following such date; <U>provided</U><I>, </I><U>however</U><I>,</I> that in the event that the Current
Market Price per Common Share is determined during a period following the announcement by the issuer of such Common Share of
(A) a dividend or distribution on such Common Shares payable in Common Shares or securities convertible into such Common
Shares (other than the Rights), or (B) any subdivision, combination, consolidation, reverse stock split or reclassification
of such Common Shares, and the ex-dividend date for such dividend or distribution, or the record date for such subdivision,
combination,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 25 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">22</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt; text-align: right; font-size: 8pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">consolidation, reverse stock split or reclassification shall not have occurred prior to the commencement of the
requisite thirty (30) Trading Day or ten (10) Trading Day period, as set forth above, then, and in each such case, the
Current Market Price shall be properly adjusted to take into account ex-dividend trading. The Closing Price for each day
shall be the last sale price, regular way, or, in case no such sale takes place on such day, the average of the closing bid
and asked prices, regular way, in either case as reported in the principal consolidated transaction reporting system with
respect to securities listed or admitted to trading on the Nasdaq or, if the Common Shares are not listed or admitted to
trading on the Nasdaq, as reported in the principal consolidated transaction reporting system with respect to securities
listed on the principal national securities exchange on which the Common Shares are listed or admitted to trading or, if the
Common Shares are not listed or admitted to trading on any national securities exchange, the last quoted price or, if not so
quoted, the average of the high bid and low asked prices in the over-the-counter market, as reported on a quotation system
then in use, or, if on any such date the Common Shares are not so quoted, the average of the closing bid and asked prices as
furnished by a professional market maker making a market in the Common Shares selected by the Board. If on any such date the
Common Shares are not publicly held and are not so listed, admitted to trading, or quoted, and no market maker is making a
market in the Common Shares, the &ldquo;<B>Current Market Price</B>&rdquo; per Common Share shall mean the fair value per
share on such date as determined in good faith by the Board, which determination shall be described in a statement filed with
the Rights Agent and shall be binding and conclusive for all purposes on the Rights Agent and the holders of the Rights.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>For the purpose of any computation hereunder, the &ldquo;<B>Current Market Price</B>&rdquo; per Preferred Share shall be
determined in the same manner as set forth above for the Common Shares in Section 11(d)(i) hereof (other than the penultimate sentence
thereof). If the Current Market Price per Preferred Share cannot be determined in the manner provided above or if the Preferred
Shares are not publicly held or listed, admitted to trading, or quoted in a manner described in Section 11(d)(i) hereof, the Current
Market Price per Preferred Share shall be conclusively deemed to be an amount equal to 1,000 (as such number may be appropriately
adjusted for such events as stock splits, stock dividends and recapitalizations with respect to the Common Shares occurring after
the first public announcement by the Company of the adoption of this Agreement) multiplied by the Current Market Price per Common
Share. If neither the Common Shares nor the Preferred Shares are publicly held or listed, admitted to trading, or quoted, the &ldquo;<B>Current
Market Price</B>&rdquo; per Preferred Share shall mean the fair value per share as determined in good faith by a majority of the
Board, whose determination shall be described in a statement filed with the Rights Agent and shall be binding and conclusive for
all purposes on the Rights Agent and the holders of the Rights. For all purposes of this Agreement, the Current Market Price of
one one-thousandth of a Preferred Share shall be equal to the Current Market Price of one Preferred Share divided by 1,000.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Anything herein to the contrary notwithstanding, no adjustment in the Purchase Price shall be required unless such adjustment
would require an increase or decrease of at least one percent (1%) in the Purchase Price; <U>provided</U>, <U>however</U><I>,</I>
that any adjustments which by reason of this Section 11(e) are not required to be made shall be carried forward and taken into
account in any subsequent adjustment. All calculations under this Section 11 shall be made to the nearest cent or to the nearest
thousandth of a Common Share or other share or one-millionth of a Preferred Share, as the case may be.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 26 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">23</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt; text-align: right; font-size: 8pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(f)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>If as a result of an adjustment made pursuant to Section 11(a)(ii) or Section 13(a) hereof, the registered holder of any
Right thereafter exercised shall become entitled to receive any shares of capital stock other than Preferred Shares, thereafter
the number of such other shares so receivable upon exercise of any Right and the Purchase Price thereof shall be subject to adjustment
from time to time in a manner and on terms as nearly equivalent as practicable to the provisions with respect to the Preferred
Shares contained in Sections 11(a), (b), (c), (d), (e), (g), (h), (i), (j), (k), (l) and (m), and the provisions of Sections 7,
9, 10, 13 and 14 hereof with respect to the Preferred Shares shall apply on like terms to any such other shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(g)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>All Rights originally issued by the Company subsequent to any adjustment made to the Purchase Price hereunder shall evidence
the right to purchase, at the adjusted Purchase Price, the number of one one-thousandths of a Preferred Share (or other securities
or amount of cash or combination thereof) purchasable from time to time hereunder upon exercise of the Rights, all subject to further
adjustment as provided herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(h)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Unless the Company shall have exercised its election as provided in Section 11(i) hereof, upon each adjustment of the Purchase
Price as a result of the calculations made in Section 11(b) and Section 11(c) hereof, each Right outstanding immediately prior
to the making of such adjustment shall thereafter evidence the right to purchase, at the adjusted Purchase Price, that number of
one one-thousandths of a Preferred Share (calculated to the nearest one-millionth) obtained by (i) multiplying (x) the number of
one one-thousandths of a share covered by a Right immediately prior to this adjustment, by (y) the Purchase Price in effect immediately
prior to such adjustment of the Purchase Price, and (ii) dividing the product so obtained by the Purchase Price in effect immediately
after such adjustment of the Purchase Price.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Company may elect on or after the date of any adjustment of the Purchase Price to adjust the number of Rights, in lieu
of any adjustment in the number of one one-thousandths of a Preferred Share purchasable upon the exercise of a Right pursuant to
Section 11(h) hereof. Each of the Rights outstanding after the adjustment in the number of Rights shall be exercisable for the
number of one one-thousandths of a Preferred Share for which a Right was exercisable immediately prior to such adjustment. Each
Right held of record prior to such adjustment of the number of Rights shall become that number of Rights (calculated to the nearest
one one-thousandth) obtained by dividing the Purchase Price in effect immediately prior to adjustment of the Purchase Price by
the Purchase Price in effect immediately after adjustment of the Purchase Price. The Company shall make a public announcement,
and notify the Rights Agent in writing, of its election to adjust the number of Rights, indicating the record date for the adjustment,
and, if known at the time, the amount of the adjustment to be made. This record date may be the date on which the Purchase Price
is adjusted or any day thereafter, but, if the Rights Certificates have been issued, shall be at least ten (10) calendar days later
than the date of the public announcement. If Rights Certificates have been issued, upon each adjustment of the number of Rights
pursuant to this Section 11(i), the Company shall, as promptly as practicable, cause to be distributed to holders of record of
Rights Certificates on such record date Rights Certificates evidencing, subject to Section 14 hereof, the additional Rights to
which such holders shall be entitled as a result of such adjustment, or, at the option of the Company, shall cause to be distributed
to such holders of record in substitution and replacement for the Rights Certificates held by such holders prior to the date of
adjustment, and upon surrender thereof, if required by the Company, new Rights Certificates evidencing all the Rights to which
such holders shall be entitled after such adjustment. Rights Certificates so to be distributed shall be issued, executed and delivered
by the Company, and countersigned and delivered by the Rights Agent, in the manner provided for herein (and may bear, at the option
of the Company, the adjusted Purchase Price) and shall be registered in the names of the holders of record of Rights Certificates
on the record date specified in the public announcement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 27 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">24</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt; text-align: right; font-size: 8pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(j)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Irrespective of any adjustment or change in the Purchase Price or the number of one one-thousandths of a Preferred Share
issuable upon the exercise of the Rights, the Rights Certificates theretofore and thereafter issued may continue to express the
Purchase Price per one one-thousandth of a share and the number of one one-thousandths of a share that were expressed in the initial
Rights Certificates issued hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(k)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Before taking any action that would cause an adjustment reducing the Purchase Price below the then par value, if any, of
the number of one one-thousandths of a Preferred Share issuable upon exercise of the Rights, the Company shall take any corporate
action that may, in the opinion of its counsel, be necessary in order that the Company may validly and legally issue, fully paid
and nonassessable, such number of one one-thousandths of a Preferred Share at such adjusted Purchase Price.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(l)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>In any case in which this Section 11 shall require that an adjustment in the Purchase Price be made effective as of a record
date for a specified event, the Company may elect to defer (and shall notify the Rights Agent in writing of any such election)
until the occurrence of such event the issuance to the registered holder of any Right exercised after such record date of the number
of one one-thousandths of a Preferred Share and other capital stock or securities of the Company, if any, issuable upon such exercise
over and above the number of one one-thousandths of a Preferred Share and other capital stock or securities of the Company, if
any, issuable upon such exercise on the basis of the Purchase Price in effect prior to such adjustment; <U>provided</U>, <U>however</U>,
that the Company shall deliver to such holder a due bill or other appropriate instrument evidencing such holder&rsquo;s right to
receive such additional shares (fractional or otherwise) or securities upon the occurrence of the event requiring such adjustment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(m)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Anything in this Section 11 to the contrary notwithstanding, prior to the Distribution Date, the Company shall be entitled
to make such reductions in the Purchase Price, in addition to those adjustments expressly required by this Section 11, as and to
the extent that the Board, in its good faith judgment, shall determine to be advisable in order that any (i) consolidation or subdivision
of the Preferred Shares, (ii) issuance wholly for cash of any Preferred Shares at less than the Current Market Price, (iii) issuance
wholly for cash of Preferred Shares or securities that by their terms are convertible into or exchangeable for Preferred Shares,
(iv) stock dividends or (v) issuance of rights, options or warrants referred to in this Section 11, hereafter made by the Company
to registered holders of its Preferred Shares shall not be taxable to such stockholders or shall reduce the taxes payable by such
holders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 28 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">25</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt; text-align: right; font-size: 8pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(n)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Company covenants and agrees that in the event that a Section 11(a)(ii) Event occurs and the Rights shall then be outstanding,
it shall not, (i) consolidate with any other Person (other than a Subsidiary of the Company in a transaction which complies with
Section 11(o) hereof), (ii) merge with or into any other Person (other than a Subsidiary of the Company in a transaction which
complies with Section 11(o) hereof), or (iii) sell or otherwise transfer (or permit any Subsidiary to sell or otherwise transfer),
in one transaction, or a series of related transactions, assets, cash flow or earning power aggregating fifty percent (50%) or
more of the assets, cash flow or earning power of the Company and its Subsidiaries (taken as a whole and calculated on the basis
of the Company&rsquo;s most recent regularly prepared financial statements) to any other Person or Persons (other than the Company
or any of its Subsidiaries in one or more transactions each of which complies with Section 11(o) hereof), if (x) at the time of
or immediately after such consolidation, merger, sale or transfer there are any charter or bylaw provisions, rights, warrants or
other instruments or securities outstanding or agreements in effect that would substantially diminish or otherwise eliminate the
benefits intended to be afforded by the Rights or (y) prior to, simultaneously with or immediately after such consolidation, merger,
sale or transfer the stockholders of the Person who constitutes, or would constitute, the &ldquo;Principal Party&rdquo; for purposes
of Section 13(a) hereof shall have received a distribution of Rights previously owned by such Person or any of its Related Persons;
<U>provided</U>, <U>however</U>, that this Section 11(n) shall not affect the ability of any Subsidiary of the Company to consolidate
with, merge with or into, or sell or transfer assets or earning power to, any other Subsidiary of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(o)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Company covenants and agrees that after the Distribution Date and so long as any Rights shall then be outstanding (other
than Rights that have become null and void pursuant to Section 7(e) hereof), it will not, except as permitted by Section 23, Section
24, or Section 27 hereof, take (or permit any Subsidiary to take) any action if at the time such action is taken it is reasonably
foreseeable that such action will diminish substantially or otherwise eliminate the benefits intended to be afforded by the Rights.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(p)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Anything in this Agreement to the contrary notwithstanding, in the event that the Company shall at any time after the Rights
Dividend Declaration Date and prior to the Distribution Date (i) declare or pay a dividend on the outstanding Common Shares payable
in Common Shares, (ii) subdivide or split the outstanding Common Shares, (iii) combine or consolidate the outstanding Common Shares
into a smaller number of shares, or (iv) issue any shares of its capital stock in a reclassification of Common Shares (including
any such reclassification in connection with a consolidation or merger in which the Company is a continuing or surviving corporation),
the number of Rights associated with each Common Share then outstanding, or issued or delivered thereafter but prior to the Distribution
Date (or issued or delivered on or after the Distribution Date pursuant to Section 22 hereof), shall be proportionately adjusted
so that the number of Rights thereafter associated with each Common Share following any such event shall equal the result obtained
by multiplying the number of Rights associated with each Common Share immediately prior to such event by a fraction, the numerator
of which shall be the total number of Common Shares outstanding immediately prior to the occurrence of the event and the denominator
of which shall be the total number of Common Shares outstanding immediately following the occurrence of such event. The adjustments
provided for in this Section 11(p) shall be made successively whenever such a dividend is declared or paid or such a subdivision,
combination or reclassification is effected. If an event occurs that would require an adjustment under Section 11(a)(ii) and this
Section 11(p), the adjustments provided for in this Section 11(p) shall be in addition and prior to any adjustment required pursuant
to Section 11(a)(ii).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 29 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">26</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt; text-align: right; font-size: 8pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 12.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Certificate of Adjusted Purchase Price or Number of Shares</U>. Whenever an adjustment is made as provided in Section
11 or Section 13 hereof, the Company shall (a) promptly prepare a certificate setting forth such adjustment and a brief reasonably
detailed statement of the facts, computations and methodology accounting for such adjustment, (b) promptly file with the Rights
Agent, and with each transfer agent for the Preferred Shares and the Common Shares, a copy of such certificate and (c) if a Distribution
Date has occurred, mail a brief summary thereof to each registered holder of a Rights Certificate in accordance with Section 26
hereof. The Rights Agent shall be fully protected in relying on any such certificate and on any adjustment or statement therein
contained and shall have no duty or liability with respect to, and shall not be deemed to have knowledge of, any adjustment or
any such event unless and until it shall have received such a certificate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 13.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Consolidation, Merger, or Sale or Transfer of Assets, Cash Flow or Earning Power</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>In the event that, at any time on or following the Shares Acquisition Date, directly or indirectly,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>the Company shall consolidate with, or merge with and into, any other Person (other than a Subsidiary of the Company in
a transaction which complies with Section 11(o) hereof), and the Company shall not be the continuing or surviving corporation or
other entity of such consolidation or merger;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>any Person (other than a Subsidiary of the Company in a transaction which complies with Section 11(o) hereof) shall consolidate
with, or merge with or into, the Company, and the Company shall be the continuing or surviving corporation of such consolidation
or merger and, in connection with such consolidation or merger, all or part of the outstanding Common Shares shall be changed into
or exchanged for stock or other securities of any other Person (or the Company) or cash or any other property; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(iii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>the Company shall sell or otherwise transfer (or one or more of its Subsidiaries shall sell or otherwise transfer), in one
transaction or a series of related transactions, assets, cash flow or earning power aggregating fifty percent (50%) or more of
the assets, cash flow or earning power of the Company and its Subsidiaries (taken as a whole and calculated on the basis of the
Company&rsquo;s most recent regularly prepared financial statements) to any Person or Persons (other than the Company or any Subsidiary
of the Company in one or more transactions each of which complies with Section 11(o) hereof);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">then, and in each such
case (except as may be contemplated by Section 13(d) hereof), proper provision shall be made so that: (A) each registered holder
of a Right, except as provided in Section 7(e) hereof, shall thereafter have the right to receive, upon the exercise thereof at
the then current Purchase Price multiplied by the number of one one-thousandths of a share of Preferred Shares for which a Right
is then exercisable in accordance with the terms of this Agreement, such number of validly authorized and issued, fully paid, nonassessable
and freely tradeable Common Shares of the Principal Party, not subject to any liens, encumbrances, rights of first refusal, transfer
restrictions, preemptive rights or other adverse claims of any nature whatsoever, as shall be equal to the result obtained by (1)
multiplying the number of one one-thousandths of a Preferred Share for which a Right was exercisable immediately prior to the first
occurrence of a Section 11(a)(ii) Event by the</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 30 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">27</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt; text-align: right; font-size: 8pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">Purchase Price in effect immediately prior to such first occurrence of a Section
11(a)(ii) Event, and (2) dividing that product (which, following the first occurrence of a Section 13 Event, shall be referred
to as the &ldquo;<B>Purchase Price</B>&rdquo; for each Right and for all purposes of this Agreement) by fifty percent (50%) of
the Current Market Price per Common Share of such Principal Party on the date of consummation of such Section 13 Event; (B) such
Principal Party shall thereafter be liable for, and shall assume, by virtue of such Section 13 Event, all the obligations and duties
of the Company pursuant to this Agreement; (C) the term &ldquo;<B>Company</B>&rdquo; shall thereafter be deemed to refer to such
Principal Party, it being specifically intended that the provisions of Section 11 hereof shall apply only to such Principal Party
following the first occurrence of a Section 13 Event; (D) such Principal Party shall take such steps (including, but not limited
to, the reservation of a sufficient number of Common Shares) in connection with the consummation of any such transaction as may
be necessary to assure that the provisions hereof shall thereafter be applicable, as nearly as reasonably may be, in relation to
its Common Shares thereafter deliverable upon the exercise of the Rights; <U>provided</U>, <U>however</U>, that upon the subsequent
occurrence of any merger, consolidation, sale of all or substantially all assets, recapitalization, reclassification of shares,
reorganization or other extraordinary transaction in respect of such Principal Party, each holder of a Right shall thereupon be
entitled to receive, upon exercise of a Right and payment of the Purchase Price, such cash, shares, rights, options warrants and
other property which such holder would have been entitled to receive had he, she or it at the time of such transaction, owned the
Common Shares of the Principal Party purchasable upon the exercise of a Right, and such Principal Party shall take such steps (including,
but not limited to, reservation of shares of stock) as may be necessary to permit the subsequent exercise of the Rights in accordance
with the terms hereof for such cash, shares, rights, warrants, options and other property; and (E) the provisions of Section 11(a)(ii)
hereof shall be of no effect with respect to events occurring at any time following the first occurrence of any Section 13 Event,
and the Rights that have not theretofore been exercised shall thereafter become exercisable in the manner described in this Section
13.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>&ldquo;<B>Principal Party</B>&rdquo; shall mean:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>in the case of any transaction described in Section 13(a)(i) or Section 13(a)(ii) hereof, the Person (including the Company
as successor thereto or as the surviving entity) that is the issuer of any securities into which Common Shares of the Company are
converted, changed, or exchanged in such merger or consolidation or, if there is more than one such issuer, the issuer of Common
Shares of such issuer that has the highest aggregate current market price (determined pursuant to Section 11(d) hereof) and if
no securities or other equity interests are so issued, the Person (including the Company as successor thereto or as the surviving
entity) that is the other party to such merger or consolidation, or, if there is more than one such Person, the Person that is
a constituent party to such merger or consolidation, the Common Shares of such Person of which has the highest aggregate current
market price (determined pursuant to Section 11(d) hereof); and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>in the case of any transaction described in Section 13(a)(iii) hereof, the Person that is the party receiving the greatest
portion of the assets, cash flow or earning power transferred pursuant to such transaction or transactions, or if each Person that
is a party to such transaction or transactions receives the same portion of the assets, cash flow or earning power transferred
pursuant to such transaction or transactions, or if the Person receiving the largest portion of the assets, cash flow or earning
power cannot be determined, whichever of such Persons is the issuer of Common Shares having the greatest aggregate value of shares
outstanding (as determined pursuant to Section 11(d) hereof); <U>provided</U>, <U>however</U>, that in any such case, (A) if the
Common Shares of such Person (who, but for this proviso, would be the Principal Party) are not at such time and have not been continuously
over the preceding twelve (12) month period registered under Section 12 of the Exchange Act, and such Person is a direct or indirect
Subsidiary of another Person the Common Shares of which are and have been so registered, &ldquo;Principal Party&rdquo; shall refer
to such other Person; and (B) in case such Person is a Subsidiary, directly or indirectly, of more than one Person, the Common
Shares of two or more of which are and have been so registered, &ldquo;Principal Party&rdquo; shall refer to whichever of such
Persons is the issuer of the Common Shares having the greatest aggregate market value.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 31 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">28</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt; text-align: right; font-size: 8pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>The Company shall not consummate a Section 13 Event unless the Principal Party shall have a sufficient number of authorized
Common Shares that have not been issued or reserved or that are held in treasury for issuance to permit the exercise in full of
the Rights in accordance with this Section 13 and unless prior thereto the Company and such Principal Party shall have executed
and delivered to the Rights Agent a supplemental agreement confirming that the requirements of Section 13(a) and Section 13(b)
hereof shall promptly be performed in accordance with their terms and further providing that, as soon as practicable after the
date of any such Section 13 Event, the Principal Party, as soon as practicable after the execution of such agreement, will:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>prepare and file a registration statement under the Act, with respect to the Rights and the securities purchasable upon
exercise of the Rights on an appropriate form, and will use its best efforts to cause such registration statement to (A) become
effective as soon as practicable after such filing and (B) remain effective (with a prospectus at all times meeting the requirements
of the Act) until the Expiration Date;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>take all such other action as may be necessary to enable the Principal Party to issue the securities purchasable upon exercise
of the Rights, including, but not limited to, the registration or qualification of such securities under all requisite securities
laws of jurisdictions of the various states and the listing of such securities on such exchanges and trading markets as may be
necessary or appropriate; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(iii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>deliver to registered holders of the Rights historical financial statements for the Principal Party and each of its Affiliates
that comply in all respects with the requirements for registration on Form 10 (or any successor form) under the Exchange Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>The provisions of this Section 13 shall similarly apply to successive mergers or consolidations or sales or other transfers.
In the event that a Section 13 Event shall occur at any time after the occurrence of a Section 11(a)(ii) Event, the Rights that
have not theretofore been exercised shall thereafter become exercisable in the manner described in Section 13(a) hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 32 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">29</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt; text-align: right; font-size: 8pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>In case the Principal Party that is to be a party to a transaction referred to in this Section 13 has at the time of such
transaction, or immediately following such transaction will have, a provision in any of its authorized securities or in its certificate
of incorporation or bylaws or other instrument governing its affairs, or any other agreements or arrangements, which provision
would have the effect of (i) causing such Principal Party to issue, in connection with, or as a consequence of, the consummation
of a transaction referred to in this Section 13, of Common Shares of such Principal Party at less than such then current market
price (other than to holders of Rights pursuant to this Section 13); (ii) providing for any special payment, tax, or similar provisions
in connection with the issuance of the Common Shares of such Principal Party pursuant to the provisions of Section 13; or (iii)
otherwise eliminating or substantially diminishing the benefits intended to be afforded by the Rights in connection with, or as
a consequence of, the consummation of a transaction referred to in this Section 13; then, in such event, the Company shall not
consummate any such transaction unless prior thereto the Company and such Principal Party shall have executed and delivered to
the Rights Agent a supplemental agreement providing that the provision in question of such Principal Party shall have been cancelled,
waived, or amended, or that the authorized securities shall be redeemed, so that the applicable provision will have no effect in
connection with, or as a consequence of, the consummation of the proposed transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 14.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp; </FONT><U>Fractional Rights and Fractional Shares</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Company shall not be required to issue fractions of Rights, except prior to the Distribution Date as provided in Section
11(p) hereof, or to distribute Rights Certificates that evidence fractional Rights. In lieu of such fractional Rights, the Company
shall pay to the registered holders of the Rights Certificates with regard to which such fractional Rights would otherwise be issuable,
an amount in cash equal to the same fraction of the current market price of a whole Right. For purposes of this Section 14(a),
the current market price of a whole Right shall be the Closing Price of the Rights for the Trading Day immediately prior to the
date on which such fractional Rights would have been otherwise issuable. The Closing Price of the Rights for any Trading Day shall
be the last sale price, regular way, or, in case no such sale takes place on such day, the average of the closing bid and asked
prices, regular way, in either case as reported in the principal consolidated transaction reporting system with respect to securities
listed or admitted to trading on the Nasdaq or, if the Rights are not listed or admitted to trading on the Nasdaq, as reported
in the principal consolidated transaction reporting system with respect to securities listed or admitted to trading on the principal
national securities exchange on which the Rights are listed or admitted to trading, or if the Rights are not listed or admitted
to trading on any national securities exchange, the last quoted price or, if not so quoted, the average of the high bid and low
asked prices in the over-the-counter market, as reported by a quotation system then in use or, if on any such date the Rights are
not so quoted, the average of the closing bid and asked prices as furnished by a professional market maker making a market in the
Rights, selected by the Board. If on any such date the Rights are not publicly held and are not so listed, admitted to trading,
or quoted, and no market maker is making a market in the Rights, the current market value of a Right shall mean the fair value
of a Right on such date as determined in good faith by the Board, which determination shall be described in a statement filed with
the Rights Agent and delivered to the holders of the Rights and shall be binding and conclusive for all purposes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Company shall not be required to issue fractions of Preferred Shares (other than fractions that are integral multiples
of one one-thousandth of a Preferred Share) upon exercise of the Rights or to distribute certificates or make any entries in the
book entry account system of the transfer agent that evidence fractional Preferred Shares (other than fractions that are integral
multiples of one one-thousandth of a Preferred Share). In lieu of fractional Preferred Shares that are not integral multiples of
one one-thousandth of a Preferred Share, the Company may pay to the registered holders of Rights Certificates at the time such
Rights are exercised as herein provided an amount in cash equal to the same fraction of the current market price of one one-thousandth
of a Preferred Share. For purposes of this Section 14(b), the current market price of one one-thousandth of a Preferred Share shall
be one one-thousandth of the Closing Price of a Preferred Share or, if unavailable, the appropriate alternative price (in each
case, as determined pursuant to Section 11(d)(ii) hereof) for the Trading Day immediately prior to the date of such exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 33 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">30</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt; text-align: right; font-size: 8pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Following the occurrence of a Triggering Event, the Company shall not be required to issue fractions of Common Shares upon
exercise of the Rights or to distribute certificates or make Book Entry Common Share notations that evidence fractional Common
Shares. In lieu of fractional Common Shares, the Company may pay to the registered holders of Rights Certificates at the time such
Rights are exercised as herein provided an amount in cash equal to the same fraction of the current market value of one Common
Share. For purposes of this Section 14(c), the current market value of one Common Share shall be the Closing Price of one Common
Share or, if unavailable, the appropriate alternative price (in each case, as determined pursuant to Section 11(d)(i) hereof) on
the Trading Day immediately prior to the date of such exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The registered holder of a Right by the acceptance of that Right expressly waives such holder&rsquo;s right to receive any
fractional Rights or any fractional shares upon exercise of a Right, except as permitted by this Section 14.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Whenever a payment for fractional Rights or fractional shares is to be made by the Rights Agent under this Agreement, the
Company shall (i) promptly prepare and deliver to the Rights Agent a certificate setting forth in reasonable detail the facts related
to such payments and the prices and formulas utilized in calculating such payments; and (ii) provide sufficient funds to the Rights
Agent in the form of fully collected funds to make such payments. The Rights Agent shall be fully protected in relying upon such
a certificate and has no duty with respect to, and will not be deemed to have knowledge of, any payment for fractional Rights or
fractional shares under any Section of this Agreement relating to the payment of fractional Rights or fractional shares unless
and until the Rights Agent has received such a certificate and sufficient monies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 15.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp; </FONT><U>Rights of Action</U>. All rights of action in respect of this Agreement, excepting the rights of action
given to the Rights Agent hereunder, are vested in the respective registered holders of the Rights Certificates (and, prior
to the Distribution Date, of the Common Shares); and any registered holder of any Rights Certificate (and, prior to the
Distribution Date, of the Common Shares), without the consent of the Rights Agent or of the registered holder of any other
Rights Certificate (or, prior to the Distribution Date, of the Common Shares), may, on such holder&rsquo;s own behalf and for
such holder&rsquo;s own benefit, enforce, and may institute and maintain any suit, action or proceeding against the Company
to enforce, or otherwise act in respect of, such holder&rsquo;s right to exercise the Rights evidenced by such Rights
Certificate in the manner provided in such Rights Certificate and in this Agreement. Without limiting the foregoing or any
remedies available to the registered holders of Rights, it is specifically acknowledged that the registered holders of Rights
would not have an adequate remedy at law for any breach of this Agreement and, accordingly, shall be entitled to specific
performance of the obligations under, and injunctive relief against actual or threatened violations of the obligations of any
Person subject to, this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 34 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">31</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt; text-align: right; font-size: 8pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 16.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp; </FONT><U>Agreement of Rights Holders</U>. Every registered holder of a Right, by accepting the same, consents
and agrees with the Company and the Rights Agent and with every other registered holder of a Right that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>prior to the Distribution Date, the Rights shall be evidenced by Book Entry Common Shares (which Book Entry Common Shares
shall also be deemed to represent certificates for Rights) or, in the case of certificated shares, the certificates for the Common
Shares registered in the names of the holders of the Common Shares (which certificates for Common Shares also constitute certificates
for Rights) and each Right will be transferable only in connection with the transfer of Common Shares;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>after the Distribution Date, the Rights Certificates are transferable only on the registry books of the Rights Agent if
surrendered at the office or offices of the Rights Agent designated for such purposes, duly endorsed or accompanied by a proper
instrument of transfer and with the appropriate forms and certificates contained therein properly completed and duly executed;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>subject to Section 6(a) and Section 7(f) hereof, the Company and the Rights Agent may deem and treat the Person in whose
name a Rights Certificate (or, prior to the Distribution Date, a Common Share certificate or Book Entry Common Share) is registered
as the absolute owner thereof and of the Rights evidenced thereby (notwithstanding any notations of ownership or writing on the
Rights Certificates or the Common Share certificate or Ownership Statement or other notices provided to holders of Book Entry Common
Shares made by anyone other than the Company or the Rights Agent) for all purposes whatsoever, and neither the Company nor the
Rights Agent, subject to the last sentence of Section 7(e) hereof, shall be required to be affected by any notice to the contrary;
and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>notwithstanding anything in this Agreement to the contrary, neither the Company nor the Rights Agent shall have any liability
to any holder of a Right or a beneficial interest in a Right or other Person as a result of its inability to perform any of its
obligations under this Agreement by reason of any preliminary or permanent injunction or other order, decree, judgment or ruling
(whether interlocutory or final) issued by a court of competent jurisdiction or by a governmental, regulatory or administrative
agency or commission, or any statute, rule, regulation or executive order promulgated or enacted by any governmental authority,
prohibiting or otherwise restraining performance of such obligation; <U>provided</U>, <U>however</U>, that the Company must use
its best efforts to have any such injunction, order, decree, judgment or ruling lifted or otherwise overturned as soon as possible.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 17.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Rights Certificate Holder Not Deemed a Stockholder</U>. No registered holder, as such, of any Rights Certificate shall
be entitled to vote, receive dividends or be deemed for any purpose the registered holder of the number of one one-thousandths
of a Preferred Share or any other securities of the Company that may at any time be issuable on the exercise of the Rights evidenced
thereby, nor shall anything contained herein or in any Rights Certificate be construed to confer upon the registered holder of
any Rights Certificate, as such, any of the rights of a stockholder of the Company or any right to vote for the election of directors
or upon any matter submitted to stockholders at any meeting thereof, or to give or withhold consent to any corporate action, or
to receive notice of meetings or other actions affecting stockholders (except as provided in Section 25 hereof), or to receive
dividends or subscription rights, or otherwise, until the Right or Rights evidenced by such Rights Certificate shall have been
exercised in accordance with the provisions hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 35 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">32</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt; text-align: right; font-size: 8pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 18.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#8239;&#8239;
</FONT><U>Concerning the Rights Agent</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Company agrees to pay to the Rights Agent reasonable compensation for all services rendered by it hereunder and, from
time to time, on demand of the Rights Agent, reimbursement for its reasonable expenses and counsel fees and disbursements and other
disbursements incurred in the preparation, delivery, negotiation, amendment, administration and execution of this Agreement and
the exercise and performance of its duties hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Company also agrees to indemnify the Rights Agent and its Affiliates and their respective employees, officers, and directors
for, and to hold them harmless against, any loss, liability, damage, judgment, fine, penalty, claim, demand, settlement, cost,
or expense (including, without limitation, the reasonable fees and expenses of legal counsel) that may be paid, incurred or suffered
by it, or which it may become subject, without gross negligence, bad faith or willful misconduct (each as determined by a final
non-appealable judgment of a court of competent jurisdiction) on the part of the Rights Agent, for any action taken, suffered or
omitted by the Rights Agent in connection with the execution, acceptance, administration, exercise and performance of its duties
under this Agreement, including reasonable attorneys&rsquo; fees and expenses and the costs and expenses of defending against any
claim of liability in the premises. The costs and expenses incurred in enforcing this right of indemnification shall be paid by
the Company. Notwithstanding anything in this Agreement to the contrary, in no event shall the Rights Agent be liable for special,
punitive, indirect, consequential or incidental loss or damage of any kind whatsoever even if the Rights Agent has been advised
of the likelihood of such loss or damage. Any liability of the Rights Agent under this Agreement (other than by reason of the Rights
Agent&rsquo;s gross negligence, bad faith or willful misconduct, as is determined by a final non-appealable judgment of a court
of competent jurisdiction) will be limited to the amount of fees paid by the Company to the Rights Agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Rights Agent may conclusively rely upon and shall be protected and shall incur no liability for or in respect of any
action taken, suffered or omitted to be taken by it in connection with its acceptance and administration of this Agreement or the
exercise or performance of its duties hereunder in reliance upon any Rights Certificate or certificate for Common Shares, Preferred
Shares or for other securities of the Company (including in the case of uncertificated securities, by notation in book entry accounts
reflecting ownership), instrument of assignment or transfer, power of attorney, endorsement, affidavit, letter, notice, direction,
consent, certificate, statement, or other paper or document believed by it to be genuine and to have been signed, executed and,
where expressly required hereunder, guaranteed, verified or acknowledged, by the proper Person or Persons, or otherwise upon the
advice of counsel as set forth herein. The Rights Agent shall not be deemed to have knowledge of any event of which it was supposed
to receive notice thereof hereunder, and the Rights Agent shall be fully protected and shall incur no liability for failing to
take any action in connection therewith, unless and until it has received such notice.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 36 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">33</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt; text-align: right; font-size: 8pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>The
provisions of this Section 18, Section 20 and Section 29 hereof shall survive the termination or expiration of this Agreement,
the exercise or expiration of the Rights and the resignation, replacement or removal of the Rights Agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 19.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><U>Merger or Consolidation or Change of Name of the Rights Agent</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Any Person into which the Rights Agent or any successor rights agent may be merged or with which it may be consolidated,
or any Person resulting from any merger or consolidation to which the Rights Agent or any successor rights agent shall be a party,
or any Person succeeding to the corporate trust, stock transfer or other stockholder services business of the Rights Agent or any
successor rights agent, shall be the successor to the Rights Agent under this Agreement without the execution or filing of any
paper or any further act on the part of any of the parties hereto; but only if such Person would be eligible for appointment as
a successor rights agent under the provisions of Section 21 hereof. The purchase of all or substantially all of the Rights Agent&rsquo;s
assets employed in the performance of transfer agent activities shall be deemed a merger or consolidation for purposes of this
Section 19. In case at the time such successor rights agent shall succeed to the agency created by this Agreement, any of the Rights
Certificates shall have been countersigned but not delivered, any such successor rights agent may adopt the countersignature of
an authorized signatory of a predecessor rights agent and deliver such Rights Certificates so countersigned; and in case at that
time any of the Rights Certificates shall not have been countersigned, an authorized signatory of any successor rights agent may
countersign such Rights Certificates either in the name of the predecessor or in the name of the successor rights agent; and in
all such cases such Rights Certificates shall have the full force provided in the Rights Certificates and in this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>In case at any time the name of the Rights Agent shall be changed and at such time any of the Rights Certificates shall
have been countersigned but not delivered, the Rights Agent may adopt the countersignature of an authorized signatory under the
Rights Agent&rsquo;s prior name and deliver Rights Certificates so countersigned; and in case at that time any of the Rights Certificates
shall not have been countersigned, an authorized signatory of the Rights Agent may countersign such Rights Certificates either
in the prior name of the Rights Agent or in the changed name of the Rights Agent; and in all such cases such Rights Certificates
shall have the full force provided in the Rights Certificates and in this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 20.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp; </FONT><U>Duties of the Rights Agent</U>. The Rights Agent undertakes to perform only the duties and obligations
expressly imposed by this Agreement (and no implied duties or obligations) upon the following terms and conditions, by all of
which the Company and the registered holders of Rights Certificates, by their acceptance thereof, shall be bound:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Rights Agent may consult with legal counsel (who may be legal counsel for the Company or an employee or legal counsel
of the Rights Agent), and the advice or opinion of such counsel shall be full and complete authorization and protection to the
Rights Agent and the Rights Agent shall incur no liability for or in respect of any action taken, suffered or omitted to be taken
by it in accordance with such advice or opinion.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 37 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">34</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt; text-align: right; font-size: 8pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Whenever in the performance of its duties under this Agreement the Rights Agent shall deem it necessary or desirable that
any fact or matter (including, without limitation, the identity of any Acquiring Person or Affiliate or Associate thereof, and
the determination of Current Market Price) be proved or established by the Company prior to the Rights Agent taking, suffering
or omitting to take any action hereunder, such fact or matter (unless other evidence in respect thereof be herein specifically
prescribed) may be deemed to be conclusively proved and established by a certificate signed by a person believed by the Rights
Agent to be any one of the Principal Executive Officer (including a Person acting in such capacity on an interim basis), the Principal
Financial Officer, any Executive Vice President, any Senior Vice President, the General Counsel, or the Corporate Secretary of
the Company and delivered to the Rights Agent; and such certificate shall be full and complete authorization and protection to
the Rights Agent, and the Rights Agent shall incur no liability, for or in respect of any action taken or suffered or omitted to
be taken by it under the provisions of this Agreement in reliance upon such certificate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Rights Agent shall be liable hereunder only for its own gross negligence, bad faith or willful misconduct (which gross
negligence, bad faith or willful misconduct must be determined by a final, non-appealable judgment of a court of competent jurisdiction).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Rights Agent shall not be assumed to have knowledge of and shall not be required to take note of or act upon any fact
or circumstance including the occurrence of facts or circumstances leading to the Shares Acquisition Date or the Distribution Date,
facts or circumstances relating to whether any Person may be an Affiliate or an Associate of any other Person, facts or circumstances
relevant to an adjustment to the Purchase Price, facts or circumstances relevant to events described in Section 13, Section 23
and Section 24, which may be relevant to performance by the Rights Agent under this Agreement unless the Company has provided written
notice thereof to the Rights Agent; and the Company agrees that it will (i) promptly notify the Rights Agent in writing of the
occurrence of the Shares Acquisition Date (including the identity of the Acquiring Person and the date on which the Shares Acquisition
Date occurred), the Distribution Date, the Redemption Date, and of any events described in Section 13, and (ii) promptly provide
the Rights Agent with such other information as the Rights Agent may reasonably request in connection with the performance of its
duties under this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Notwithstanding anything in this Agreement to the contrary, any liability of the Rights Agent under this Agreement will
be limited to the amount of annual fees paid by the Company to the Rights Agent during the twelve (12) months immediately preceding
the event for which recovery from the Rights Agent is being sought. Anything to the contrary notwithstanding, in no event will
the Rights Agent be liable for special, punitive, indirect, incidental or consequential damage or loss of any kind whatsoever (including
but not limited to lost profits), even if the Rights Agent has been advised of the likelihood of such loss or damage and regardless
of the form of action.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(f)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Rights Agent shall not be liable for or by reason of any of the statements of fact or recitals contained in this Agreement
or in the Rights Certificates and it shall not be required to verify the same (except as to a countersignature by one of its authorized
signatories on such Rights Certificates), but all such statements and recitals are and shall be deemed to have been made by the
Company only.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 38 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">35</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt; text-align: right; font-size: 8pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(g)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Rights Agent shall not have any liability for or be under any responsibility in respect of the validity of this Agreement
or the execution and delivery hereof (except the due execution and delivery hereof by the Rights Agent) or in respect of the validity
or execution of any Rights Certificate (except a countersignature by one of its authorized signatories on any such Rights Certificate);
nor shall it be responsible for any breach by the Company of any covenant or failure by the Company to satisfy any condition contained
in this Agreement or in any Rights Certificate; nor shall it be responsible for any change in the exercisability of the Rights
(including the Rights becoming null and void pursuant to Section 7(e) hereof) or any adjustment required under the provisions of
Section 11, Section 13, Section 23 or Section 24 hereof or responsible for the manner, method or amount of any such change or adjustment
or the ascertaining of the existence of facts that would require any such change or adjustment (except with respect to the exercise
of Rights evidenced by Rights Certificates after receipt by the Rights Agent of a certificate describing any such adjustment, delivered
pursuant to Section 12); nor shall it by any act hereunder be deemed to make any representation or warranty as to the authorization
or reservation of any Common Shares or Preferred Shares or any other securities to be issued pursuant to this Agreement or any
Rights Certificate or as to whether any Common Shares or Preferred Shares will, when so issued, be validly authorized and issued,
fully paid and nonassessable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(h)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Company agrees that it will perform, execute, acknowledge, and deliver or cause to be performed, executed, acknowledged
and delivered all such further and other acts, instruments, and assurances as may reasonably be required by the Rights Agent for
the carrying out or performing by the Rights Agent of the provisions of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Rights Agent is hereby authorized and directed to accept instructions with respect to the performance of its duties
hereunder from the Chairman of the Board, the Principal Executive Officer, the Principal Financial Officer, any Vice President,
the Secretary, any Assistant Secretary, the Treasurer or any Assistant Treasurer of the Company, and to apply to such officers
for advice or instructions in connection with its duties, and such instructions shall be full authorization and protection to the
Rights Agent and the Rights Agent shall not be liable for any action taken, suffered, or omitted to be taken by it in accordance
with instructions of any such officer or for any delay in acting while waiting for those instructions. The Rights Agent shall be
fully authorized and protected in relying upon the most recent instructions received by any such officer. Notwithstanding anything
in this Agreement to the contrary, the Rights Agent shall not be required to take any instruction of the Company that the Rights
Agent believes, in its sole discretion, would cause the Rights Agent to take action that is illegal.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(j)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Rights Agent and any stockholder, Affiliate, director, officer or employee of the Rights Agent may buy, sell, or deal
in any of the Rights or other securities of the Company or become pecuniarily interested in any transaction in which the Company
may be interested, or contract with or lend money to the Company or otherwise act as fully and freely as though it were not the
Rights Agent under this Agreement. Nothing herein shall preclude the Rights Agent or any such stockholder, Affiliate, director,
officer or employee from acting in any other capacity for the Company or for any other Person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(k)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Rights Agent may execute and exercise any of the rights or powers hereby vested in it or perform any duty hereunder
either itself (through its directors, officers, and employees) or by or through its attorneys or agents, and the Rights Agent shall
not be answerable or accountable for any act, default, neglect or misconduct of any such attorneys or agents or for any loss to
the Company or any other Person resulting from any such act, default, neglect, or misconduct, absent gross negligence, bad faith,
or willful misconduct (which gross negligence, bad faith or willful misconduct must be determined by a final, non-appealable judgment
of a court of competent jurisdiction) of the Rights Agent in the selection and continued employment thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 39 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">36</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt; text-align: right; font-size: 8pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(l)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>No provision of this Agreement shall require the Rights Agent to expend or risk its own funds or otherwise incur any financial
liability in the performance of any of its duties hereunder (other than internal costs incurred by the Rights Agent in providing
services to the Company in the ordinary course of its business as Rights Agent) or in the exercise of any of its rights or powers
if there shall be reasonable grounds for believing that repayment of such funds or adequate indemnification against such risk or
liability is not reasonably assured to it.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(m)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>If, with respect to any Rights Certificate surrendered to the Rights Agent for exercise or transfer, the certificate contained
in the form of assignment or form of election to purchase, as the case may be, has either not been properly completed or duly executed
or indicates an affirmative response to clause 1 or 2 thereof, the Rights Agent shall not take any further action with respect
to such requested exercise or transfer without first consulting with the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(n)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Rights Agent shall have no responsibility to the Company, any holders of Rights or any holders of Common Shares for
interest or earnings on any monies held by the Rights Agent pursuant to this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(o)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Rights Agent shall not be required to take notice or be deemed to have notice of any event or condition hereunder, including
any event or condition that may require action by the Rights Agent, unless the Rights Agent shall be specifically notified in writing
of such event or condition by the Company, and all notices or other instruments required by this Agreement to be delivered to the
Rights Agent must, in order to be effective, be received by the Rights Agent as specified in Section 26 hereof, and in the absence
of such notice so delivered, the Rights Agent may conclusively assume no such event or condition exists.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 21.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp; </FONT><U>Change of the Rights Agent</U>. The Rights Agent or any successor rights agent may resign and be discharged
from its duties under this Agreement upon thirty (30) calendar days&rsquo; prior written notice given to the Company (or such
lesser notice as is acceptable to the Company in its sole discretion) in accordance with Section 26 hereof, and to the extent
that the Rights Agent or one of its Affiliates is not also the transfer agent for the Company, to each transfer agent of the
Common Shares and Preferred Shares by registered or certified mail. In the event the transfer agency relationship in effect
between the Company and the Rights Agent terminates, the Rights Agent will be deemed to have resigned automatically and be
discharged from its duties under this Agreement as of the effective date of such termination, and the Company shall be
responsible for sending any required notice. The Company may remove the Rights Agent or any successor rights agent upon
thirty (30) calendar days&rsquo; notice given to the Rights Agent or successor rights agent, as the case may be, in
accordance with Section 26 hereof, and to each transfer agent of the Common Shares and Preferred Shares by registered or
certified mail, and, if such removal occurs after the Distribution Date, to the registered holders of the Rights Certificates
in accordance with Section 26 of this Agreement. If the Rights Agent shall resign or be removed or shall otherwise become
incapable of acting, the</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 40 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">37</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt; text-align: right; font-size: 8pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">Company shall appoint a successor to the Rights Agent. If the Company shall fail to make such
appointment within a period of thirty (30) calendar days after giving proper notice of such removal or after it has been
properly notified of such resignation or incapacity by the resigning or incapacitated Rights Agent or by the registered
holder of a Rights Certificate (who shall, with such notice, submit such holder&rsquo;s Rights Certificate for inspection by
the Company), then any registered holder of any Rights Certificate may apply to any court of competent jurisdiction for the
appointment of a new rights agent. Any successor rights agent, whether appointed by the Company or by such a court, shall be
(a) a legal business entity organized and doing business under the laws of the United States or of any State thereof, in good
standing, which is authorized under such laws to exercise stockholder service powers and which has, along with its
Affiliates, at the time of its appointment as rights agent a combined capital and surplus of at least $50,000,000.00 or (b)
an Affiliate of a legal business entity described in clause (a) of this sentence. After appointment, the successor rights
agent shall be vested with the same powers, rights, duties, and responsibilities as if it had been originally named as rights
agent without further act or deed; but the predecessor rights agent shall deliver and transfer to the successor rights agent
any property at the time held by it hereunder, and execute and deliver any further assurance, conveyance, act or deed
necessary for that purpose, but such predecessor rights agent shall not be required to make any additional expenditure or
assume any additional liability in connection with the foregoing; and, except as the context herein otherwise requires, such
successor rights agent shall be deemed to be the &ldquo;Rights Agent&rdquo; for all purposes of this Agreement. Not later
than the effective date of any such appointment, the Company shall file notice thereof in writing with the predecessor rights
agent and each transfer agent of the Common Shares and the Preferred Shares, and, if such appointment occurs after the
Distribution Date, the Company shall give notice thereof to the registered holders of the Rights Certificates in accordance
with Section 26 hereof. Failure to give any notice provided for in this Section 21, however, or any defect therein, shall not
affect the legality or validity of the resignation or removal of the Rights Agent or the appointment of the successor rights
agent, as the case may be.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 22.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Issuance of New Rights Certificates</U>. Notwithstanding any of the provisions of this Agreement or of the Rights to
the contrary, the Company may, at its option, issue new Rights Certificates evidencing Rights in such form as may be approved by
the Board to reflect any adjustment or change in the Purchase Price and the number or kind or class of shares or other securities
or property purchasable under the Rights Certificates made in accordance with the provisions of this Agreement. In addition, in
connection with the issuance or sale of Common Shares following the Distribution Date and prior to the earlier of the redemption
of the Rights, the exchange of the Rights, and the Final Expiration Date, the Company (a) shall, with respect to Common Shares
so issued or sold pursuant to the exercise of stock options or under any employee benefit plan or arrangement, granted or awarded
as of the Distribution Date, or upon the exercise, conversion, or exchange of securities hereinafter issued by the Company, and
(b) may, in any other case, if deemed necessary or appropriate by the Board, issue Rights Certificates evidencing the appropriate
number of Rights in connection with such issuance or sale; <U>provided</U>, <U>however</U><I>,</I> that (i) no such Rights Certificate
shall be issued if, and to the extent that, the Company shall be advised by counsel that such issuance would create a significant
risk of material adverse tax consequences to the Company or the Person to whom such Rights Certificate would be issued, and (ii)
no such Rights Certificate shall be issued if, and to the extent that, appropriate adjustment shall otherwise have been made in
lieu of the issuance thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 41 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">38</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt; text-align: right; font-size: 8pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 23.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><U>Redemption and Termination</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Board may, at its option, at any time prior to the earlier of (i) the Close of Business on the tenth (10th) Business
Day following the Shares Acquisition Date (or, if the tenth (10th) Business Day following the Shares Acquisition Date occurs before
the Record Date, the Close of Business on the Record Date) and (ii) the Final Expiration Date (the &ldquo;<B>Redemption Period</B>&rdquo;),
direct the Company to, and if directed the Company shall, redeem all but not less than all of the then outstanding Rights at a
redemption price of $0.001 per Right, as such amount may be appropriately adjusted to reflect any stock split, stock dividend,
or similar transaction occurring after the first public announcement by the Company of the adoption of this Agreement (such redemption
price, as adjusted, being hereinafter referred to as the &ldquo;<B>Redemption Price</B>&rdquo;). Notwithstanding anything contained
in this Agreement to the contrary, the Rights shall not be exercisable after the first occurrence of a Section 11(a)(ii) Event
until the expiration of the Redemption Period. The Company may, at its option, pay the Redemption Price in cash, Common Shares
(based on the Current Market Price of the Common Shares at the time of redemption) or any other form of consideration determined
by the Board, in the exercise of its sole discretion, to be at least equal to the Redemption Price.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Immediately upon the time of the effectiveness of the redemption of the Rights pursuant to paragraph (a) of this Section
23 or such earlier time as may be determined by the Board in the action ordering such redemption (although not earlier than the
time of such action), evidence of which shall be filed with the Rights Agent, and without any further action and without any notice,
the right to exercise the Rights shall terminate, whether or not previously exercised, and each Right, whether or not previously
exercised, will thereafter represent only the right to receive the Redemption Price for each Right so held. Promptly after the
action of the Board directing the Company to make the redemption of the Rights, the Company shall give notice of such redemption
to the Rights Agent and the registered holders of the then outstanding Rights in accordance with Section 26 hereof. Any notice
given in accordance with Section 26 hereof shall be deemed given whether or not the holder receives the notice. Each such notice
of redemption will state the method by which the payment of the Redemption Price will be made. Notwithstanding anything in this
Section 23 to the contrary, the redemption of the Rights as directed by the Board may be made effective at such time, on such basis
and subject to such conditions as the Board, in its sole discretion, may establish.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 24.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><U>Exchange of Rights</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT>The
Board may, at its option, at any time after any Person becomes an Acquiring Person, authorize and direct the Company to, and
if directed the Company shall, exchange all or part of the then outstanding and exercisable Rights (which shall not include
Rights that have become null and void pursuant to the provisions of Section 7(e) hereof) for Common Shares at an exchange
ratio of one Common Share per Right, appropriately adjusted to reflect any stock split, stock dividend or similar transaction
occurring after the first public announcement by the Company of the adoption of this Agreement (such exchange ratio being
hereinafter referred to as the &ldquo;<B>Exchange Ratio</B>&rdquo;). The exchange of the Rights by the Board may be made
effective at such time, on such basis, and with such conditions as the Board in its sole discretion may establish.
Notwithstanding the foregoing, the Board shall not be empowered to direct the Company to effect such exchange at any time
after any Person (other than an Exempt Person or a Grandfathered Person), together with all Related Persons of such Person,
becomes the Beneficial Owner of fifty percent (50%) or more of the Common Shares then outstanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 42 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">39</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt; text-align: right; font-size: 8pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Immediately upon the action of the Board directing the Company to exchange any Rights pursuant to Section 24(a) hereof and
without any further action and without any notice, the right to exercise such Rights shall terminate and the only right thereafter
of a registered holder of such Rights shall be to receive that number of Common Shares equal to the number of such Rights held
by such holder multiplied by the Exchange Ratio. The Company shall promptly give public notice of any such exchange (with prompt
written notice thereof to the Rights Agent); <U>provided</U>, <U>however</U><I>,</I> that the failure to give, or any defect in,
such notice shall not affect the validity of such exchange. The Company promptly shall give notice of any such exchange to all
of the registered holders of such Rights in accordance with Section 26 hereof. Any notice given in accordance with Section 26 hereof
shall be deemed given whether or not the holder receives the notice. Each such notice of exchange will state the method by which
the exchange of the Common Shares for Rights will be effected and, in the event of any partial exchange, the number of Rights that
will be exchanged. Any partial exchange shall be effected pro rata based on the number of Rights (other than Rights that have become
null and void pursuant to the provisions of Section 7(e) hereof) held by each registered holder of Rights.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>In any exchange pursuant to this Section 24, the Company, at its option, may substitute Preferred Shares (or Equivalent
Preferred Shares) for Common Shares exchangeable for Rights, at the initial rate of one one-thousandth of a Preferred Share (or
Equivalent Preferred Shares) for each Common Share, as appropriately adjusted to reflect stock splits, stock dividends, and other
similar transactions after the first public announcement by the Company of the adoption of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>In the event the number of Common Shares authorized by the Restated Certificate of Incorporation, but which are not outstanding
or reserved for issuance for purposes other than upon exercise of the Rights, is not sufficient to permit any exchange of Rights
as contemplated in accordance with this Section 24, the Company may either take such action as may be necessary to authorize additional
Common Shares for issuance upon exchange of the Rights or alternatively, at the option of the Board, substitute to the extent of
such insufficiency for each Common Share that would otherwise be issuable upon exchange of a Right, cash, debt securities of the
Company, other assets, or any combination of the foregoing, in any event having an aggregate value, as determined in good faith
by the Board (whose determination shall be described in a statement filed with the Rights Agent and shall be binding and conclusive
for all purposes on the Rights Agent and the holders of the Rights), equal to the Current Market Price per Common Share (as determined
pursuant to Section 11(d)(i)) for the Trading Day immediately prior to the date of exchange pursuant to this Section 24.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Company shall not be required to issue fractions of Common Shares or to distribute certificates or make Book Entry Common
Share notations that evidence fractional Common Shares. In lieu of such fractional Common Shares, there shall be paid to the registered
holders of the Rights Certificates with regard to which such fractional Common Shares would otherwise be issuable, an amount in
cash equal to the same fraction of the current market price of a whole Common Share. For the purposes of this Section 24(e), the
current market price of a whole Common Share shall be the Closing Price of a Common Share (as determined pursuant to the second
sentence of Section 11(d)(i) hereof) for the Trading Day immediately prior to the date of exchange pursuant to this Section 24.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 43 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">40</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt; text-align: right; font-size: 8pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(f)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Notwithstanding anything in this Section 24 to the contrary, the exchange of the Rights may be made effective at such time,
on such basis and with such conditions as the Board in its sole discretion may establish. Without limiting the preceding sentence,
the Board may (i) in lieu of issuing Common Shares or any other securities contemplated by this Section 24 to the Persons entitled
thereto in connection with the exchange (such Persons, the &ldquo;<B>Exchange Recipients</B>,&rdquo; and such shares and other
securities, together with any dividends or distributions made on such shares or other securities, the &ldquo;<B>Exchange Property</B>&rdquo;)
issue, transfer or deposit the Exchange Property to or into a trust or other entity that may hold such Exchange Property for the
benefit of the Exchange Recipients (provided that such trust or other entity may not be controlled by the Company or any of its
Related Persons and provided further that the trustee or similar fiduciary of the trust or other entity will attempt to distribute
the Exchange Property to the Exchange Recipients as promptly as practicable), (ii) permit such trust or other entity to exercise
all of the rights that a stockholder of record would possess with respect to any shares deposited in such trust or entity and (iii)
impose such procedures as are necessary to verify that the Exchange Recipients are not Acquiring Persons or Related Persons of
Acquiring Persons as of any time periods established by such trust or entity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 25.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><U>Notice of Certain Events</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>In case the Company shall propose, at any time after the Distribution Date, (i) to pay any dividend payable in stock of
any class to the registered holders of Preferred Shares or to make any other distribution to the registered holders of Preferred
Shares (other than a regular periodic cash dividend out of earnings or retained earnings of the Company), (ii) to offer to the
registered holders of Preferred Shares rights or warrants to subscribe for or to purchase any additional Preferred Shares or shares
of stock of any class or any other securities, rights or options, (iii) to effect any reclassification of its Preferred Shares
(other than a reclassification involving only the subdivision of outstanding Preferred Shares), (iv) to effect any consolidation
or merger into or with any other Person (other than a Subsidiary of the Company in a transaction which complies with Section 11(o)),
or to effect any sale or other transfer (or to permit one or more of its Subsidiaries to effect any sale or other transfer), in
one transaction or a series of related transactions, of fifty percent (50%) or more of the assets, cash flow or earning power of
the Company and its Subsidiaries (taken as a whole and calculated on the basis of the Company&rsquo;s most recent regularly prepared
financial statements) to any other Person or Persons (other than the Company and/or any of its Subsidiaries in one or more transactions
each of which complies with Section 11(o) hereof), or (v) to effect the liquidation, dissolution, or winding up of the Company,
then, in each such case, the Company shall give to each registered holder of a Rights Certificate, to the extent feasible and in
accordance with Section 26 hereof, a notice of such proposed action, which shall specify the record date for the purposes of such
stock dividend, distribution of rights or warrants, or the date on which such reclassification, consolidation, merger, sale, transfer,
liquidation, dissolution, or winding up is to take place and the date of participation therein by the registered holders of the
Preferred Shares, if any such date is to be fixed, and such notice shall be so given in the case of any action covered by clause
(i) or (ii) above at least twenty (20) calendar days prior to the record date for determining registered holders of the Preferred
Shares for purposes of such action, and in the case of any such other action, at least twenty (20) calendar days prior to the date
of the taking of such proposed action or the date of participation therein by the registered holders of the Preferred Shares, whichever
shall be the earlier; <U>provided</U>, <U>however</U>, that no such action shall be taken pursuant to this Section 25(a) that will
or would conflict with any provision of the Company&rsquo;s Restated Certificate of Incorporation; <U>provided</U>, <U>further</U>,
that no such notice shall be required pursuant to this Section 25, if any Subsidiary of the Company effects a consolidation or
merger with or into, or effects a sale or other transfer of assets or earning power to, any other Subsidiary of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 44 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">41</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt; text-align: right; font-size: 8pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>In case a Section 11(a)(ii) Event shall occur, then, in any such case, (i) the Company shall as soon as practicable thereafter
give to the Rights Agent, and, to the extent feasible, each registered holder of a Rights Certificate, to the extent feasible and
in accordance with Section 26 hereof, a notice of the occurrence of such event, which shall specify the event and the consequences
of the event to registered holders of Rights under Section 11(a)(ii) hereof, and (ii) all references in Section 25(a) to Preferred
Shares shall be deemed thereafter to refer to Common Shares and/or, if appropriate, other securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Notwithstanding anything
to the contrary that may be contained in this Section 25 or elsewhere in this Agreement, the failure to give, or any defect in,
any notice required to be given pursuant to this Section 25 shall not affect the legality or validity of the transaction or event
to which the notice requirement was applicable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In case any Section
13 Event shall occur, then the Company shall, as soon as practicable thereafter, give to each registered holder of a Rights Certificate,
to the extent feasible, and to the Rights Agent in accordance with Section 26 hereof, a written notice of the occurrence of such
event, which notice shall describe such event and the consequences of such event to the holders of Rights under Section 13(a) hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 26.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Notices</U>. Notices or demands authorized by this Agreement to be given or made by the Rights Agent or by the holder
of any Rights Certificate to or on the Company will be sufficiently given or made if in writing and sent by a recognized national
overnight delivery service, or first-class mail, postage prepaid, addressed (until another address is filed in writing with the
Rights Agent by the Company) as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">ADMA Biologics, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">465 State Route 17</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">Ramsey, NJ 07446</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">Attention: General Counsel</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">with copies (which will not constitute notice) to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">Morgan, Lewis &amp; Bockius LLP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">502 Carnegie Center</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">Princeton, NJ 08540</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">Attention: David C. Schwartz, Esq.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in"></P>

<!-- Field: Page; Sequence: 45 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">42</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt; text-align: right; font-size: 8pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Subject to the provisions
of Section 21 hereof, any notice or demand authorized by this Agreement to be given or made by the Company, or by the registered
holder of any Rights Certificate to or on the Rights Agent shall be sufficiently given or made if sent by (i) first-class mail,
postage prepaid, (ii) a recognized national overnight delivery service, prepaid, or (iii) courier or messenger service, in each
case addressed (until another address is filed in writing by the Rights Agent with the Company) as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">Continental Stock Transfer and Trust Company</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">1 State Street</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">30th Floor</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">New York, NY 10004</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">Attention: General Counsel</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Notices or demands
authorized by this Agreement to be given or made by the Company or the Rights Agent to the registered holder of any Rights Certificate
or, if prior to the Distribution Date, to the registered holder of the Common Shares shall be sufficiently given or made if sent
by first-class mail, postage prepaid, addressed to such holder at the address of such holder as shown on the registry books of
the Rights Agent or, if prior to the Distribution Date, as shown on the registry books of the transfer agent for the Common Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 27.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Supplements and Amendments</U>. Except as otherwise provided in this Section&nbsp;27, the Company, by action of the Board,
may from time to time and in its sole and absolute discretion, and the Rights Agent shall if the Company so directs, supplement
or amend this Agreement in any respect without the approval of any holders of Rights, including, without limitation, in order to
(a)&nbsp;cure any ambiguity contained herein, (b)&nbsp;correct or supplement any provision contained herein that may be defective
or inconsistent with any other provisions contained herein, (c)&nbsp;shorten or lengthen any time period hereunder, or (d)&nbsp;otherwise
change, amend, or supplement any provisions hereunder in any manner that the Company may deem necessary or desirable; <U>provided</U>,&nbsp;<U>however</U>,
that from and after such time as any Person becomes an Acquiring Person, this Agreement shall not be supplemented or amended in
any manner that would adversely affect the interests of the holders of Rights (other than Rights that have become null and void
pursuant to Section&nbsp;7(e)&nbsp;hereof) as such or cause this Agreement to become amendable other than in accordance with this
Section&nbsp;27. Any such supplement or amendment shall be evidenced by a writing executed by the Company and the Rights Agent.
Without limiting the foregoing, the Company, by action of the Board, may at any time before any Person becomes an Acquiring Person
amend this Agreement to make the provisions of this Agreement inapplicable to a particular transaction by which a Person might
otherwise become an Acquiring Person or to otherwise alter the terms and conditions of this Agreement as they may apply with respect
to any such transaction. Upon the delivery of a certificate from an authorized officer of the Company which states that the proposed
supplement or amendment is in compliance with the terms of this Section 27, the Rights Agent shall execute such supplement or amendment;
provided that the Rights Agent shall not be obligated to enter into any supplement or amendment that adversely affects the rights,
duties, obligations or immunities of the Rights Agent under this Agreement. Prior to the Distribution Date, the interests of the
holders of Rights shall be deemed coincident with the interests of the holders of the Common Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 28.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Successors</U>. All the covenants and provisions of this Agreement by or for the benefit of the Company or the Rights
Agent shall bind and inure to the benefit of their respective successors and assigns hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 46 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">43</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt; text-align: right; font-size: 8pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 29.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Determinations and Actions by the Board</U>. The Board shall have the exclusive power and authority to administer this
Agreement and to exercise all rights and powers specifically granted to the Board or to the Company, or as may be necessary or
advisable in the administration of this Agreement, including, without limitation, the right and power to (i) interpret the provisions
of this Agreement, and (ii) make all determinations deemed necessary or advisable for the administration of this Agreement (including,
without limitation, a determination to redeem or not redeem the Rights or to amend or supplement this Agreement and whether any
proposed amendment adversely affects the interests of the holders of Right Certificates). For all purposes of this Agreement, any
calculation of the number of Common Shares or other securities outstanding at any particular time, including for purposes of determining
the particular percentage of such outstanding Common Shares or any other securities of which any Person is the Beneficial Owner,
shall be made in accordance with the last sentence of Rule 13d-3(d)(1)(i) of the General Rules and Regulations under the Exchange
Act as in effect on the date of this Agreement. All such actions, calculations, interpretations and determinations (including,
for purposes of clause (y) below, all omissions with respect to the foregoing) that are done or made by the Board in good faith,
shall (x) be final, conclusive and binding on the Company, the Rights Agent, the registered holders of the Rights and all other
parties, and (y) not subject the Board, or any member thereof, to any liability to the registered holders of the Rights. The Rights
Agent is entitled always to assume the Company&rsquo;s Board acted in good faith and shall be fully protected and incur no liability
in reliance thereon.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 30.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Benefits of this Agreement</U>. Nothing in this Agreement shall be construed to give to any Person other than the Company,
the Rights Agent and the registered holders of the Rights Certificates (and, prior to the Distribution Date, the Common Shares)
any legal or equitable right, remedy or claim under this Agreement; but this Agreement shall be for the sole and exclusive benefit
of the Company, the Rights Agent and the registered holders of the Rights Certificates (and, prior to the Distribution Date, the
Common Shares).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 31.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Severability</U>. If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction
or other authority to be invalid, void or unenforceable, the remainder of the terms, provisions, covenants and restrictions of
this Agreement shall remain in full force and effect and shall in no way be affected, impaired or invalidated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 32.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Governing Law</U>. This Agreement, each Right and each Rights Certificate issued hereunder shall be deemed to be a contract
made under the laws of the State of Delaware and for all purposes shall be governed by and construed in accordance with the laws
of such jurisdiction applicable to contracts made and to be performed entirely within such jurisdiction; <U>provided</U>, <U>however</U>,
that all provisions regarding the rights, duties, and obligations of the Rights Agent shall be governed by and construed in accordance
with the laws of the State of New York applicable to contracts made and to be performed entirely within such State.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 33.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Counterparts; Facsimiles and PDFs</U>. This Agreement and any supplements or amendments hereto may be executed in any
number of counterparts and each of such counterparts will for all purposes be deemed to be an original, and all such counterparts
will together constitute one and the same instrument, it being understood that all parties need not sign the same counterpart.
A signature to this Agreement executed or transmitted electronically (including by facsimile and a portable document format signature)
will have the same authority, effect and enforceability as an original signature. No party hereto may raise the use of such electronic
execution or transmission to deliver a signature, or the fact that any signature or agreement or instrument was transmitted or
communicated through such electronic transmission, as a defense to the formation of a contract, and each party forever waives any
such defense, except to the extent such defense relates to lack of authenticity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 47 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">44</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt; text-align: right; font-size: 8pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 34.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Descriptive Headings</U>. Descriptive headings of the several sections of this Agreement are inserted for convenience
only and shall not control or affect the meaning or construction of any of the provisions of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 35.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><U>Force Majeure</U>. Notwithstanding anything to the contrary contained herein, the
Rights Agent shall not be liable for any delays or failures in performance resulting from acts beyond its reasonable control
including, without limitation, acts of God, terrorist acts, shortage of supply, breakdowns or malfunctions, interruptions or
malfunction of computer facilities, or loss of data due to power failures or mechanical difficulties with information storage
or retrieval systems, labor difficulties, war, or civil unrest.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 36.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&#8239;</FONT><U>Further Assurance.</U> The Company shall perform, acknowledge and deliver or cause to be performed, acknowledged and
delivered all such further and other acts, documents, instruments and assurances as may be reasonably required by the Rights Agent
for its carrying out or performing the provisions of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>[SIGNATURE PAGE FOLLOWS]</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 2in"></P>

<!-- Field: Page; Sequence: 48 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">45</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt; text-align: right; font-size: 8pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 2in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF,
the parties hereto have caused this Agreement to be duly executed as of the day and year first above written.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="text-transform: uppercase">adma biologics, INC.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 35%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>By:</TD>
    <TD STYLE="border-bottom: Black 1pt solid">/s/ Adam S. Grossman</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Name:&nbsp;</TD>
    <TD>Adam S. Grossman</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Title:</TD>
    <TD>President and Chief Executive Officer</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="text-transform: uppercase">CONTINENTAL STOCK TRANSFER AND TRUST COMPANY, AS RIGHTS AGENT</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>By:</TD>
    <TD STYLE="border-bottom: Black 1pt solid">/s/ Stacy Aqui</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Name:</TD>
    <TD>Stacy Aqui</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Title:</TD>
    <TD>Vice President</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in"><B></B></P>

<!-- Field: Page; Sequence: 49 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt; text-align: right; font-size: 8pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in"><B>&nbsp;</B></P>

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in"><B><U>EXHIBIT A</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">CERTIFICATE OF DESIGNATION</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">OF</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">SERIES A JUNIOR PARTICIPATING PREFERRED
STOCK</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">OF</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase">ADMA
BIOLOGICS, inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Pursuant to Section 151 of the Delaware
General Corporation Law)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">ADMA Biologics, Inc.
(the &ldquo;<B>Corporation</B>&rdquo;), a corporation organized and existing under the General Corporation Law of the State of
the Delaware, as amended (the &ldquo;<B>DGCL</B>&rdquo;), hereby certifies that, pursuant to the authority granted by Article FOURTH
of the Certificate of Incorporation of the Corporation, as amended (the &ldquo;<B>Restated Certificate of Incorporation</B>&rdquo;),
and in accordance with Section 151 of the DGCL, the Board of Directors of the Corporation (hereinafter being referred to as the
&ldquo;<B>Board of Directors</B>&rdquo; or the &ldquo;<B>Board</B>&rdquo;), at a meeting duly called and held on December 16, 2020,
has adopted the following resolution with respect to the designations, number of shares, preferences, voting powers and other rights
and the restrictions and limitations thereof, of the Series A Junior Participating Preferred Stock:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">RESOLVED, that, pursuant
to the authority granted to and vested in the Board of Directors in accordance with the provisions of the Restated Certificate
of Incorporation, the designations, number of shares, preferences, voting powers and other rights and the restrictions and limitations
thereof of the Series A Junior Participating Preferred Stock are as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Designation and Amount</U>. The shares of such series shall be designated as &ldquo;Series A Junior Participating Preferred
Stock&rdquo; (the &ldquo;<B>Series A Preferred Stock</B>&rdquo;) and the number of shares constituting the Series A Preferred Stock
shall be 10,000. Such number of shares may be increased or decreased by resolution of the Board of Directors prior to issuance;
<U>provided</U>, <U>however</U><I>,</I> that no decrease shall reduce the number of shares of the Series A Preferred Stock to a
number less than the number of shares then outstanding plus the number of shares reserved for issuance upon the exercise of outstanding
options, rights or warrants or upon the conversion of any outstanding securities issued by the Corporation convertible into the
Series A Preferred Stock; <U>provided</U>, <U>further</U>, that if more than a total 10,000 shares of Series A Preferred Stock
shall be issuable upon the exercise of Rights (the &ldquo;<B>Rights</B>&rdquo;) issued pursuant to the Rights Agreement, dated
as of December 16, 2020, and as supplemented, restated or amended from time to time, by and between the Corporation and Continental
Stock Transfer and Trust Company, as rights agent (the &ldquo;<B>Rights Agreement</B>&rdquo;), the Board, pursuant to Section 151(g)
of the DGCL, shall direct by resolution or resolutions that a certificate be properly executed, acknowledged, filed and recorded,
in accordance with the provisions of Section 103 of the DGCL, providing for the total number of shares of Series A Preferred Stock
authorized to be issued to be increased (to the extent that the Restated Certificate of Incorporation then permits) to the largest
number of whole shares (rounded up to the nearest whole number) issuable upon exercise of such Rights.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 50 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt; text-align: right; font-size: 8pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Dividends and Distributions</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Subject to the rights of the holders of any shares of any series of Preferred Stock of the Corporation (the &ldquo;<B>Preferred
Stock</B>&rdquo;) (or any similar stock) ranking prior and superior to the shares of Series A Preferred Stock with respect to dividends,
the holders of shares of the Series A Preferred Stock, in preference to the holders of common stock, par value $0.0001 per share,
of the Corporation (the &ldquo;<B>Common Stock</B>&rdquo;) and of any other stock of the Corporation ranking junior to the Series
A Preferred Stock, shall be entitled to receive, when, as and if declared by the Board of Directors out of funds of the Corporation
legally available for the payment of dividends, quarterly dividends payable in cash on the last day of each fiscal quarter of the
Corporation in each year, or such other dates as the Board of Directors shall approve (each such date being referred to herein
as a &ldquo;<B>Quarterly Dividend Payment Date</B>&rdquo;), commencing on the first Quarterly Dividend Payment Date after the first
issuance of a share or fraction of a share of the Series A Preferred Stock (the &ldquo;<B>Issue Date</B>&rdquo;), in an amount
per share (rounded to the nearest cent) equal to the greater of (i) $1.00 or (ii) subject to the provision for adjustment hereinafter
set forth, 1,000 times the aggregate per share amount of all cash dividends, and 1,000 times the aggregate per share amount (payable
in kind) of all non-cash dividends or other distributions other than a dividend payable in shares of Common Stock or a subdivision
of the outstanding shares of the Common Stock (by reclassification or otherwise), declared on the Common Stock since the immediately
preceding Quarterly Dividend Payment Date or, with respect to the first Quarterly Dividend Payment Date, since the first issuance
of any share or fraction of a share of Series A Preferred Stock. In the event the Corporation shall at any time after the Issue
Date (A) declare and pay any dividend on the Common Stock payable in shares of Common Stock, or (B) effect a subdivision or combination
or consolidation of the outstanding shares of Common Stock (by reclassification or otherwise than by payment of a dividend in shares
of Common Stock) into a greater or lesser number of shares of Common Stock, then in each such case the amount to which holders
of shares of Series A Preferred Stock were entitled immediately prior to such event under clause (ii) of the preceding sentence
shall be adjusted by multiplying such amount by a fraction, the numerator of which is the number of shares of Common Stock outstanding
immediately after such event and the denominator of which is the number of shares of Common Stock that were outstanding immediately
prior to such event. In the event the Corporation shall at any time declare or pay any dividend on the Series A Preferred Stock
payable in shares of Series A Preferred Stock, or effect a subdivision, combination or consolidation of the outstanding shares
of Series A Preferred Stock (by reclassification or otherwise than by payment of a dividend in shares of Series A Preferred Stock)
into a greater or lesser number of shares of Series A Preferred Stock, then in each such case the amount to which holders of shares
of Series A Preferred Stock were entitled immediately prior to such event under clause (ii) of the first sentence of this Section
2(a) shall be adjusted by multiplying such amount by a fraction, the numerator of which is the number of shares of Series A Preferred
Stock that were outstanding immediately prior to such event and the denominator of which is the number of shares of Series A Preferred
Stock outstanding immediately after such event.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Corporation shall declare a dividend or distribution on the Series A Preferred Stock as provided in paragraph (a) of
this Section 2 immediately after it declares a dividend or distribution on the Common Stock (other than a dividend payable in shares
of Common Stock); and the Corporation shall pay such dividend or distribution on the Series A Preferred Stock before the dividend
or distribution declared on the Common Stock is paid or set apart; <U>provided that</U>, in the event no dividend or distribution
shall have been declared on the Common Stock during the period between any Quarterly Dividend Payment Date and the next subsequent
Quarterly Dividend Payment Date, a dividend of $1.00 per share on the Series A Preferred Stock shall nevertheless be payable, when,
as and if declared, on such subsequent Quarterly Dividend Payment Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 51 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt; text-align: right; font-size: 8pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Dividends shall begin to accrue and be cumulative, whether or not declared, on outstanding shares of Series A Preferred
Stock from the Quarterly Dividend Payment Date next preceding the date of issue of such shares, unless the date of issue of such
shares is prior to the record date for the first Quarterly Dividend Payment Date, in which case dividends on such shares shall
begin to accrue from the date of issue of such shares, or unless the date of issue is a Quarterly Dividend Payment Date or is a
date after the record date for the determination of holders of shares of Series A Preferred Stock entitled to receive a quarterly
dividend and before such Quarterly Dividend Payment Date, in either of which events such dividends shall begin to accrue and be
cumulative from such Quarterly Dividend Payment Date. Accrued but unpaid dividends shall not bear interest. Dividends paid on the
shares of Series A Preferred Stock in an amount less than the total amount of such dividends at the time accrued and payable on
such shares shall be allocated pro rata on a share-by-share basis among all such shares at the time outstanding. The Board of Directors
may fix a record date for the determination of holders of shares of Series A Preferred Stock entitled to receive payment of a dividend
or distribution declared thereon, which record date shall be not more than sixty (60) calendar days prior to the date fixed for
the payment thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Voting Rights</U>. The holders of shares of Series A Preferred Stock shall have the following voting rights:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Subject to the provision for adjustment hereinafter set forth and except as otherwise provided in the Restated Certificate
of Incorporation or required by law, each share of Series A Preferred Stock shall entitle the holder thereof to 1,000 votes on
all matters upon which the holders of the Common Stock of the Corporation are entitled to vote. In the event the Corporation shall
at any time after the Issue Date (i) declare or pay any dividend on the Common Stock payable in shares of Common Stock, or (ii)
effect a subdivision or combination or consolidation of the outstanding shares of Common Stock (by reclassification or otherwise
than by payment of a dividend in shares of Common Stock) into a greater or lesser number of shares of Common Stock, then in each
such case the number of votes per share to which holders of shares of Series A Preferred Stock were entitled immediately prior
to such event shall be adjusted by multiplying such number by a fraction, the numerator of which is the number of shares of Common
Stock outstanding immediately after such event and the denominator of which is the number of shares of Common Stock that were outstanding
immediately prior to such event. In the event the Corporation shall at any time declare or pay any dividend on the Series A Preferred
Stock payable in shares of Series A Preferred Stock, or effect a subdivision, combination or consolidation of the outstanding shares
of Series A Preferred Stock (by reclassification or otherwise than by payment of a dividend in shares of Series A Preferred Stock)
into a greater or lesser number of shares of Series A Preferred Stock, then in each such case the number of votes per share to
which holders of shares of Series A Preferred Stock were entitled immediately prior to such event shall be adjusted by multiplying
such amount by a fraction, the numerator of which is the number of shares of Series A Preferred Stock that were outstanding immediately
prior to such event and the denominator of which is the number of shares of Series A Preferred Stock outstanding immediately after
such event.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 52 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt; text-align: right; font-size: 8pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Except as otherwise provided herein, in the Restated Certificate of Incorporation or in any other Certificate of Designations
creating a series of Preferred Stock or any similar stock, and except as otherwise required by law, the holders of shares of Series
A Preferred Stock and the holders of shares of Common Stock and any other capital stock of the Corporation having general voting
rights shall vote together as one class on all matters submitted to a vote of stockholders of the Corporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT>(i)&#9;
&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;If at any time dividends on any Series A Preferred Stock shall be in arrears in an amount equal to six (6) quarterly
dividends thereon, then and in such event the holders of the Series A Preferred Stock, voting as a separate series from all
other series of Preferred Stock and classes of capital stock, shall be entitled to elect two (2) members of the Board in
addition to any Directors elected by any other series, class or classes of securities and the authorized number of Directors
will automatically be increased by two (2). Promptly thereafter, the Board of the Corporation shall, as soon as may be
practicable, call a special meeting of holders of Series A Preferred Stock for the purpose of electing such members of the
Board. Such special meeting shall in any event be held within forty-five (45) calendar days of the occurrence of such
arrearage.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>During any period when the holders of Series A Preferred Stock, voting as a separate series, shall be entitled and shall
have exercised their right to elect two (2) Directors, then, and during such time as such right continues, (a) the then authorized
number of Directors shall be increased by two (2), and the holders of Series A Preferred Stock, voting as a separate series, shall
be entitled to elect the additional Directors so provided for, and (b) each such additional Director shall serve until the next
annual meeting of stockholders for the election of Directors, or until his successor shall be elected and shall qualify, or until
his right to hold such office terminates pursuant to the provisions of this <U>Section 3(c)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(iii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>A Director elected pursuant to the terms hereof may be removed with or without cause by the holders of Series A Preferred
Stock entitled to vote in an election of such Director.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(iv)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>If, during any interval between annual meetings of stockholders for the election of Directors and while the holders of Series
A Preferred Stock shall be entitled to elect two (2) Directors, there is no such Director in office by reason of resignation, death
or removal, then, promptly thereafter, the Board shall call a special meeting of the holders of Series A Preferred Stock for the
purpose of filling such vacancy and such vacancy shall be filled at such special meeting. Such special meeting shall in any event
be held within forty-five (45) calendar days of the occurrence of such vacancy.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(v)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>At such time as the arrearage is fully cured, and all dividends accumulated and unpaid on any shares of Series A Preferred
Stock outstanding are paid, and, in addition thereto, at least one regular dividend has been paid subsequent to curing such arrearage,
the term of office of any Director elected pursuant to this Section 3(c), or his successor, shall automatically terminate, and
the authorized number of Directors shall automatically decrease by two (2), the rights of the holders of the shares of the Series
A Preferred Stock to vote as provided in this <U>Section 3(c)</U> shall cease, subject to renewal from time to time in the case
of any such future dividend default or defaults upon the same terms and conditions, and the holders of shares of the Series A Preferred
Stock shall have only the limited voting rights elsewhere herein set forth.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 53 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt; text-align: right; font-size: 8pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Except as set forth herein, or as otherwise provided by law, the holders of Series A Preferred Stock shall have no special
voting rights and their consent shall not be required (except to the extent they are entitled to vote with holders of Common Stock
as set forth herein) for taking any corporate action.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Certain Restrictions</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Whenever quarterly dividends or other dividends or distributions payable on the Series A Preferred Stock as provided in
<U>Section 2</U> hereof are in arrears, thereafter and until all accrued and unpaid dividends and distributions, whether or not
declared, on shares of Series A Preferred Stock outstanding shall have been paid in full, the Corporation shall not:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>declare or pay dividends, or make any other distributions, on any shares of stock ranking junior (either as to dividends
or upon liquidation, dissolution or winding up) to the Series A Preferred Stock;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>declare or pay dividends, or make any other distributions, on any shares of stock ranking on a parity (either as to dividends
or upon liquidation, dissolution or winding up) with the Series A Preferred Stock, except dividends paid ratably on the Series
A Preferred Stock and all such parity stock on which dividends are payable or in arrears in proportion to the total amounts to
which the holders of all such shares are then entitled;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(iii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>redeem or purchase or otherwise acquire for consideration shares of any stock ranking junior (either as to dividends or
upon liquidation, dissolution or winding up) to the Series A Preferred Stock, <U>provided that</U>, the Corporation may at any
time redeem, purchase or otherwise acquire shares of any such junior stock in exchange for shares of any stock of the Corporation
ranking junior (either as to dividends or upon dissolution, liquidation or winding up) to the Series A Preferred Stock or rights,
warrants or options to acquire such junior stock; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(iv)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>redeem or purchase or otherwise acquire for consideration any shares of Series A Preferred Stock, or any shares of stock
ranking on a parity (either as to dividends or upon liquidation, dissolution or winding up) with the Series A Preferred Stock,
except in accordance with a purchase offer made in writing or by publication (as determined by the Board of Directors) to all holders
of such shares upon such terms as the Board of Directors, after consideration of the respective annual dividend rates and other
relative rights and preferences of the respective series and classes, shall determine in good faith will result in fair and equitable
treatment among the respective series or classes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Corporation shall not permit any subsidiary of the Corporation to purchase or otherwise acquire for consideration any
shares of stock of the Corporation unless the Corporation could, under paragraph (a) of this <U>Section 4</U>, purchase or otherwise
acquire such shares at such time and in such manner.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Reacquired Shares</U>. Any shares of Series A Preferred Stock purchased or otherwise acquired by the Corporation in any
manner whatsoever shall be retired and cancelled promptly after the acquisition thereof. All such shares shall upon their cancellation
become authorized but unissued shares of Preferred Stock and may be reissued, without designation as to series until such shares
are once more designated as part of a particular series of Preferred Stock by resolution or resolutions of the Board of Directors,
subject to the conditions and restrictions on issuance set forth herein, in the Restated Certificate of Incorporation, or in any
other Certificate of Designations creating a series of Preferred Stock or any similar stock or as otherwise required by law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 54 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt; text-align: right; font-size: 8pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">6.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Liquidation, Dissolution or Winding Up</U>. (a) Upon any liquidation, dissolution or winding up of the Corporation, no
distribution shall be made (i) to the holders of the Common Stock or of shares of any other stock of the Corporation ranking junior,
either as to dividends or upon liquidation, dissolution or winding up, to the Series A Preferred Stock unless, prior thereto, the
holders of shares of Series A Preferred Stock shall have received $1,000 per share, plus an amount equal to accrued and unpaid
dividends and distributions thereon, whether or not declared, to the date of such payment, <U>provided that</U>, the holders of
shares of Series A Preferred Stock shall be entitled to receive an aggregate amount per share, subject to the provision for adjustment
hereinafter set forth, equal to 1,000 times the aggregate amount to be distributed per share to holders of shares of Common Stock,
or (ii) to the holders of shares of stock ranking on a parity either as to dividends or upon liquidation, dissolution or winding
up with the Series A Preferred Stock, except distributions made ratably on the Series A Preferred Stock and all such parity stock
in proportion to the total amounts to which the holders of all such shares are entitled upon such liquidation, dissolution or winding
up. In the event, however, that there are not sufficient assets available to permit payment in full of the Series A Preferred Stock
liquidation preference and the liquidation preferences of all other classes and series of stock of the Corporation, if any, that
rank on a parity with the Series A Preferred Stock in respect thereof, then the assets available for such distribution shall be
distributed ratably to the holders of the Series A Preferred Stock and the holders of such parity shares in the proportion to their
respective liquidation preferences. In the event the Corporation shall at any time after the Issue Date (A) declare or pay any
dividend on the Common Stock payable in shares of Common Stock, or (B) effect a subdivision or combination or consolidation of
the outstanding shares of Common Stock (by reclassification or otherwise than by payment of a dividend in shares of Common Stock)
into a greater or lesser number of shares of Common Stock, then in each such case the aggregate amount to which holders of shares
of Series A Preferred Stock were entitled immediately prior to such event under the proviso in clause (i) of this <U>Section 6(a)</U>
shall be adjusted by multiplying such amount by a fraction the numerator of which is the number of shares of Common Stock outstanding
immediately after such event and the denominator of which is the number of shares of Common Stock that were outstanding immediately
prior to such event. In the event the Corporation shall at any time declare or pay any dividend on the Series A Preferred Stock
payable in shares of Series A Preferred Stock, or effect a subdivision, combination or consolidation of the outstanding shares
of Series A Preferred Stock (by reclassification or otherwise than by payment of a dividend in shares of Series A Preferred Stock)
into a greater or lesser number of shares of Series A Preferred Stock, then in each such case the aggregate amount to which holders
of shares of Series A Preferred Stock were entitled immediately prior to such event under the proviso in clause (i) of this <U>Section
6(a)</U> shall be adjusted by multiplying such amount by a fraction, the numerator of which is the number of shares of Series A
Preferred Stock that were outstanding immediately prior to such event and the denominator of which is the number of shares of Series
A Preferred Stock outstanding immediately after such event.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Neither the merger, consolidation or other business combination of the Corporation into or with another entity nor the merger,
consolidation or other business combination of any other entity into or with the Corporation (nor the sale, lease, exchange or
conveyance of all or substantially all of the property, assets or business of the Corporation) shall be deemed to be a liquidation,
dissolution or winding up of the Corporation within the meaning of this Section 6.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 55 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt; text-align: right; font-size: 8pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">7.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Consolidation, Merger, etc.</U> Notwithstanding anything to the contrary contained herein, in case the Corporation shall
enter into any consolidation, merger, combination or other transaction in which the shares of Common Stock are converted into,
exchanged for or changed into other stock or securities, cash and/or any other property (payable in kind), then in any such case
each share of Series A Preferred Stock shall at the same time be similarly converted into, exchanged for or changed into an amount
per share (subject to the provision for adjustment hereinafter set forth) equal to 1,000 times the aggregate amount of stock, securities,
cash and/or any other property (payable in kind), as the case may be, into which or for which each share of Common Stock is converted
or exchanged. In the event the Corporation shall at any time after the Issue Date (i) declare or pay any dividend on the Common
Stock payable in shares of Common Stock, or (ii) effect a subdivision or combination or consolidation (by reclassification or otherwise
than by payment of a dividend in shares of Common Stock) of the outstanding shares of Common Stock into a greater or lesser number
of shares of Common Stock, then in each such case the amount set forth in the preceding sentence with respect to the conversion,
exchange or change of shares of Series A Preferred Stock shall be adjusted by multiplying such amount by a fraction, the numerator
of which is the number of shares of Common Stock outstanding immediately after such event and the denominator of which is the number
of shares of Common Stock that were outstanding immediately prior to such event. In the event the Corporation shall at any time
declare or pay any dividend on the Series A Preferred Stock payable in shares of Series A Preferred Stock, or effect a subdivision,
combination or consolidation of the outstanding shares of Series A Preferred Stock (by reclassification or otherwise than by payment
of a dividend in shares of Series A Preferred Stock) into a greater or lesser number of shares of Series A Preferred Stock, then
in each such case the amount set forth in the first sentence of this Section 7 with respect to the exchange or change of shares
of Series A Preferred Stock shall be adjusted by multiplying such amount by a fraction, the numerator of which is the number of
shares of Series A Preferred Stock that were outstanding immediately prior to such event and the denominator of which is the number
of shares of Series A Preferred Stock outstanding immediately after such event.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">8.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>No Redemption</U>. The shares of Series A Preferred Stock shall not be redeemable from any holder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">9.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Rank</U>. The Series A Preferred Stock shall rank, with respect to the payment of dividends and the distribution of assets
upon liquidation, dissolution or winding up of the Corporation, junior to all series of any other class of the Preferred Stock
issued either before or after the issuance of the Series A Preferred Stock, unless the terms of any such series shall provide otherwise,
and shall rank senior to the Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">10.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Amendment</U>. At such time as any shares of Series A Preferred Stock are outstanding, if any proposed amendment to the
Restated Certificate of Incorporation (including this Certificate of Designation) would materially alter, change or repeal any
of the preferences, powers or special rights given to the Series A Preferred Stock so as to affect the Series A Preferred Stock
adversely, then the holders of the Series A Preferred Stock shall be entitled to vote separately as a class upon such amendment,
and the affirmative vote of two-thirds of the outstanding shares of the Series A Preferred Stock, voting separately as a single
class, shall be necessary for the adoption thereof, in addition to such other vote as may be required by the DGCL.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 56 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt; text-align: right; font-size: 8pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">11.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Fractional Shares</U>. Series A Preferred Stock may be issued in fractions of a share that shall entitle the holder,
in proportion to such holder&rsquo;s fractional shares, to exercise voting rights, receive dividends, participate in distributions
and to have the benefit of all other rights of holders of Series A Preferred Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>IN WITNESS WHEREOF</B>,
the undersigned have signed and attested this Certificate of Designation on this 16th day of December 2020.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="text-transform: uppercase">ADMA BIOLOGICS, INC.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 35%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>By:</TD>
    <TD STYLE="border-bottom: Black 1pt solid"></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Name:&nbsp;</TD>
    <TD>Adam S. Grossman</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Title:</TD>
    <TD>Chief Executive Officer</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">Attest:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">__________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Secretary</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 57 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt; text-align: right; font-size: 8pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B><U>EXHIBIT B</U></B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">FORM OF RIGHTS CERTIFICATE</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 50%">Certificate No. R-</TD>
    <TD STYLE="text-align: right; width: 50%; vertical-align: top">_______________ Rights</TD></TR>
</TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">NOT EXERCISABLE AFTER 5:00 P.M., NEW YORK
CITY TIME, ON DECEMBER 15, 2021 UNLESS THE RIGHTS ARE EARLIER REDEEMED OR EXCHANGED. THE RIGHTS ARE SUBJECT TO REDEMPTION AT $0.001
PER RIGHT AND TO EXCHANGE, IN EACH CASE, AT THE OPTION OF THE COMPANY, ON THE TERMS SET FORTH IN THE RIGHTS AGREEMENT. THE RIGHTS
EVIDENCED BY THIS CERTIFICATE SHALL NOT BE EXERCISABLE, AND SHALL BE VOID SO LONG AS HELD BY A HOLDER IN ANY JURISDICTION WHERE
THE REQUISITE QUALIFICATION FOR THE ISSUANCE TO SUCH HOLDER, OR THE EXERCISE BY SUCH HOLDER, OF THE RIGHTS IN SUCH JURISDICTION
SHALL NOT HAVE BEEN OBTAINED OR BE OBTAINABLE. UNDER CERTAIN CIRCUMSTANCES SET FORTH IN THE RIGHTS AGREEMENT, RIGHTS BENEFICIALLY
OWNED BY ANY PERSON WHO IS, WAS OR BECOMES AN ACQUIRING PERSON OR ANY RELATED PERSON THEREOF (AS SUCH TERMS ARE DEFINED IN THE
RIGHTS AGREEMENT), WHETHER CURRENTLY BENEFICIALLY OWNED BY OR ON BEHALF OF SUCH PERSON OR BY ANY SUBSEQUENT BENEFICIAL OWNER, MAY
BECOME NULL AND VOID AND NO LONGER TRANSFERABLE. [THE RIGHTS REPRESENTED BY THIS RIGHTS CERTIFICATE ARE OR WERE BENEFICIALLY OWNED
BY OR ON BEHALF OF A PERSON WHO IS, WAS OR BECAME AN ACQUIRING PERSON OR A RELATED PERSON OF AN ACQUIRING PERSON (AS SUCH TERMS
ARE DEFINED IN THE RIGHTS AGREEMENT). ACCORDINGLY, THIS RIGHTS CERTIFICATE AND THE RIGHTS REPRESENTED HEREBY MAY BECOME NULL AND
VOID IN THE CIRCUMSTANCES SPECIFIED IN SECTION 7(e) OF SUCH AGREEMENT.]<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>1</SUP></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">RIGHTS CERTIFICATE</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase">ADMA
BIOLOGICS, INC.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This certifies that
___________, or registered assigns, is the registered owner of the number of Rights set forth above, each of which entitles the
owner thereof, subject to the terms, provisions and conditions of the Rights Agreement, dated as of December 16, 2020, and as supplemented,
restated or amended from time to time (the &ldquo;<B>Rights Agreement</B>&rdquo;), by and between ADMA Biologics, Inc., a Delaware
corporation (the &ldquo;<B>Company</B>&rdquo;), and Continental Stock Transfer and Trust Company, as rights agent (the &ldquo;<B>Rights
Agent</B>&rdquo;), to purchase from the Company at any time after the Distribution Date (as such term is defined in the Rights
Agreement) and prior to 5:00 p.m., New York City time, on December 15, 2021, unless the Rights are previously redeemed or exchanged,
at the office or offices of the Rights Agent designated for such purpose, or its successors as Rights Agent, one one-thousandth
of a fully paid, nonassessable share of Series A Junior Participating Preferred Stock, par value $0.0001 per share, of the Company
(a &ldquo;<B>Preferred Share</B>&rdquo;), at a purchase price of $12.50 in cash per one one-thousandth of a Preferred Share
(such purchase price, as may be adjusted, the &ldquo;<B>Purchase Price</B>&rdquo;), upon presentation and surrender of this Rights
Certificate with the Form of Election to Purchase and related certificate duly executed. The Company reserves the right to require
prior to the occurrence of a Triggering Event (as such term is defined in the Rights Agreement) that a number of Rights be exercised
so that only whole Preferred Shares will be issued. Capitalized terms used herein and not otherwise defined herein shall have the
meanings ascribed to such terms in the Rights Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">_____________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>1</SUP></FONT>
The portion of the legend in brackets shall be inserted only if applicable and shall replace the preceding sentence.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 58 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt; text-align: right; font-size: 8pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Rights Certificate
is subject to all of the terms, covenants, and restrictions of the Rights Agreement, which terms, covenants, and restrictions are
hereby incorporated herein by reference and made a part hereof and to which Rights Agreement reference is hereby made for a full
description of the rights, limitations of rights, obligations, duties and immunities hereunder of the Rights Agent, the Company
and the holders of the Rights Certificates, which limitations of rights include the temporary suspension of the exercisability
of such Rights under the specific circumstances set forth in the Rights Agreement. Copies of the Rights Agreement are on file at
the principal executive offices of the Company and the office or offices of the Rights Agent and are also available upon written
request to the Rights Agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In certain circumstances
described in the Rights Agreement, the Rights evidenced thereby may entitle the registered holder thereof to purchase capital stock
of an entity other than the Company or receive capital stock, cash, or other assets of an entity other than the Company, all as
provided in the Rights Agreement. Upon the occurrence (whether prior to, on or after the date of this Rights Certificate) of a
Section 11(a)(ii) Event (as such term is defined in the Rights Agreement), if the Rights evidenced by this Rights Certificate are
beneficially owned by (i) an Acquiring Person or a Related Person of any such Acquiring Person (as such terms are defined in the
Rights Agreement), (ii) a transferee of any such Acquiring Person or of any such Related Person thereof who becomes a transferee
after the Acquiring Person becomes an Acquiring Person, or (iii) under certain circumstances specified in the Rights Agreement,
a transferee of a person who, concurrently with or prior to such transfer, became an Acquiring Person, or a Related Person of an
Acquiring Person, such Rights shall become null and void and will no longer be transferable and no holder hereof shall have any
right with respect to such Rights from and after the occurrence of such Section 11(a)(ii) Event.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As provided in the
Rights Agreement, the Purchase Price, and the number of one one-thousandths of a Preferred Share or other securities issuable upon
exercise of a Right and the number of Rights outstanding are subject to modification and adjustment upon the happening of certain
events, including Triggering Events.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Rights Certificate,
with or without other Rights Certificates, upon surrender at the office or offices of the Rights Agent designated for such purpose,
with the Form of Election and Certificate set forth on the reverse side properly completed and duly executed, may be exchanged
for another Rights Certificate or Rights Certificates of like tenor and date evidencing Rights entitling the holder to purchase
a like aggregate number of one one-thousandths of a Preferred Share as the Rights evidenced by the Rights Certificate or Rights
Certificates surrendered shall have entitled such holder to purchase. If this Rights Certificate shall be exercised in part, the
holder shall be entitled to receive upon surrender hereof another Rights Certificate or Rights Certificates for the number of whole
Rights not exercised.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 59 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt; text-align: right; font-size: 8pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Subject to the provisions
of the Rights Agreement, the Rights evidenced by this Rights Certificate may be redeemed by the Company under certain circumstances,
at its option, at a redemption price of $0.001 per Right, payable in cash, or other securities or property of the Company, as determined
by the Board of Directors of the Company, in the exercise of its sole discretion, at any time prior to the earlier of (i) the Close
of Business on the tenth (10th) Business Day (or such later date as may be determined by the Board pursuant to clause (i) of the
first sentence of Section 3(a) of the Rights Agreement with respect to the Distribution Date) following the Shares Acquisition
Date (or, if the Shares Acquisition Date shall have occurred prior to the Record Date, the Close of Business on the tenth (10th)
Business Day following the Record Date), and (ii) the Final Expiration Date. The redemption of the Rights may be made effective
at such time, on such basis, and subject to such conditions as the Board of Directors in its sole discretion may establish.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, subject
to the provisions of the Rights Agreement, under certain circumstances following the occurrence of a Section 11(a)(ii) Event, but
before any person (other than certain exempted or grandfathered persons) acquires beneficial ownership of fifty percent (50%) or
more of the Common Shares (as such term is defined in the Rights Agreement), the then outstanding and exercisable Rights (which
shall not include Rights held by the Acquiring Person that shall have become null and void and nontransferable pursuant to the
provisions of the Rights Agreement) may be exchanged, in whole or in part, for Common Shares at an exchange rate of one Common
Share for each Right (subject to adjustment for certain events as provided in the Rights Agreement).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In any such exchange,
the Company, at its option, may, and to the extent there are an insufficient number of authorized Common Shares not reserved for
any other purpose to exchange for all of the outstanding Rights, shall, substitute Preferred Shares or other securities of the
Company for some or all of the Common Shares exchangeable for Rights such that the aggregate value received by a holder of Rights
in exchange for each Right is substantially the same value as one Common Share. The exchange of the Rights by the Company may be
made effective at such time, on such basis, and subject to such conditions as the Board in its sole discretion may establish.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Immediately upon the
action of the Board of Directors of the Company authorizing any such redemption or exchange, and without any further action or
any notice, the Rights (other than Rights that are not subject to such redemption or exchange) will terminate and the Rights will
only enable holders to receive the redemption price without any interest thereon or the shares issuable upon such exchange, as
applicable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">No fractional Preferred
Shares or fractional shares of other securities will be issued upon the exercise of any Right or Rights evidenced hereby (other
than fractions that are integral multiples of one one-thousandth of a Preferred Share, which may, at the election of the Company,
be evidenced by depositary receipts), but in lieu thereof a cash payment may be made, as provided in the Rights Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 60 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt; text-align: right; font-size: 8pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">No holder of this Rights
Certificate, as such, shall be entitled to vote or receive dividends or be deemed for any purpose the holder of Preferred Shares
or of any other securities of the Company which may at any time be issuable on the exercise hereof, nor shall anything contained
in the Rights Agreement or herein be construed to confer upon the holder hereof, as such, any of the rights of a stockholder of
the Company or any right to vote for the election of directors or upon any matter submitted to stockholders at any meeting thereof,
or to give or withhold consent to any corporate action, or to receive notice of meetings or other actions affecting stockholders
(except as may otherwise be provided in the Rights Agreement), or to receive dividends or other distributions or to exercise any
preemptive or subscription rights, or otherwise, unless and until the Right or Rights evidenced by this Rights Certificate shall
have been exercised as provided in the Rights Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Rights Certificate
shall not be valid or obligatory for any purpose until it shall have been countersigned by the Rights Agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WITNESS the facsimile
signature or portable document format of the proper officers of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Dated as of __, 20__.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">ADMA BIOLOGICS, <FONT STYLE="text-transform: uppercase">INC.</FONT></TD>
    </TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 35%">&nbsp;</TD>
    </TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>By:</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    </TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Name:</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    </TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Title:</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    </TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    </TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    </TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>By:</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    </TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Name:</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    </TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Title:</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    </TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    </TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">Countersigned:</TD>
    </TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    </TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="text-transform: uppercase">CONTINENTAL STOCK TRANSFER AND TRUST COMPANY,</FONT> as Rights Agent</TD>
    </TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    </TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>By:</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    </TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Name:</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    </TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Title:</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    </TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 61 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt; text-align: right; font-size: 8pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;[Form of Reverse Side of Rights Certificate]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>FORM OF ASSIGNMENT</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(To be executed by the registered holder
if such</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 3pt">holder desires to transfer
the Rights Certificate.)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">FOR VALUE RECEIVED ______________________________________________________________
hereby sells, assigns and transfers unto _______________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Please print name and address of transferee)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Please spell out and include in numerals
the</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">number of Rights being transferred by this
Agreement)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">of the Rights evidenced by this Rights
Certificate, together with all right, title and interest therein, and does hereby irrevocably constitute and appoint _____ Attorney,
to transfer the number of Rights indicated on the books of the within named Company, with full power of substitution.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dated as of: __________ ___, 20__</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">SIGNATURE</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">By: &#8239;&#8239;&#8239;&#8239;&#8239; &#8239;&#8239;______________________________________&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Name:&#9; &#8239;&#8239;______________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Title:&#9; &#8239;&#8239;&#8239;&#8239;______________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Medallion Signature Guaranteed:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Signatures must be guaranteed by an eligible guarantor institution
(a bank, stockbroker, savings and loan association or credit union with membership in an approved signature guarantee medallion
program), at a guarantee level reasonably satisfactory to the Rights Agent. A notary public is not sufficient guarantee of a signature.<BR STYLE="clear: both"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 62 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt; text-align: right; font-size: 8pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>CERTIFICATE</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The undersigned hereby certifies by checking
the appropriate boxes that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(1) the Rights evidenced by this Rights
Certificate [ &#8239;&#8239;&#8239;] are [ &#8239;&#8239;&#8239;] are not being sold, assigned and transferred by or on behalf of a Person who is or was an Acquiring Person
or a Related Person of any such Acquiring Person (as such terms are defined in the Rights Agreement); and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(2) after due inquiry and to the best knowledge
of the undersigned, he, she or it [&#8239;&#8239;&#8239; ] did [ &#8239;&#8239;&#8239;] did not acquire the Rights evidenced by this Rights Certificate from any Person who
is, was or subsequently became an Acquiring Person or a Related Person of an Acquiring Person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dated as of: __________ ___, 20__</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">SIGNATURE</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">By: &#8239;&#8239;&#8239;&#8239;&#8239; &#8239;&#8239;______________________________________&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Name:&#9; &#8239;&#8239;______________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Title:&#9; &#8239;&#8239;&#8239;&#8239;______________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Medallion Signature Guaranteed:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Signatures must be guaranteed by an eligible guarantor institution
(a bank, stockbroker, savings and loan association or credit union with membership in an approved signature guarantee medallion
program), at a guarantee level reasonably satisfactory to the Rights Agent. A notary public is not sufficient guarantee of a signature.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 63 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt; text-align: right; font-size: 8pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>NOTICE</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The signature to the foregoing Assignment
and Certificate must correspond to the name as written upon the face of this Rights Certificate in every particular, without alteration
or enlargement or any change whatsoever.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 64 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt; text-align: right; font-size: 8pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[Form of Reverse Side of Rights Certificate
&ndash; Continued]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>FORM OF ELECTION TO PURCHASE</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(To be executed by the registered holder
if such holder desires to</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">exercise any or all Rights evidenced by
the Rights Certificate.)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To:&#9;<FONT STYLE="text-transform: uppercase">ADMA
BIOLOGICS, inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The undersigned hereby irrevocably elects
to exercise __________ (_______) Rights evidenced by this Rights Certificate to purchase the Preferred Shares issuable upon the
exercise of the Rights (or such other securities of the Company or of any other person which may be issuable upon the exercise
of the Rights) and requests that certificates for such shares be issued in the name of and delivered to or that such shares be
credited to the book entry account of:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Please print name, address and social security,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">tax identification or other identifying
number.)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If such number of Rights shall not be all
the Rights evidenced by this Rights Certificate, a new Rights Certificate for the balance of such Rights shall be registered in
the name of and delivered to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Please print name, address and social security,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">tax identification or other identifying
number.)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dated: __________ ___, ____</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">SIGNATURE</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">By: &#8239;&#8239;&#8239;&#8239;&#8239; &#8239;&#8239;______________________________________&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Name:&#9; &#8239;&#8239;______________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Title:&#9; &#8239;&#8239;&#8239;&#8239;______________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Medallion Signature Guaranteed:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Signatures must be guaranteed by an eligible guarantor institution
(a bank, stockbroker, savings and loan association or credit union with membership in an approved signature guarantee medallion
program), at a guarantee level reasonably satisfactory to the Rights Agent. A notary public is not sufficient guarantee of a signature.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 65 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt; text-align: right; font-size: 8pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>CERTIFICATE</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The undersigned hereby certifies by checking
the appropriate boxes that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(1) the Rights evidenced by this Rights
Certificate [&#8239;&#8239;&#8239; ] are [&#8239;&#8239;&#8239; ] are not being exercised by or on behalf of a Person who is or was an Acquiring Person or a Related Person
of any such Acquiring Person (as such terms are defined pursuant to the Rights Agreement); and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(2) after due inquiry and to the best knowledge
of the undersigned, he, she or it [&#8239;&#8239;&#8239; ] did [&#8239;&#8239;&#8239; ] did not acquire the Rights evidenced by this Rights Certificate from any Person who
is, was or became an Acquiring Person or a Related Person of an Acquiring Person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dated: __________ ___, ____</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">SIGNATURE</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">By: &#8239;&#8239;&#8239;&#8239;&#8239; &#8239;&#8239;______________________________________&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Name:&#9; &#8239;&#8239;______________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Title:&#9; &#8239;&#8239;&#8239;&#8239;______________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Medallion Signature Guaranteed:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Signatures must be guaranteed by an eligible guarantor institution
(a bank, stockbroker, savings and loan association or credit union with membership in an approved signature guarantee medallion
program), at a guarantee level reasonably satisfactory to the Rights Agent. A notary public is not sufficient guarantee of a signature.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 66 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt; text-align: right; font-size: 8pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>NOTICE</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The signature to the foregoing Election
to Purchase and Certificate must correspond to the name as written upon the face of this Rights Certificate in every particular,
without alteration or enlargement or any change whatsoever.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 67 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt; text-align: right; font-size: 8pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B><U>EXHIBIT C</U></B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase">ADMA
BIOLOGICS, INC.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">SUMMARY OF RIGHTS<BR>
TO PURCHASE PREFERRED STOCK</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On December 16, 2020,
the Board of Directors (the &ldquo;<B>Board</B>&rdquo;) of ADMA Biologics, Inc., a Delaware corporation (the &ldquo;<B>Company</B>&rdquo;),
declared a dividend distribution of one preferred share purchase right (each, a &ldquo;<B>Right</B>&rdquo;) for each outstanding
share of common stock, par value $0.0001 per share, of the Company (the &ldquo;<B>Common Shares</B>&rdquo;). The dividend was payable
to holders of record as of the close of business on December 30, 2020 (the &ldquo;<B>Record Date</B>&rdquo;) and with respect to
Common Shares issued thereafter until the Distribution Date (as defined below) and, in certain circumstances, with respect to Common
Shares issued after the Distribution Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following is a
summary description of the Rights. This summary is intended to provide a general description only and is subject to the detailed
terms and conditions of the Rights Agreement, dated as of December 16, 2020 (the &ldquo;<B>Rights Agreement</B>&rdquo;), by and
between the Company and Continental Stock Transfer and Trust Company, as rights agent (the &ldquo;<B>Rights Agent</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><B>Issuance of Rights</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Each holder of Common
Shares as of the Record Date will receive a dividend of one Right per Common Share. One Right will also be issued together with
each Common Share issued by the Company after the Record Date and prior to the Distribution Date (as defined in Section 2 below),
and in certain circumstances, after the Distribution Date. New certificates (or, if uncertificated, the book entry account that
evidences record ownership of such shares) for Common Shares issued after the Record Date will contain a notation incorporating
the Rights Agreement by reference.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Until the Distribution
Date:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">                                                                                                                                                                                                                                                                                                                                                                                                                              <TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&#9679;</TD><TD STYLE="text-align: justify">the Rights
will not be exercisable;</TD></TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&#9679;</TD><TD STYLE="text-align: justify">the Rights will be evidenced by the certificates for Common Shares (or, if uncertificated, by the
book entry account that evidences record ownership of such shares) and not by separate rights certificates; and</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&#9679;</TD><TD STYLE="text-align: justify">the Rights will be transferable by, and only in connection with, the transfer of Common Shares.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><B>Distribution Date; Exercise of Rights; Beneficial Ownership</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Rights are not
exercisable until the Distribution Date. As of and after the Distribution Date, the Rights will separate from the Common Shares
and each Right will become exercisable to purchase from the Company one one-thousandth of a share of Series A Junior Participating
Preferred Stock, par value $0.0001 per share, of the Company (each whole share, a &ldquo;<B>Preferred Share</B>&rdquo;) at a purchase
price of $12.50 per one one-thousandth of a Preferred Share (such purchase price, as may be adjusted from time to time, the
&ldquo;<B>Purchase Price</B>&rdquo;). This portion of a Preferred Share would give the holder thereof approximately the same dividend,
voting, and liquidation rights as would one Common Share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 68 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt; text-align: right; font-size: 8pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The &ldquo;<B>Distribution
Date</B>&rdquo; is the earlier of:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&#9679;</TD><TD STYLE="text-align: justify">the close of business on the tenth (10th) business day (or such later date as may be determined
from time to time by action of a majority of the Board prior to the Distribution Date that would otherwise have occurred) following
the first date of public announcement that any person, together with such person&rsquo;s Related Persons (as defined below) (other
than the Company or certain related entities), has become the beneficial owner of ten percent (10%) or more of the then outstanding
Common Shares (other than as a result of repurchases of Common Shares by the Company, certain stock option or restricted stock
grants by the Company or the exercise or conversion thereof, certain inadvertent acquisitions or purchases of Common Shares directly
from the Company) (such person, an &ldquo;<B>Acquiring Person</B>&rdquo;) or that discloses information which reveals the existence
of an Acquiring Person; <U>provided</U>, <U>however</U>, that stockholders who beneficially own ten percent (10%) or more of the
outstanding Common Shares as of the time immediately prior to the first public announcement by the Company of the adoption of the
Rights Agreement (including any Common Shares beneficial ownership of which is acquired on the date of such announcement pursuant
to orders placed prior to such announcement), will not be considered an Acquiring Person unless and until such stockholder or any
of its Related Persons acquires, without the prior approval of the Board, beneficial ownership of any additional Common Shares,
subject to certain exceptions (such date being the <B>&ldquo;Shares Acquisition Date</B>&rdquo;); and</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&#9679;</TD><TD STYLE="text-align: justify">the close of business on the tenth (10th) business day (or such later date as a majority of the
Board shall determine prior to the Distribution Date that would otherwise have occurred) after the date of the commencement of,
or first public announcement of the intent of any person (other than the Company or certain related entities) to commence (within
the meaning of Rule 14d-2(a) of the General Rules and Regulations under the U.S. Securities Exchange Act of 1934, as amended (the
&ldquo;<B>Exchange Act</B>&rdquo;)), a tender or exchange offer that, if successfully completed, would result in such person becoming
an Acquiring Person; <U>provided</U>, <U>however</U>, that if a tender or exchange offer is terminated prior to the occurrence
of a Distribution Date, then no Distribution Date shall occur as a result of such tender or exchange offer.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">A person will be deemed
to &ldquo;<B>beneficially own</B>&rdquo; any Common Shares if such person or any Related Person:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&#9679;</TD><TD STYLE="text-align: justify">is considered a &ldquo;beneficial owner&rdquo; of the Common Shares under Rule 13d-3 of the General
Rules and Regulations under the Exchange Act;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 69 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt; text-align: right; font-size: 8pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&#9679;</TD><TD STYLE="text-align: justify">has the right to acquire the Common Shares, either immediately or in the future, pursuant to any
agreement, arrangement, or understanding (other than a customary underwriting agreement relating to a bona fide public offering
of the Common Shares) or upon the exercise of conversion rights, exchange rights, rights, warrants or options, or otherwise, except
that a person will not be deemed to be a beneficial owner of (a) Common Shares tendered pursuant to a tender offer or exchange
offer by or on behalf of such person or any affiliated or associated persons of such person until the tendered Common Shares are
accepted for purchase or exchange, (b) securities issuable upon exercise of a Right before the occurrence of a Triggering Event
(as defined in Section 5 below), or (c) securities issuable upon exercise of a Right after the occurrence of a Triggering Event
if the Rights are originally issued Rights or were issued in connection with an adjustment to originally issued Rights;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&#9679;</TD><TD STYLE="text-align: justify">has the right to vote or dispose of the Common Shares pursuant to any agreement, arrangement, or
understanding (other than a right to vote arising from the granting of a revocable proxy or consent); or</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&#9679;</TD><TD STYLE="text-align: justify">has an agreement, arrangement, or understanding with another person who beneficially owns Common
Shares and the agreement, arrangement, or understanding is for the purpose of acquiring, holding, voting, or disposing of any securities
of the Company (other than customary underwriting agreements relating to a bona fide public offering of Common Shares or a right
to vote arising from the granting of a revocable proxy or consent).</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For purposes of the
Rights Agreement, a &ldquo;<B>Related Person</B>&rdquo; means, as to any person, any Affiliates or Associates of such person. For
purposes of the Rights Agreement, &ldquo;Affiliate&rdquo; and &ldquo;Associate&rdquo; have the respective meanings ascribed to
such terms in Rule 12b-2 of the General Rules and Regulations under the Exchange Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Certain synthetic interests
in securities created by derivative positions &mdash; whether or not such interests are considered to be ownership of the underlying
Common Shares or are reportable for purposes of Regulation 13D of the Securities Exchange Act &mdash; are treated as beneficial
ownership of the number of Common Shares specified in the documentation evidencing the derivative position as being subject to
being acquired upon the exercise or settlement of the derivative position or as the basis upon which the value or settlement amount
of such derivative position is to be calculated in whole or in part.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><B>Issuance of Rights Certificates</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As soon as practicable
after the Distribution Date, the Rights Agent will mail rights certificates to holders of record of the Common Shares as of the
close of business on the Distribution Date and, thereafter, the separate rights certificates alone will evidence the Rights.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 70 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt; text-align: right; font-size: 8pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><B>Expiration of Rights</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Rights will expire
on the earliest of (a) 5:00 p.m., New York City time, on December 15, 2021, (b) the time at which the Rights are redeemed (as described
in Section 6 below), and (c) the time at which the Rights are exchanged in full (as described in Section 7 below).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><B>Change of Exercise of Rights Following Certain Events</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following described
events are referred to as &ldquo;<B>Triggering Events</B>.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><B>&ldquo;Flip-In&rdquo; Event</B>. In the event that a person becomes an Acquiring Person, each holder of a Right will
thereafter have the right to receive, upon exercise, Common Shares (or, in certain circumstances, other securities, cash, or other
assets of the Company) having a value equal to two times the Purchase Price. Notwithstanding the foregoing, following the occurrence
of a person becoming an Acquiring Person, all Rights that are, or (under certain circumstances specified in the Rights Agreement)
were, beneficially owned by any Acquiring Person (or by certain related parties) will be null and void. However, Rights are not
exercisable following the occurrence of a person becoming an Acquiring Person until such time as the Rights are no longer redeemable
by the Company as set forth in Section 6 below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>&ldquo;<B>Flip-Over&rdquo; Events</B>. In the event that, at any time after a person has become an Acquiring Person, (i)
the Company engages in a merger or other business combination transaction in which the Company is not the continuing or surviving
corporation or other entity, (ii) the Company engages in a merger or other business combination transaction in which the Company
is the continuing or surviving corporation and the Common Shares of the Company are changed or exchanged, or (iii) fifty percent
(50%) or more of the Company&rsquo;s assets or earning power is sold or transferred, each holder of a Right (except Rights that
have previously become null and void as set forth above) shall thereafter have the right to receive, upon exercise, common shares
of the acquiring company having a value equal to two times the Purchase Price.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">6.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><B>Redemption</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">At any time until ten
(10) business days following the Shares Acquisition Date (as defined in Section 2 above), the Board may direct the Company to redeem
the Rights in whole, but not in part, at a price of $0.001 per Right (payable in cash, Common Shares, or other consideration deemed
appropriate by the Board). Immediately upon the action of the Board directing the Company to redeem the Rights, the Rights will
terminate and the only right of the holders of Rights will be to receive the $0.001 redemption price.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 71 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt; text-align: right; font-size: 8pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">7.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><B>Exchange of Rights</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">At any time after a
person (other than certain exempted or grandfathered persons) becomes an Acquiring Person, but before such person acquires beneficial
ownership of fifty percent (50%) or more of the outstanding Common Shares, the Board may direct the Company to exchange the Rights
(other than Rights owned by such person or certain related parties, which will have become null and void), in whole or in part,
at an exchange ratio of one Common Share per Right (subject to adjustment). The Company may substitute Preferred Shares (or shares
of a class or series of the Company&rsquo;s preferred stock having equivalent rights, preferences, and privileges) for Common Shares
at an initial rate of one one-thousandth of a Preferred Share (or of a share of a class or series of the Company&rsquo;s preferred
stock having equivalent rights, preferences, and privileges) per Common Share. Immediately upon the action of the Board directing
the Company to exchange the Rights, the Rights will terminate and the only right of the holders of Rights will be to receive the
number of Common Shares (or one one-thousandth of a Preferred Share or of a share of a class or series of the Company&rsquo;s preferred
stock having equivalent rights, preferences, and privileges) equal to the number of Rights held by such holder multiplied by the
exchange ratio.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">8.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><B>Adjustments to Prevent Dilution; Fractional Shares</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Board may adjust
the Purchase Price, the number of Preferred Shares or other securities or assets issuable upon exercise of a Right, and the number
of Rights outstanding to prevent dilution that may occur (a) in the event of a stock dividend on, or a subdivision, combination,
or reclassification of, the Preferred Shares, (b) in the event of a stock dividend on, or a subdivision or combination of, the
Common Shares, (c) if holders of the Preferred Shares are granted certain rights, options, or warrants to subscribe for Preferred
Shares or convertible securities at less than the current market price of the Preferred Shares, or (d) upon the distribution to
holders of the Preferred Shares of evidences of indebtedness or assets (excluding regular periodic cash dividends) or of subscription
rights or warrants (other than those referred to above).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">With certain exceptions,
no adjustment in the Purchase Price will be required until cumulative adjustments amount to at least one percent (1%) of the Purchase
Price. No fractional Preferred Shares will be issued (other than fractions that are integral multiples of one one-thousandth of
a Preferred Share), and in lieu thereof, an adjustment in cash may be made based on the market price of the Preferred Shares on
the last trading date prior to the date of exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">9.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><B>No Stockholder Rights Prior to Exercise; Tax Considerations</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Until a Right is exercised,
the holder thereof, as such, will have no rights as a stockholder of the Company, including, without limitation, the right to vote
or to receive dividends. While the distribution of the Rights should not be taxable to stockholders or to the Company, stockholders
may, depending upon the circumstances then existing, recognize taxable income in the event that the Rights become exercisable for
Common Shares (or other consideration) of the Company or for common shares of the acquiring company or in the event of the redemption
of the Rights as set forth in Section 6 above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 72 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt; text-align: right; font-size: 8pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">10.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><B>Amendment of the Rights Agreement</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company (by action
of the Board) may supplement or amend any provision of the Rights Agreement in order to (a) cure any ambiguity, (b) correct or
supplement any provision contained in the Rights Agreement that may be defective or inconsistent with other provisions of the Rights
Agreement, (c) shorten or lengthen any time period under the Rights Agreement, or (d) make any other provisions with respect to
the Rights that the Company deems necessary or desirable; <U>provided</U>, <U>however</U>, that no supplement or amendment made
after the time any person becomes an Acquiring Person may adversely affect the interests of the registered holders of rights certificates
(other than an Acquiring Person or any affiliates or associates of an Acquiring Person). Without limiting the foregoing, the Company
may at any time before any person becomes an Acquiring Person amend the Rights Agreement to make the provisions of the Rights Agreement
inapplicable to a particular transaction by which a person might otherwise become an Acquiring Person or to otherwise alter the
terms and conditions of the Rights Agreement as they may apply with respect to any such provision.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">11.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><B>Availability of Rights Agreement</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company intends
to file, on December 16, 2020, a copy of the Rights Agreement with the Securities and Exchange Commission as an exhibit to a Current
Report on Form 8-K. In addition, a copy of the Rights Agreement will be available free of charge from the Company. This summary
description of the Rights does not purport to be complete and is qualified in its entirety by reference to the complete text of
the Rights Agreement, which is incorporated by reference in this summary description.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>4
<FILENAME>e620138_ex99-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0pt">&nbsp;</P>

<P STYLE="margin: 0pt; text-align: right"><B><U>Exhibit 99.1</U></B></P>

<P STYLE="margin: 0pt; text-align: right">&nbsp;</P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; text-align: center"><IMG SRC="image_001.jpg" ALT="">&nbsp;</P>

<P STYLE="margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ADMA BIOLOGICS ADOPTS</B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>LIMITED DURATION STOCKHOLDER RIGHTS PLAN</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>RAMSEY, N.J. and BOCA RATON, Fla., December
16, 2020</B> &ndash; ADMA Biologics, Inc. (Nasdaq: ADMA), an end-to-end commercial biopharmaceutical company dedicated to manufacturing,
marketing and developing specialty plasma-derived biologics, today announced that its Board of Directors has approved the adoption
of a limited duration stockholder rights plan and declared a dividend distribution of one right for each outstanding share of common
stock. The record date for such dividend distribution is December 30, 2020. The rights plan expires, without any further action
being required to be taken by ADMA&rsquo;s Board of Directors, on December 15, 2021.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The adoption of the rights plan is intended
to protect ADMA and its stockholders from the actions of third parties that ADMA&rsquo;s Board of Directors determines are not
in the best interests of ADMA and its stockholders, and to enable all stockholders to realize the full potential value of their
investment in ADMA. The rights plan was not adopted in response to any specific takeover proposal, any current accumulation of
shares, or any currently threatened or pending effort to acquire control of ADMA of which the Board of Directors is aware. The
rights plan was adopted to provide the Board of Directors with time to make informed decisions that are in the best long-term interests
of ADMA and its stockholders and does not prevent ADMA&rsquo;s Board of Directors from considering any offer to acquire ADMA that
it considers to be in the best interest of ADMA&rsquo;s stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The rights plan is similar to stockholder
rights plans adopted by other publicly-traded companies. Under the rights plan, the rights generally would become exercisable only
if a person or group acquires beneficial ownership of 10% or more of ADMA&rsquo;s common stock in a transaction or series of transactions
not approved by ADMA&rsquo;s Board of Directors. In that situation, each holder of a right (other than the acquiring person or
group, whose rights will become void and will not be exercisable) will have the right to purchase, upon payment of the exercise
price and in accordance with the terms of the rights plan, a number of shares of ADMA&rsquo;s common stock having a market value
of twice such price. In addition, if ADMA is acquired in a merger or other business combination after an acquiring person acquires
10% or more of ADMA&rsquo;s common stock, each holder of the right would thereafter have the right to purchase, upon payment of
the exercise price and in accordance with the terms of the rights plan, a number of shares of common stock of the acquiring person
having a market value of twice such price. The acquiring person or group would not be entitled to exercise these rights. In the
rights plan, the definition of &ldquo;beneficial ownership&rdquo; includes derivative securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Stockholders who beneficially owned 10%
or more of ADMA&rsquo;s outstanding common stock prior to the first public announcement by ADMA of the adoption of the rights plan
will not trigger the rights plan so long as they do not acquire beneficial ownership of any additional shares of common stock at
a time when they still beneficially own 10% or more of such common stock, subject to certain exceptions as set forth in the rights
plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Further details of the rights plan will
be contained in a Current Report on Form 8-K and in a Registration Statement on Form 8-A that ADMA will be filing with the Securities
and Exchange Commission (SEC). These filings will be available on the SEC&rsquo;s web site at www.sec.gov. Copies will also be
available at no charge on the Investors section of ADMA&rsquo;s corporate website at www.admabiologics.com.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt; text-align: right; font-size: 8pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Jefferies LLC acted as financial advisor
to ADMA in connection with the adoption of the rights plan. Morgan, Lewis &amp; Bockius LLP is serving as legal advisor to ADMA.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5in 0pt 0; text-align: justify"><B>About&nbsp;ADMA Biologics,
Inc.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5in 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">ADMA Biologics is an end-to-end American
commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for
the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. ADMA currently
manufactures and markets three United States Food and Drug Administration (FDA) approved plasma-derived biologics for the treatment
of immune deficiencies and the prevention of certain infectious diseases: BIVIGAM&reg; (immune globulin intravenous, human) for
the treatment of primary humoral immunodeficiency (PI); ASCENIV&trade; (immune globulin intravenous, human &ndash; slra 10% liquid)
for the treatment of PI; and NABI-HB&reg; (hepatitis B immune globulin, human) to provide enhanced immunity against the hepatitis
B virus. ADMA manufactures its immune globulin products at its FDA-licensed plasma fractionation and purification facility located
in Boca Raton, Florida. Through its ADMA BioCenters subsidiary, ADMA also operates as an FDA-approved source plasma collector in
the U.S., which provides a portion of its blood plasma for the manufacture of its products. ADMA&rsquo;s mission is to manufacture,
market and develop specialty plasma-derived, human immune globulins targeted to niche patient populations for the treatment and
prevention of certain infectious diseases and management of immune compromised patient populations who suffer from an underlying
immune deficiency, or who may be immune compromised for other medical reasons. ADMA has received U.S. Patents: 9,107,906, 9,714,283,
9,815,886, 9,969,793 and 10,259,865 related to certain aspects of its products and product candidates. For more information, please
visit www.admabiologics.com.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Forward-Looking Statements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Any statements contained in this press
release that do not describe historical facts may constitute forward-looking statements within the meaning of Section 27A of the
Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements regarding
the anticipated benefits and expected consequences of the rights plan that ADMA has adopted. Such statements are identified by
use of the words &ldquo;anticipates,&rdquo; &ldquo;believes,&rdquo; &ldquo;estimates,&rdquo; &ldquo;expects,&rdquo; &ldquo;intends,&rdquo;
&ldquo;plans,&rdquo; &ldquo;predicts,&rdquo; &ldquo;projects,&rdquo; &ldquo;should,&rdquo; and similar expressions. Any forward-looking
statements contained herein are based on current expectations, but are subject to risks and uncertainties that could cause actual
results to differ materially from those indicated, including, but not limited to, the effectiveness of the rights plan in providing
the Board of Directors with time to make informed decisions that are in the best long-term interests of ADMA and its stockholders,
and other risk factors discussed from time to time in our filings with the SEC, including those factors discussed under the caption
&ldquo;Risk Factors&rdquo; in our most recent annual report on Form 10-K, filed with the SEC on March 13, 2020, and in subsequent
reports filed with or furnished to the SEC. ADMA assumes no obligation and does not intend to update these forward-looking statements,
except as required by law, to reflect events or circumstances occurring after today&rsquo;s date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt; text-align: right; font-size: 8pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>COMPANY CONTACT:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Skyler Bloom</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Director, Investor Relations and Corporate Strategy | 201-478-5552
| sbloom@admabio.com </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>INVESTOR RELATIONS CONTACT:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Sam Martin</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Managing Director, Argot Partners | 212-600-1902 | sam@argotpartners.com</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>adma-20201216.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.5c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: /KM5s7xRiXgOn8uFZXIsSaaFqcP9wZJ1uelBsG19famKHyYrpODt4i/yvg2mUf4C -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:srt-types="http://fasb.org/srt-types/2020-01-31" xmlns:ADMA="http://admabiologics.com/20201216" elementFormDefault="qualified" targetNamespace="http://admabiologics.com/20201216">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://admabiologics.com/role/Cover" id="Cover">
	  <link:definition>00000001 - Document - Cover</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="adma-20201216_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="adma-20201216_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2020-01-31" schemaLocation="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd" />
    <import namespace="http://fasb.org/us-gaap/2020-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd" />
    <import namespace="http://fasb.org/us-types/2020-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2020-01-31" schemaLocation="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd" />
    <import namespace="http://fasb.org/srt/2020-01-31" schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd" />
    <import namespace="http://fasb.org/srt-types/2020-01-31" schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>6
<FILENAME>adma-20201216_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.5c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInformationFormerLegalOrRegisteredName" xlink:label="dei_EntityInformationFormerLegalOrRegisteredName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInformationFormerLegalOrRegisteredName" xlink:to="dei_EntityInformationFormerLegalOrRegisteredName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInformationFormerLegalOrRegisteredName_lbl" xml:lang="en-US">Entity Information, Former Legal or Registered Name</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>7
<FILENAME>adma-20201216_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.5c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://admabiologics.com/role/Cover" xlink:href="adma-20201216.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://admabiologics.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInformationFormerLegalOrRegisteredName" xlink:label="loc_deiEntityInformationFormerLegalOrRegisteredName" />
      <link:presentationArc order="580" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInformationFormerLegalOrRegisteredName" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1" !$ -4# 2(  A$! Q$!_\0
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MW?\ \D5\/45V_P#$+N%/^@&'X_YG'_Q$_BK_ *#9_A_D?=.D_P#!>WXDPZG
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M[K\KO!7B;_A"_&&EZP+&PU-M+NH[M;2^C:2VN&1@P61592R$@9&1D<5^J/\
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M\'G/$%&&&P^5YDW1J3]DK<T>63Y=XM+3WKJU]GMI?UK_ (?L_&/_ * _P_\
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MT[2+EKM(=+MY85GD*[0TF^1\[1NVXQ]]LYXQX1L'H/RKZ&M_VZ?#MC;I#;?
M#X*>1"H2'[1I=Q-+L'"[W:8EVQC+$Y)R:X3]J75_A[XE\:Z9J_PYM6TJQU72
M8+G5-($<JPZ1J)R)X8FD)+1Y 88) W8'2OH.'TL#RY=1P#P]+5JSC*-]W?E;
MLW?2^CM:^U_ S^^-YLQJXY8BJK)W4E*VRMS)72ZVU6]M[7/V2_VR?&/[&7BS
M4M5\(G393K%L+6[M-0B>6VF"MN1RJ.AWJ2V#G@.P[UUG[5G_  4?\:?MB^!+
M30?%NB>#HXK"[%Y:W5A93Q75NX4J0K-,PVL#AACG /4"OH*R^#NI^'OAC\/_
M /A5_P"SW\._BEHM_P"%K&_U'7-0A6\N&U*56:YA:3SU^XVWY<?+G'; \4_;
M/\%V_AWX8V-QXA^"=Y\)?'\NLX:?3+:5= U*Q,'"J6E=$G5P/DCXQN8\G%?*
MX/,<BS+.H8QX2/UCFLI\]-U%RW2<H*?.E96>C:5DU;;ZG&9;GF79-/"+%R]A
MRW<.2HJ;YK-J,W'D;N[K5)ZM.Y\TP0FXG2->6=@H^IK]^?V1?@A!^SK^SEX3
M\)QV\<%SIUA&U]M4 RW;C?,QP3D[RW<\  < 5^!.G3"WU""0Y(216('L:_H1
MU;QZEQX6\-^(;9I(=,OY;>>42##B":([=P!(R"Z$\\8.,U^8_2BSR66Y7A*E
M9VH*4I3\K<B4GY14I-^29^@?1NR^E7QN,J+^*HPC'TES-_>XQ.MHHS17\RG]
M0A7BGQUU*3X?_&;0=>B<1)+$J3 $_.%8ALCT*L!^%>UU\V?M3:\NL_$Z*VA8
MN+"!(64'(WDEC^C ?A7\^_26S:.7<(1Q4':M&O1E2?53C+FNO^W5+[SZW@S#
MNMF#IOX7&7-Z-6_.Q])(XD0,.01D455T"VDL]"LHIG,LT4"([G^-@H!/XFBO
MWS#5)5*,:DU9M)M=KK;Y'RDTE)I'Q7_P7G_Y-0\,_P#8V0?^DEW7Y@_!+Q=:
M> /C/X0UZ_\ -^PZ)K=EJ%SY:[G\J*=)'VCN=JG K]L?V^?V11^V?\"#X7BU
M&/2M2LKZ/4K"YE1GB65%=-K@<[2DCC/."0<'&*_+GQ=_P23^.WA76Y+./P=_
M:Z)]VZL+Z!X9!DC(+,K=LX(!P1D"OZZ\&N*,DAPY+*L;B8TY\T[J4E'275-V
M3_3L?R;XQ<,9U/B*.:X+#RJ0M"SC%RUCT:5VOGH^YTWQ9\:_L]_%;XH^(O$\
MOQ+^,NGR>(=2GU%[6WTJ/RK<RR%RB9D^Z,X'TKE?VMOVE_!?C/\ 9]\!?##P
M2_B36M.\&75Q?MKNN*D-S<O.\K-#Y8SPN\?-NYP!CC-4/^'6WQZ_Z)WJ/_@7
M;?\ QRC_ (=;?'K_ *)WJ/\ X%VW_P <K[S!_P"K%"I1G/,XS5%W@I5J5DU%
MQ3]U1;M%M:MK78^&QD^)J].M3AEDH.LK3<:-6[3DI->]S)7:3T5SF_B+\:=&
M\4?L>_#7P/:_:_[;\*ZKJMY?;XL0^7<NACV-GYCA3GCBNK^$WQ=^%_C/]E_3
MOAM\1;SQ?X?_ +!UZXURTU#1;2&\6[\Z)8S&RN04*X)SR#Z]J@_X=;?'K_HG
M>H_^!=M_\<H_X=;?'K_HG>H_^!=M_P#'*[JN-X8G0]A',*<;5)5%)5J?,IR<
MFVKMK[35FGH^^IPT<+Q-"O[>6 J2O3C3<71J6<8J*2>B?V4[IK4ZKX1ZY^S3
M\"OB=H?C.Q\5?%77+[PQ=IJ5K82:-;0)=2Q_,B,^[@;@,_TKS;]GW]H#3O!G
M[;.C_$KQ!%-!IR>()]9O([5/->(2F1BJ D9P7QUK?_X=;?'K_HG>H_\ @7;?
M_'*/^'6WQZ_Z)WJ/_@7;?_'*QAB>&N6LJ^91J.K#V;<JU.ZCKHK62^)N]FS:
M='B3FHNAELJ:I3]HE&C4LY::N]V]EI<TM?\ #?[,.OZ]?7[^/?BO&]]<27#(
MOA^VPI=BQ ^?WKF/V:?C?X2_9@_:ZC\2VT>N:_X,LS>643,B07\UM/!)")"O
MW0X#YVY XZUJ_P##K;X]?]$[U'_P+MO_ (Y1_P .MOCU_P!$[U'_ ,"[;_XY
M51QG#SP]3"8C-8U:=2+@U*M2T35M.51:=NMR987B!8BEB\/E<J=2G)33C1JZ
MM.^O-S)J_D69/ O[+OF-L\?_ !:5,G:#H%L<#MSNYK"_:N^-7A+QGX&^'7@?
MP.VMWGASX=6=[#%J.K0)!<WTEW<>>_[M"0%7 4=">?:M3_AUM\>O^B=ZC_X%
MVW_QRC_AUM\>O^B=ZC_X%VW_ ,<IX?'</PQ%/$5LUC5=-MQ4ZU*R;BXW]U1U
MY9-:NVNU["Q&#S^IAZF'HY5*DJB2DX4:MVE)2MKS:<T8O17T.NB_: ^#_P =
M?V6_AMX'\?ZAXX\+:E\-DN88IM(L8;V+4!,RG?EF!7 1>,=2>378>$OVT?A]
M\%3J>M:=\5/CM\0]3_LNZL['1=?E*Z;)--$8UDFS*<JF[/ SW'(Q7D/_  ZV
M^/7_ $3O4?\ P+MO_CE'_#K;X]?]$[U'_P "[;_XY7E5L'PE5C*E+,8^SE*4
MN3VM+E]^7-))M.24FW>TK]FM#U*..XKI2C5CETO:*,8\_LJO-[D5&+:346XI
M*UX^J*__  3B_:*\._LM?M&KXH\4?;_[+&D75E_H<'G2>9)LV_+D<?*><US_
M .QC\>=*_9R_:%T_Q1K=C?:CI MKNRNXK-E6=8[B%XBZ;N"5W9P2,^M=1_PZ
MV^/7_1.]1_\  NV_^.4?\.MOCU_T3O4?_ NV_P#CE>UB<=PKB)XF=7&TG]8A
M&G/][#X8\UK:Z/WWKZ'BX;!\4X>&&A2P57_9YRG#]U/XI<M[Z:KW%IZEA_ G
M[+H<[?'_ ,6@N?E!T"V.!VYW5QW[6GQ \">-O$?AJQ^'FFSVFA^&- M](DO[
MFSBM+K6IT+L]U,D?&\[@I)))V9]!74_\.MOCU_T3O4?_  +MO_CE'_#K;X]?
M]$[U'_P+MO\ XY4X3,LAHXB.(JYLJCC>RE6I65]+VCRW=N]U\R\7@,]K8>6'
MI94Z:E:[C1JW=M;7ES6U[6^XZ*7XC_ ;XJ>%O#$^K:M\0?AQJ^CZ)::1?V'A
MW3+=K2_GA3#WI967=)*3\Q8;OE&2>M9WQJ_:#^'^A?LOW?PP\!WWB_Q9'K6N
MPZY=ZMXE@2(V'EQ[!%;H&8AVP,OQ\K,O.>,[_AUM\>O^B=ZC_P"!=M_\<H_X
M=;?'K_HG>H_^!=M_\<KCIRX8C5A.69QE&$E*,76I\J:=U_>=GM>3\[G74_UF
ME2G".6RC*<>5R5&IS--6>GPJZWM%>5CP"OV#_P""6W[36A?M/_LLVO@+4)8K
M7Q)X2L5TV>U\S]Y<6L8"PW48/7 VJW7#KDX#+7Y]_P##K;X]?]$[U'_P+MO_
M (Y6_P###]@;]I?X->.M.\2>&_!FL:7K&ERB6WGBO+;(/0@CS,,I!(*G@@D$
M8->/XFY?PMQADE3*L3C:%W>UZD&M4TXR7-K&2;3^_I8]'P[Q7$G"^;1Q]/ U
MI0>DTJ<[VNG=>[\2>J[[=;GZM^$OB^G@R^_X1SQ3(;:]LL10WC*3'=)CY6)Q
MP<=^A[D&N^3Q'I\E@;I;ZS:U7K,)E\L=OO9Q7RU\-OC=\7?&'A:'3?BU\ ]:
MOKB%2O\ :&@W=GEFXPWE23KL)Q\Q63''"X.!Z%/^R?!K5I%>6&HWMC]H"R+;
MWL'[Z $9VL0?O#Z5_F=Q#E7B-P3? X.A1S7#QNJ<HUX1JQBOA51WE&I962E[
MLY6O))W9_=629QD6?0]O>IAY[RC.E-*_6RDDU^*71V.B^)O[2VE>%;>6VTIT
MU+4.5W*3Y,1QUS_%VX''O7G7[/O@"Y^(7CIM:U$--:V<OGR/+D^?*>0,]^<$
M^WUKMO"_[(^F:=>1S:G?37X49,*+Y:L?<Y)(^F#7JNE:5;:)81VMI!';V\0V
MI'&N !7YAEOAUQCQAG^'SWC[DHX?#2YJ>&@U+71KF:<E:Z7,W*3=G'EBF?55
MLXR[+L)/"Y3>4YJTIO3[O^&7S+%%%%?U,?#!1110 4444 %%%% !1110 444
H4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>e620138_8k-adma_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="adma-20201216.xsd" xlink:type="simple"/>
    <context id="From2020-12-16to2020-12-16">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001368514</identifier>
        </entity>
        <period>
            <startDate>2020-12-16</startDate>
            <endDate>2020-12-16</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2020-12-16to2020-12-16">0001368514</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2020-12-16to2020-12-16">false</dei:AmendmentFlag>
    <dei:CurrentFiscalYearEndDate contextRef="From2020-12-16to2020-12-16">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentType contextRef="From2020-12-16to2020-12-16">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="From2020-12-16to2020-12-16">2020-12-16</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="From2020-12-16to2020-12-16">ADMA BIOLOGICS, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2020-12-16to2020-12-16">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="From2020-12-16to2020-12-16">001-36728</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="From2020-12-16to2020-12-16">56-2590442</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2020-12-16to2020-12-16">465 State Route 17</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="From2020-12-16to2020-12-16">Ramsey</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2020-12-16to2020-12-16">NJ</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2020-12-16to2020-12-16">07446</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2020-12-16to2020-12-16">(201)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2020-12-16to2020-12-16">478-5552</dei:LocalPhoneNumber>
    <dei:EntityInformationFormerLegalOrRegisteredName contextRef="From2020-12-16to2020-12-16">Not Applicable</dei:EntityInformationFormerLegalOrRegisteredName>
    <dei:WrittenCommunications contextRef="From2020-12-16to2020-12-16">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="From2020-12-16to2020-12-16">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="From2020-12-16to2020-12-16">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="From2020-12-16to2020-12-16">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="From2020-12-16to2020-12-16">Common Stock, $0.0001 par value</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2020-12-16to2020-12-16">ADMA</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2020-12-16to2020-12-16">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="From2020-12-16to2020-12-16">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140514549472776">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Dec. 16, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 16,  2020<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-36728<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">ADMA BIOLOGICS, INC.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001368514<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">56-2590442<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">465 State Route 17<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Ramsey<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NJ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">07446<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(201)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">478-5552<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.0001 par value<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ADMA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationFormerLegalOrRegisteredName', window );">Entity Information, Former Legal or Registered Name</a></td>
<td class="text">Not Applicable<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInformationFormerLegalOrRegisteredName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Former Legal or Registered Name of an entity</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInformationFormerLegalOrRegisteredName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>11
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MJ#(9BBJ6<%H@XLD@;6E6?;!/3K3G>1<W]T6NS>,)KM\,<'AT_@%02P,$%
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M?^:+X3]>?P%02P$"% ,4    " "HA)!1!T%-8H$   "Q    $
M    @ $     9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    ( *B$D%%U'ZO=
M[@   "L"   1              "  :\   !D;V-0<F]P<R]C;W)E+GAM;%!+
M 0(4 Q0    ( *B$D%&97)PC$ 8  )PG   3              "  <P!  !X
M;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%     @ J(204<\PHBUW!   >A$
M !@              ("!#0@  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+
M 0(4 Q0    ( *B$D%&#J:4#U $  #(&   -              "  ;H,  !X
M;"]S='EL97,N>&UL4$L! A0#%     @ J(2049>*NQS     $P(   L
M         ( !N0X  %]R96QS+RYR96QS4$L! A0#%     @ J(204:K$(A8S
M 0  (@(   \              ( !H@\  'AL+W=O<FMB;V]K+GAM;%!+ 0(4
M Q0    ( *B$D%$D'INBK0   /@!   :              "  0(1  !X;"]?
M<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    ( *B$D%%ED'F2&0$
M ,\#   3              "  ><1  !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%
3!@     )  D /@(  #$3      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.20.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>96</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="e620138_8k-adma.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://admabiologics.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="e620138_8k-adma.htm">e620138_8k-adma.htm</File>
    <File>adma-20201216.xsd</File>
    <File>adma-20201216_lab.xml</File>
    <File>adma-20201216_pre.xml</File>
    <File>e620138_ex3-1.htm</File>
    <File>e620138_ex4-1.htm</File>
    <File>e620138_ex99-1.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2020-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>17
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "e620138_8k-adma.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "definitionLink": {
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml",
      "http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml"
     ]
    },
    "inline": {
     "local": [
      "e620138_8k-adma.htm"
     ]
    },
    "labelLink": {
     "local": [
      "adma-20201216_lab.xml"
     ],
     "remote": [
      "https://xbrl.sec.gov/dei/2020/dei-doc-2020-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "adma-20201216_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.sec.gov/dei/2020/dei-ref-2020-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "adma-20201216.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd",
      "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 60,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2020-01-31": 3,
    "total": 3
   },
   "keyCustom": 0,
   "keyStandard": 96,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "ADMA",
   "nsuri": "http://admabiologics.com/20201216",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "baseRef": "e620138_8k-adma.htm",
      "contextRef": "From2020-12-16to2020-12-16",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00000001 - Document - Cover",
     "role": "http://admabiologics.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "baseRef": "e620138_8k-adma.htm",
      "contextRef": "From2020-12-16to2020-12-16",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://admabiologics.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://admabiologics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AnnualInformationForm": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
        "label": "Annual Information Form"
       }
      }
     },
     "localname": "AnnualInformationForm",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://admabiologics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditedAnnualFinancialStatements": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
        "label": "Audited Annual Financial Statements"
       }
      }
     },
     "localname": "AuditedAnnualFinancialStatements",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://admabiologics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://admabiologics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://admabiologics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://admabiologics.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://admabiologics.com/role/Cover"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r9",
      "r11",
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://admabiologics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://admabiologics.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://admabiologics.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://admabiologics.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentPeriodStartDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.",
        "label": "Document Period Start Date"
       }
      }
     },
     "localname": "DocumentPeriodStartDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://admabiologics.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://admabiologics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://admabiologics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyEventDate": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of event requiring a shell company report.",
        "label": "Document Shell Company Event Date"
       }
      }
     },
     "localname": "DocumentShellCompanyEventDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://admabiologics.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://admabiologics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://admabiologics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://admabiologics.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://admabiologics.com/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://admabiologics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://admabiologics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://admabiologics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://admabiologics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://admabiologics.com/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://admabiologics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://admabiologics.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
        "label": "Entity Bankruptcy Proceedings, Reporting Current"
       }
      }
     },
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://admabiologics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://admabiologics.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://admabiologics.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://admabiologics.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://admabiologics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Elected Not To Use the Extended Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://admabiologics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://admabiologics.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://admabiologics.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://admabiologics.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInformationFormerLegalOrRegisteredName": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Former Legal or Registered Name of an entity",
        "label": "Entity Information, Former Legal or Registered Name"
       }
      }
     },
     "localname": "EntityInformationFormerLegalOrRegisteredName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://admabiologics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://admabiologics.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPrimarySicNumber": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.",
        "label": "Entity Primary SIC Number"
       }
      }
     },
     "localname": "EntityPrimarySicNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://admabiologics.com/role/Cover"
     ],
     "xbrltype": "sicNumberItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://admabiologics.com/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://admabiologics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://admabiologics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://admabiologics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://admabiologics.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://admabiologics.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://admabiologics.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_Extension": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extension number for local phone number.",
        "label": "Extension"
       }
      }
     },
     "localname": "Extension",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://admabiologics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://admabiologics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://admabiologics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_OtherReportingStandardItemNumber": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
        "label": "Other Reporting Standard Item Number"
       }
      }
     },
     "localname": "OtherReportingStandardItemNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://admabiologics.com/role/Cover"
     ],
     "xbrltype": "otherReportingStandardItemNumberItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://admabiologics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://admabiologics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://admabiologics.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_Security12gTitle": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(g) registered security.",
        "label": "Title of 12(g) Security"
       }
      }
     },
     "localname": "Security12gTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://admabiologics.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://admabiologics.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SecurityReportingObligation": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
        "label": "Security Reporting Obligation"
       }
      }
     },
     "localname": "SecurityReportingObligation",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://admabiologics.com/role/Cover"
     ],
     "xbrltype": "securityReportingObligationItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://admabiologics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://admabiologics.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://admabiologics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 3
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r10": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r11": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r12": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r13": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r14": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r15": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r16": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  },
  "r17": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  },
  "r18": {
   "Name": "Securities Act",
   "Number": "Section",
   "Publisher": "SEC",
   "Section": "12"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "g"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12, 13, 15d"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r6": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r7": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d"
  },
  "r8": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r9": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>18
<FILENAME>0001193805-20-001546-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193805-20-001546-xbrl.zip
M4$L#!!0    ( *B$D%%C?1#80@,  )X,   1    861M82TR,#(P,3(Q-BYX
M<V2U5MERVC 4?6YG^@^JWX4P65H()).&H:4ARX0FD^:E(V29:")+CB2S_'TE
M+T# ,$!:/\E7YQS=*YTKNWDVB3@84:69%"W/KU0]0 61 1/#EG??A^?]BV[7
M V>GGSX"^S0_0P@ZC/*@ =J2P*X(Y0FXQA%M@.]44(6-5"?@ ?/$162'<:K
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MP2() @C8E\G$-4.E%"FMOWQ;#<N61AGEKC"PVM( - J#Z'J;H]9 T.AQKY/
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M#36O:>K3!\'40),F6458\S2\"$0RTG]FIGJJ?W@!V! Y7C=;#!K+YIHB"%)
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M2^TK@IZ_KF^Z$I_$9KU)_%KAC(@M_P502P,$%     @ J(204?:\[\UW!P
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M9]@;DG!!SE/3W*)^&U@5]3@$)OFB$MBCL2,D8XSGRTP@YPR\R#>F)-3<4_O
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MB[N \1[Y-,#U(/N2 JZ+E?.T//P!CA$+?DW>^HM1^E4J9PC]+,M+032"X:;
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MJ0Q*U7'B10ZBMXT*@8,$!UP\T%R<%'?2:F-='EEZ2IJAY@__K:%0#P!&$$,
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MFMX 1K%" [ZR=:MS!BIQA5$Z8WJZR<\-^BNP2*H.\ZG''GD9GC'@%1K1JQ+
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MSB=QNUYKUH?AJ+(_P](R4\7?1"[>H').@5I[+ /+AA&I&SZV#]^UV4L;Q-[
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M:]7!<9<:*UWQJ[_3%KQYVB60DM>Y_(6,8(08OI(18>I3KO@F*GRR\OX*V97
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M0^I:K1V,UUZBLH<L0=RQU?034G#[G"#0)Z-*8.IQB'7 IG]+U87=B'36(5S
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MCQ-7CJ! TK$@U,]%52S*3L)0)89!)$EQL\+7#ND$A_3HR.)_#V-1J#<%S$V
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M6U$9JI+;5V:?2XGND^EX=)?IN(U,QZ<^7)_#<,>W>W<4]+!6J"#,88=:L1S
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MZ'BD,G^ZR!>_@F!]]'"HO*LI:/F=_3#T8OB$6XS8^C5TPMI;AM-\;L:3D"P
M[B 9?03^(ZQ3;AE%B/4L5I+B:+"Z!@R=E)'C8!GN(AY9GS<8 A?3K%=&9HV^
M2_P+&)FYB8D:\4.6=2 JAJIR!LWB-,0_NS.D76?*"]$8F4R)<UNJ[,RO"=WZ
M('(QZ%F<>UQ>#3XTK%W!,-,.BHY4JJ "Z+\O""D636+Z?O)VR\6AF(8_2"XK
MW#K*Z_.($,^'+=O:,F[RQK;4)$003Y8 J[>\"]%HRK/#:,O&<.L%!6=!I>%X
M-+1JUZP:'EP4GP\D/JG^=EQS5H.UDVX:H1]_@ 2CGU9,ZCI)#%Q5%IV<>EA@
M2RK"<66_S#DXFJF-U&',T51-Q\P?Q(AN*%\O!'K=%=%TX6?3O;WGZX?7M_O.
M5CY'L((4@1[X7I';U'#6ZC UW60=99BFR?9R4@HH8R4ALFR@DSW/UMD<EB>-
MUIDCD9 ^S$RJ<MU]/+K#W[,1F.Q($PNE$6(A7UC=^/FD0>QS0,/83B^\>$T0
M6U!CC"7-?7CMT%A\;'=PW@<HEW!LJZ(YX_ D'UU56@<7T&H_35-I:8B(LM3-
M=D*XAT*7JNX34TW-,G$HW\8[41\CS+T&-\ -1$)5"46J@K3!!PX@"'A1S)A2
M2&"M+E(' ]"OHD)U/K61>F_G6%"\>(W!T4(6:\N"ZZBRE(R#61:N2M);E&,1
M'(S6/_M2(AW##-=[EXB X@"5M&SMK?9K\RDI*&QNG)?(-\LKCSX;CBEHM:XH
M3"[DB H[]@F[?G?88=='=V'70SU=D_,O41#5[Y(75==<#1)X)DB'9,G0P4O#
MKQ3X%5NY[S%;P^\4_SG^ZH@DS!=59A$[#XJ\8@NE:YY=:;AUEKP!O[&!W\)D
M-A7]%9E#Z1\F.CS+JG><YH75ZS;"8R]Z[4TG9;2X.O]3-^\8R>K4%II',UC^
M3*@SEMDE SC W*8 *XE>5(M(Q7541^Z/+_S(7<%>1K@$;)A4W MKKC_EXE9!
M;TE9Z\]7]_ Q7"AKJ+0,:1<V[A%,;,I1+$.%+[3UMEYV5>><,Q!^47JVKKBE
M_SVFT_7NP$]7Y$3U>J=X=:\LP1B"2 =#';=O?GSP(%G?7]U/G2!ZAA@RJ:LQ
MB23X6A_D B.)%4P87":]JY1 M\<2E&)I][5&04%_V"L&Z144+G&-8N"1QW1"
MEP=^0O<XK=PTIIP7?H6VCR8.3J[BIZ"JLZR%XY 1[@L>E$HQ5I-<X@$+4D-7
MEA",R,!,-I6^WF7O8,G6X+L4ZL!+UZ,,6YXK.CD9^ZQD<9RU[XJ<!]"&(S!X
M,W!/RS66^G0--3G&;7]7=,Y0"&#-PF:&GSXN0J#5 9[KV/G5F9PM:MSAHN?\
M#<)$IYC6%]3 _WIP_\&#!R>8->)/IR%B&D. *JKNGIBM,2P2AUE39% ?+4%:
MF-OCV$\-/0:#@G,JMT.$)<GQ<,:&;%-/>6L"V;5"",KT?+X9NV"]27F4D43H
MUA'E.O)\PN67@. :-%!C(314A>I%I6V@4?[D&.ZE=18]@"QI4_=I.&TX-I55
M&:-;*3"N!G5,E[,ZP,NYYT6EX_0"-A]N':)$/Y;&ZRAYO.HO<O^#5J'79R;B
M!G96,&8:2V&,875&D#T!RQ^/[WRLO\#S076U7?)/ML=Z]N@U94-^C-O^YY>[
M[?^%-MB=+OB 36\.?-.#K8<]_[^OB[9H+L"?^G\);OD1;5;[96V6NZ<1,/&V
M"'V/Y!IM?XV#XFH<)M[\-KMW$JD.%7X2#F-)@Q.\]>RN"0Q<$-_L<S$>_PKE
MA'4OI#&*![%"O"$&P@AB17@6;,.,).C">M*5,R1?,F$ ]U><I?3(HH@#3!RQ
M#VMXH&F=53-Z@N(;U'D5@QP4CLB:?%EP1:ZIPT/^!.&3%H0V#>"J9?R1.%5"
ML&*0Y&Y81&/K?[]L#?N-0))2;HA%F#&A=R1 ?BH@>2Q9;^K-V3GLS1)VK%%T
M()JAG.6KQW-^7N1G!FQ9P,#K53FWP>^%/[ C$LG[)/J_/^Q$_S=WB?Y#/5V3
M[HO0(<.:)*2NV99\"W,I)I!K^E"#A"-*GD1:-N+?D)/_'(D1NO/I>*13'03)
M(ZF$D+N&DR*9;1^MRG%Z23="U%H:LPR^\D?-DE$W11CDZ,&T2"==7\+F+63C
M"K$0MI&W9$,"3W^J('G<2EO*D,+)>FF=WG-0G08/HI=BP=:BEC(XU?-;^BUL
MW0;U<09.DD(:'!<EAS[?)M XJ6G5-38A%V@ U_ZL5H5ISR65@L/]N^1+W/+"
MY%-<I;\", 3(ZRF'/_E=R41QX1DO"#FJR'1ZE-\[)8:G#R.(9!,KU;V1SV^V
MK^TPU4;*-8!"]+'8+(DI8+-:9>99'#7GG1*8<.DU]=V^B-M!L67C2.(IE&Q,
M,HF%FT96MBK(<)GY47H/Z6R ]JA5]^.SH]YUO$+$LA6PD6#ZR;2_R;?3GO4.
MNMS?JHZ0A;&89<D9TL K'I/^IG$5%=^S%>6.%VC2%PV>.JP8P7/$0;CYDA@3
MA"&,!$-M&[W/.6N,Q! XA90?PBD%3HMK/Y^&Q,]CY@'+%)Y*KS-;;:ED"L'#
MX-!'_\AH?;\ ,Z,N/:9;K>OM0YUVCLA^G6P.W,*(6!4NHQ#B_SXFPS [QH#2
M%U.[KW9?$4KMU_+'HZ#BWC^/CK7WS^5GW_#QJ/^[9'B77S7UNFBZ:R>3+ GF
MH\D"7(/CN]KO/_M.?_C5?HUVX4?L^%$F J^^Y T'LVU=?@Q&@.[Y$>[ZO[[$
M75>^VX *-P$>RVA!3@7Z:V_ ;"]S*HT.62\X;$T-,TVQ,T&:P->QO!GK)2Z$
M_3L7M7;T:P=80FZ!HFK9.P77[JS)5N1C:,*]$#!F>W-Q+UT[3C!!4G+XE#<K
M#'L!.<&"*[7#9DE,@&I FN@?\22&!M9$Z!+&H\7&%COO?HBTS45*/(TF:\[@
M!OZ+^CZMUS5&.W*_F6BOH[1B00H7Y8:FFV\:$\R@N)'7YW?N4BGCD:FD/R;Q
MD&4')1\&4L-'EAF>'4H[U:AP7I=-MB5@OY\Z_NXX;;#YP?=6_87(]N]V^1/G
M?'\X[)SOMW<YWT,]79/\4#KW1J3'UJ33@"G_"MD43Q\]P(K=&5$K/DW^NLJS
M]OSQCMP5$33?1?'Z1Z0X^/:T?P,#/5]DQ/R1;W?UE(.!7&2&G?H:Y'*&PUIH
M NE4B'M&+H%J:>8GUFXP^ZDYDV!2LA)A+O*QF?]^*</K<>W!&(2_G.!SG/;*
MDMA6>)U4P=LM8HG3!#F(KI<N'H^ND2^^YNQDO):6W)"G2;$?NH5$=X05?QHD
MD X2:!*55,Y]Z>!OOC/N)9Q]]BH3G- $2B%A(HQ!E82;7*NW9-KQ)94OQ9!Y
M0/RDOV0"(5*KE9=$TXO$>_1SNUZ6'0(0L9T;9MSU;]O-##_?2JJS+4%>9(V&
M^0F@K^_&EZ9D$G= $:VK;B3^ZA'7,M6+Y9QI[6"B3!T&-A+^KPG7<&59QH$+
M:M:%>>[@_<@-#ZZ\X;/#EG+,<4?:XVM%;T=CL8WG;#LZZ878ZHF[>C35(=&?
M1C",L"-1&$8RVU!6:'PA))9#%R8*);!1B35)N9T7F@K#2G1_ LY@#LYTS&1M
M4M@7,!%">FJB9=77S_)0]]<FV;(T*0>!;F:3QB-OE_ %34G'+2#I;/3?>)DV
M%3X[[$ 1?&@@@"?KK:)&XU%L8<U9BB^M*VVVHU1#8TC4Q6[!8)N+C$<,>G(K
M.,5+MO1#6).=@G$JE<L],4=GJ:@,-RHBM/XR511U#,$(6*4#RN)CLJH6A]N-
M_:ZD@@GX#H6!+V+Q_IJU>?:GM>]@8Y2-BT@J_H!4Q7+IVS'=KO-#(2V+[=W_
MO'FQ!4MBN5&DHED\T6/:O0-K4[EC/X<;G%X/%<;MJ8XPQ#GYXW"YONYT(=-E
M'0I?UGCTU__X_O3A#X_OM@4YH@Z7)"HF**WS2;R(JX]!X!PI_\+J$[,G\=TR
M_[-].W?&6;&9Y469;[)EBK&\50J><K.N.15(#$F='(C45LPNRVQ6+K'T9FZ
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M4[V)NY[6I.K:4BC@ Z(5&SO/6I^2O &_$M3I;'GEPOZMVT;S,?X^+L;BBO(
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MF&2<>2 EUOSP>_PKGUZJLL28)?G^8K3+B8*G%\NV8*U*%\<GU:V*4A+P<.K
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M^F$S(5D\KS?+G.(#M1A"MUVZ^=GS#S'4P7ADLQ)(EG+#L /\OF'NZF5_+ Y
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M4H,ORE3*%4Y<=8%#P:[1_NTZPZEKA<JV*L!8ZP*?MR"XXKWE<7W7;5ICR"U
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M;3L<S+DA-3LVG26X@\@9154W="GD*@0Z41 8$W4S=)'V=/ $6N&EJNW4":Q
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M<C3)<@XWYJ^UUY>)0B7A<SJ'@Z8D[SMY6.L>9F2\K7!-DZU@'4?D[,K5JF!
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M>T]4QXXX8;P2_F +=F"WSN%>Q(H5%(^ ?WWPG)C" M0-3Q<HL+FS)-EM5&?
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MVO/4PJLBS2EM5)U06C:L'@/TWVAP.0ECRUZX>T=PV8_D^CN,DX4E;#W7?,N
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M:[/\>,PLO[\DB])D,!\!LF=05C5#//M]5""% B5.P:-4-8'P&(OM$8T2YGO
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MR>!GNKW24J]#BYX7-;.?.01G>N/A#Y *2OS=[".JQ?BV]_?@;=]ZA.42-S.
M&14<#X\PU=TNQ3^FC HMO:R[NQ5*^/90_C- R%(NNT!@8B6<5>5D."JDU3AC
M'76;RJ8F6 D.$9\01RCP;VX.(C,*][I-MBV8E#U+[58%"?0::8V5Q$#Z6#9?
MI,DZF#%$OV9_TV),E$/6S4V%3,52HO%:Q[49#O?JF97OUCRSLO>865G7_?6
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M8<?3A!V\= ')H,*1>.U775>?(;<TL":M2\>4PX9]BCT(//;3AIUJ%;^575Z
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MU"O_8#+ONY/O7R+08)^RM;=]8V<C^9^XJ?"_B.=>^"4!F1 I5XX&$HE@QHW
MMP.<$R 5+[+1D,'?EOP(!#2 ^K(H Q-B_^Z8CZH)T/L9!OTGV05/MID]:3 '
M3Q\6YUJ7B_7 ;?PX*:]&^> \MR7WZB"EYB0!SI8*!F?)_\2M[_]-!L6@?8_
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M-R,"2C! Q!Q+];-J5* U]1@N6$=[.9I30SO8+.-%LK6W.[O8=E\.C.JPY Z
M":\PH:&TRB"'? @$&;N=AF+!E$7?:8IQ]J\2*J-%@5)*=DD<$]TYEOB@1*[
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M1F\#1<F,5H! A>3< GW)AAVMIP\:FMPLO]2\-!M8B[EOSG=)1W1: 3"H3T0
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MLVLIM>EVMIY%*K'X=K9N3 0_$'%6"!"?&LF$>.8:.%<A*\DD%!4\K$63;1&
M1\OD;@>UV;3*+XMR7H^N9>-XDM 7+5FOO,RW&?-\*[THG*%<O2_E/G:C]GDY
M;Z79-D+,L<'X_$'[."=&EXT1:K9YCLN^$M^,.<NA+\?>KE]$4P?V14OY5#M5
M'YW65!7+0MDM53=ZL@O/*Q@7'J>=))",N36?H4CG-!(W[G!T$\!Q0107+&V8
MI!=-7K1D PBF%=Z2B"1!*X4!7H>X:S?^;:,.%6K3YN%<E;";*DU3UN[_MW=M
M+6X;4?C=X/^@ET(-:M/M2U,"A;1I*+2E2[(0^BA;LCU$LHRD79)_WSF7.7-&
M,TJTFT!WD5]]T6ANY_J=[T0S56961#I"+*U8*B*R'VF 2+KQ,"I/,.81$O&'
M/^3EZ>3(T\HM+"8S*W1_=0G=7T+W#QWYIR>M$7_WU6&+#=R_C!V;]2I1;>E+
MCT&BDL$-J+5R7Z!1*A#OS:?#/J#7&'NM@>"NG'H:@Q)8\EG2D)^LF9^GCP6L
M[W63-1'4&CB$M0M^C #P$_&.G%TA5%5HM:>,_DV>0H\ Y^^ '<:DD #4MN,U
M#MB(E2V@2L8]TIN9_=V$81WL[ZA+637FA.JIG-B[#$6VJXN^)Z ,,G-->$^J
M"0(R3K!7816.L7X%EE^P"7 6TMX^=_S(=Z:N#DGZ8+<2YF3M,.N8=%QA/)MM
MJ^U&#&/WG])Z]45SB@FH[V]:A:&$]*F-*=V^IG&U7DU!P7")9V['_[\;WK\-
MT&T\]Z-5Z7+'V;EO;NO!G&LC7*@0FM3W<F'VY?,GK?U?BF1$#-)U1_&^5Z9&
M\-"+['5'-Q&Z,TB;E&7M\$V@-DF7D 0*PT#YZ!)%VD2\3X6MI0HQ"+5]ME@J
M%[E%8Z!*<NI8:7UL&$+[6/(^4C($7I\( P!^8'2 E\002A+?-^"4$W#?:DCX
M$(KZ<AWM)!*+KD*91< QDMFT$N/Y$WCA0<,2^M^'67F($40X1QR#V6LIGGH1
MC)EBM8']2 P6%I>Z$%$*%)%K9TN97M3*UU[^^LVEVL<!FZ"J+;8KCSP[0MA!
MZ1K8C^Y]-?AX1GK1((Q;;KQF#)HN 4KX<[.UGWM>:6#RL<=[:Z=.B$$Y?Q"J
M96*C#H'46-MBVM+L,)@B.T35GP@+WDH7FO6J\Z5W;ME"IA( *P:)<0P3+4Q=
MO(/:H9C"R%ZED[93W34))8P8(UWE(.$8Q]O=-@A\OZO4(WI&<.-2PQ$L 'IT
MJA3GUC?"\G(M9*Z2J\WV7O1'9\J]")=*ZHUV?_,96"P".$ ]!AL/= Z35I*U
M<,>C,4;)KHBU.FXI_ \"("SAY)"?8_AKBA*Q[IYJ:\YMRUIFQ:EAL8:NP.N
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MA*+3R#T9 "8Z9!=$U!I2:YY9&0?\/BR-H3-D&)9)&4MO' 02118YI%E=%R_
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M+"WG1%:&YX9_<2+JGY416S6D.^FO!J13X%V"97WO&$K_48UWJFOBX-1M6%X
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M-GM*']>[K^WIH_S_ E!+ 0(4 Q0    ( *B$D%%C?1#80@,  )X,   1
M          "  0    !A9&UA+3(P,C Q,C$V+GAS9%!+ 0(4 Q0    ( *B$
MD%&3?GLR-PL  (R*   5              "  7$#  !A9&UA+3(P,C Q,C$V
M7VQA8BYX;6Q02P$"% ,4    " "HA)!1]KSOS7<'  #T6@  %0
M    @ ';#@  861M82TR,#(P,3(Q-E]P<F4N>&UL4$L! A0#%     @ J(20
M42GEWW:.*P  8?(  !,              ( !A18  &4V,C Q,SA?.&LM861M
M82YH=&U02P$"% ,4    " "HA)!1W#EJ@W0=   =N@  $0
M@ %$0@  938R,#$S.%]E>#,M,2YH=&U02P$"% ,4    " "HA)!1IAI Y)+\
M  !OAP8 $0              @ 'G7P  938R,#$S.%]E>#0M,2YH=&U02P$"
M% ,4    " "HA)!10B6WM:L-  ";+P  $@              @ &H7 $ 938R
E,#$S.%]E>#DY+3$N:'1M4$L%!@     '  < Q $  (-J 0    $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
